id	sid	tid	token	lemma	pos
dpc-5027	1	1	dermatology	dermatology	NOUN
dpc-5027	1	2	:	:	PUNCT
dpc-5027	1	3	practical	practical	ADJ
dpc-5027	1	4	and	and	CCONJ
dpc-5027	1	5	conceptual	conceptual	ADJ
dpc-5027	1	6	original	original	ADJ
dpc-5027	1	7	article	article	NOUN
dpc-5027	1	8	|	|	ADV
dpc-5027	1	9	dermatol	dermatol	ADJ
dpc-5027	1	10	pract	pract	NOUN
dpc-5027	1	11	concept	concept	NOUN
dpc-5027	1	12	.	.	PUNCT
dpc-5027	2	1	2025;15(3):5027	2025;15(3):5027	NUM
dpc-5027	2	2	1	1	NUM
dpc-5027	2	3	serum	serum	NOUN
dpc-5027	2	4	zonulin	zonulin	NOUN
dpc-5027	2	5	and	and	CCONJ
dpc-5027	2	6	its	its	PRON
dpc-5027	2	7	role	role	NOUN
dpc-5027	2	8	in	in	ADP
dpc-5027	2	9	rosacea	rosacea	NOUN
dpc-5027	2	10	pathogenesis	pathogenesis	PROPN
dpc-5027	2	11	:	:	PUNCT
dpc-5027	2	12	a	a	DET
dpc-5027	2	13	comprehensive	comprehensive	ADJ
dpc-5027	2	14	estimation	estimation	NOUN
dpc-5027	2	15	study	study	NOUN
dpc-5027	2	16	fatma	fatma	PROPN
dpc-5027	2	17	h.	h.	PROPN
dpc-5027	2	18	shabaka1	shabaka1	PROPN
dpc-5027	2	19	,	,	PUNCT
dpc-5027	2	20	laila	laila	PROPN
dpc-5027	2	21	a.	a.	PROPN
dpc-5027	2	22	rashed2	rashed2	PROPN
dpc-5027	2	23	,	,	PUNCT
dpc-5027	2	24	mona	mona	PROPN
dpc-5027	2	25	s.	s.	PROPN
dpc-5027	2	26	ali3	ali3	PROPN
dpc-5027	2	27	,	,	PUNCT
dpc-5027	2	28	aya	aya	PROPN
dpc-5027	2	29	a.	a.	NOUN
dpc-5027	2	30	salama4	salama4	NOUN
dpc-5027	3	1	1	1	NUM
dpc-5027	3	2	department	department	NOUN
dpc-5027	3	3	of	of	ADP
dpc-5027	3	4	dermatology	dermatology	NOUN
dpc-5027	3	5	and	and	CCONJ
dpc-5027	3	6	venereology	venereology	NOUN
dpc-5027	3	7	,	,	PUNCT
dpc-5027	3	8	faculty	faculty	NOUN
dpc-5027	3	9	of	of	ADP
dpc-5027	3	10	medicine	medicine	NOUN
dpc-5027	3	11	for	for	ADP
dpc-5027	3	12	girls	girl	NOUN
dpc-5027	3	13	,	,	PUNCT
dpc-5027	3	14	al	al	PROPN
dpc-5027	3	15	-	-	PUNCT
dpc-5027	3	16	azhar	azhar	PROPN
dpc-5027	3	17	university	university	PROPN
dpc-5027	3	18	,	,	PUNCT
dpc-5027	3	19	cairo	cairo	PROPN
dpc-5027	3	20	,	,	PUNCT
dpc-5027	3	21	egypt	egypt	PROPN
dpc-5027	3	22	2	2	NUM
dpc-5027	3	23	department	department	NOUN
dpc-5027	3	24	of	of	ADP
dpc-5027	3	25	biochemistry	biochemistry	NOUN
dpc-5027	3	26	,	,	PUNCT
dpc-5027	3	27	faculty	faculty	NOUN
dpc-5027	3	28	of	of	ADP
dpc-5027	3	29	medicine	medicine	NOUN
dpc-5027	3	30	-	-	PUNCT
dpc-5027	3	31	cairo	cairo	PROPN
dpc-5027	3	32	university	university	PROPN
dpc-5027	3	33	,	,	PUNCT
dpc-5027	3	34	cairo	cairo	PROPN
dpc-5027	3	35	,	,	PUNCT
dpc-5027	3	36	egypt	egypt	PROPN
dpc-5027	3	37	3	3	NUM
dpc-5027	3	38	department	department	NOUN
dpc-5027	3	39	of	of	ADP
dpc-5027	3	40	dermatology	dermatology	NOUN
dpc-5027	3	41	and	and	CCONJ
dpc-5027	3	42	venereology	venereology	NOUN
dpc-5027	3	43	,	,	PUNCT
dpc-5027	3	44	faculty	faculty	NOUN
dpc-5027	3	45	of	of	ADP
dpc-5027	3	46	medicine	medicine	NOUN
dpc-5027	3	47	for	for	ADP
dpc-5027	3	48	girls	girl	NOUN
dpc-5027	3	49	,	,	PUNCT
dpc-5027	3	50	al	al	PROPN
dpc-5027	3	51	-	-	PUNCT
dpc-5027	3	52	azhar	azhar	PROPN
dpc-5027	3	53	university	university	PROPN
dpc-5027	3	54	,	,	PUNCT
dpc-5027	3	55	cairo	cairo	PROPN
dpc-5027	3	56	,	,	PUNCT
dpc-5027	3	57	egypt	egypt	PROPN
dpc-5027	3	58	4	4	NUM
dpc-5027	3	59	department	department	NOUN
dpc-5027	3	60	of	of	ADP
dpc-5027	3	61	dermatology	dermatology	NOUN
dpc-5027	3	62	and	and	CCONJ
dpc-5027	3	63	venereology	venereology	NOUN
dpc-5027	3	64	,	,	PUNCT
dpc-5027	3	65	damanhour	damanhour	PROPN
dpc-5027	3	66	medical	medical	PROPN
dpc-5027	3	67	national	national	PROPN
dpc-5027	3	68	institute	institute	PROPN
dpc-5027	3	69	,	,	PUNCT
dpc-5027	3	70	cairo	cairo	PROPN
dpc-5027	3	71	,	,	PUNCT
dpc-5027	3	72	egypt	egypt	PROPN
dpc-5027	3	73	key	key	PROPN
dpc-5027	3	74	words	word	NOUN
dpc-5027	3	75	:	:	PUNCT
dpc-5027	3	76	rosacea	rosacea	NOUN
dpc-5027	3	77	pathogenesis	pathogenesis	NOUN
dpc-5027	3	78	,	,	PUNCT
dpc-5027	3	79	dermoscopy	dermoscopy	NOUN
dpc-5027	3	80	,	,	PUNCT
dpc-5027	3	81	zonulin	zonulin	PROPN
dpc-5027	3	82	biomarker	biomarker	NOUN
dpc-5027	3	83	,	,	PUNCT
dpc-5027	3	84	gut	gut	VERB
dpc-5027	3	85	microbiome	microbiome	NOUN
dpc-5027	3	86	in	in	ADP
dpc-5027	3	87	rosacea	rosacea	PROPN
dpc-5027	3	88	citation	citation	NOUN
dpc-5027	3	89	:	:	PUNCT
dpc-5027	3	90	shabaka	shabaka	PROPN
dpc-5027	3	91	fh	fh	PROPN
dpc-5027	3	92	,	,	PUNCT
dpc-5027	3	93	rashed	rashe	VERB
dpc-5027	3	94	la	la	PROPN
dpc-5027	3	95	,	,	PUNCT
dpc-5027	3	96	ali	ali	PROPN
dpc-5027	3	97	ms	ms	PROPN
dpc-5027	3	98	,	,	PUNCT
dpc-5027	3	99	salama	salama	PROPN
dpc-5027	3	100	aa	aa	PROPN
dpc-5027	3	101	.	.	PUNCT
dpc-5027	4	1	serum	serum	PROPN
dpc-5027	4	2	zonulin	zonulin	PROPN
dpc-5027	4	3	and	and	CCONJ
dpc-5027	4	4	its	its	PRON
dpc-5027	4	5	role	role	NOUN
dpc-5027	4	6	in	in	ADP
dpc-5027	4	7	rosacea	rosacea	NOUN
dpc-5027	4	8	pathogenesis	pathogenesis	PROPN
dpc-5027	4	9	:	:	PUNCT
dpc-5027	4	10	a	a	DET
dpc-5027	4	11	comprehensive	comprehensive	ADJ
dpc-5027	4	12	estimation	estimation	NOUN
dpc-5027	4	13	study	study	NOUN
dpc-5027	4	14	.	.	PUNCT
dpc-5027	5	1	dermatol	dermatol	NOUN
dpc-5027	5	2	pract	pract	PROPN
dpc-5027	5	3	concept	concept	NOUN
dpc-5027	5	4	.	.	PUNCT
dpc-5027	6	1	2025;15(3):5027	2025;15(3):5027	NUM
dpc-5027	6	2	.	.	PUNCT
dpc-5027	7	1	doi	doi	NOUN
dpc-5027	7	2	:	:	PUNCT
dpc-5027	7	3	https://doi.org/10.5826/dpc.1503a5027	https://doi.org/10.5826/dpc.1503a5027	PUNCT
dpc-5027	7	4	accepted	accept	VERB
dpc-5027	7	5	:	:	PUNCT
dpc-5027	7	6	march	march	PROPN
dpc-5027	7	7	31	31	NUM
dpc-5027	7	8	,	,	PUNCT
dpc-5027	7	9	2025	2025	NUM
dpc-5027	7	10	;	;	PUNCT
dpc-5027	7	11	published	publish	VERB
dpc-5027	7	12	:	:	PUNCT
dpc-5027	8	1	july	july	PROPN
dpc-5027	8	2	2025	2025	NUM
dpc-5027	8	3	copyright	copyright	NOUN
dpc-5027	8	4	:	:	PUNCT
dpc-5027	8	5	©	©	PROPN
dpc-5027	8	6	2025	2025	NUM
dpc-5027	8	7	shabaka	shabaka	NOUN
dpc-5027	8	8	et	et	PROPN
dpc-5027	8	9	al	al	PROPN
dpc-5027	8	10	.	.	PUNCT
dpc-5027	9	1	this	this	PRON
dpc-5027	9	2	is	be	AUX
dpc-5027	9	3	an	an	DET
dpc-5027	9	4	open	open	ADJ
dpc-5027	9	5	-	-	PUNCT
dpc-5027	9	6	access	access	NOUN
dpc-5027	9	7	article	article	NOUN
dpc-5027	9	8	distributed	distribute	VERB
dpc-5027	9	9	under	under	ADP
dpc-5027	9	10	the	the	DET
dpc-5027	9	11	terms	term	NOUN
dpc-5027	9	12	of	of	ADP
dpc-5027	9	13	the	the	DET
dpc-5027	9	14	creative	creative	ADJ
dpc-5027	9	15	commons	common	NOUN
dpc-5027	9	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5027	9	17	license	license	NOUN
dpc-5027	9	18	(	(	PUNCT
dpc-5027	9	19	by	by	ADP
dpc-5027	9	20	-	-	PUNCT
dpc-5027	9	21	nc-4.0	nc-4.0	NOUN
dpc-5027	9	22	)	)	PUNCT
dpc-5027	9	23	,	,	PUNCT
dpc-5027	9	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5027	9	25	,	,	PUNCT
dpc-5027	9	26	which	which	PRON
dpc-5027	9	27	permits	permit	VERB
dpc-5027	9	28	unrestricted	unrestricted	ADJ
dpc-5027	9	29	noncommercial	noncommercial	ADJ
dpc-5027	9	30	use	use	NOUN
dpc-5027	9	31	,	,	PUNCT
dpc-5027	9	32	distribution	distribution	NOUN
dpc-5027	9	33	,	,	PUNCT
dpc-5027	9	34	and	and	CCONJ
dpc-5027	9	35	reproduction	reproduction	NOUN
dpc-5027	9	36	in	in	ADP
dpc-5027	9	37	any	any	DET
dpc-5027	9	38	medium	medium	NOUN
dpc-5027	9	39	,	,	PUNCT
dpc-5027	9	40	provided	provide	VERB
dpc-5027	9	41	the	the	DET
dpc-5027	9	42	original	original	ADJ
dpc-5027	9	43	authors	author	NOUN
dpc-5027	9	44	and	and	CCONJ
dpc-5027	9	45	source	source	NOUN
dpc-5027	9	46	are	be	AUX
dpc-5027	9	47	credited	credit	VERB
dpc-5027	9	48	.	.	PUNCT
dpc-5027	10	1	funding	funding	NOUN
dpc-5027	10	2	:	:	PUNCT
dpc-5027	10	3	none	none	NOUN
dpc-5027	10	4	.	.	PUNCT
dpc-5027	11	1	competing	compete	VERB
dpc-5027	11	2	interests	interest	NOUN
dpc-5027	11	3	:	:	PUNCT
dpc-5027	11	4	none	none	NOUN
dpc-5027	11	5	.	.	PUNCT
dpc-5027	12	1	authorship	authorship	NOUN
dpc-5027	12	2	:	:	PUNCT
dpc-5027	12	3	all	all	DET
dpc-5027	12	4	authors	author	NOUN
dpc-5027	12	5	have	have	AUX
dpc-5027	12	6	contributed	contribute	VERB
dpc-5027	12	7	significantly	significantly	ADV
dpc-5027	12	8	to	to	ADP
dpc-5027	12	9	this	this	DET
dpc-5027	12	10	publication	publication	NOUN
dpc-5027	12	11	.	.	PUNCT
dpc-5027	13	1	corresponding	correspond	VERB
dpc-5027	13	2	author	author	NOUN
dpc-5027	13	3	:	:	PUNCT
dpc-5027	13	4	aya	aya	PROPN
dpc-5027	13	5	a.	a.	NOUN
dpc-5027	13	6	salama	salama	PROPN
dpc-5027	13	7	,	,	PUNCT
dpc-5027	13	8	resident	resident	NOUN
dpc-5027	13	9	of	of	ADP
dpc-5027	13	10	dermatology	dermatology	NOUN
dpc-5027	13	11	and	and	CCONJ
dpc-5027	13	12	venereology	venereology	NOUN
dpc-5027	13	13	,	,	PUNCT
dpc-5027	13	14	damanhour	damanhour	PROPN
dpc-5027	13	15	medical	medical	PROPN
dpc-5027	13	16	national	national	PROPN
dpc-5027	13	17	institute	institute	PROPN
dpc-5027	13	18	,	,	PUNCT
dpc-5027	13	19	cairo	cairo	PROPN
dpc-5027	13	20	,	,	PUNCT
dpc-5027	13	21	egypt	egypt	PROPN
dpc-5027	13	22	,	,	PUNCT
dpc-5027	13	23	11511	11511	NUM
dpc-5027	13	24	.	.	PUNCT
dpc-5027	14	1	e	e	X
dpc-5027	14	2	-	-	NOUN
dpc-5027	14	3	mail	mail	NOUN
dpc-5027	14	4	:	:	PUNCT
dpc-5027	14	5	dr_ahmed_578@yahoo.com	dr_ahmed_578@yahoo.com	X
dpc-5027	14	6	introduction	introduction	NOUN
dpc-5027	14	7	:	:	PUNCT
dpc-5027	14	8	rosacea	rosacea	NOUN
dpc-5027	14	9	is	be	AUX
dpc-5027	14	10	a	a	DET
dpc-5027	14	11	chronic	chronic	ADJ
dpc-5027	14	12	inflammatory	inflammatory	ADJ
dpc-5027	14	13	skin	skin	NOUN
dpc-5027	14	14	disorder	disorder	NOUN
dpc-5027	14	15	distinguished	distinguish	VERB
dpc-5027	14	16	by	by	ADP
dpc-5027	14	17	recurrent	recurrent	ADJ
dpc-5027	14	18	episodes	episode	NOUN
dpc-5027	14	19	of	of	ADP
dpc-5027	14	20	inflammatory	inflammatory	ADJ
dpc-5027	14	21	papules	papule	NOUN
dpc-5027	14	22	,	,	PUNCT
dpc-5027	14	23	persistent	persistent	ADJ
dpc-5027	14	24	erythema	erythema	NOUN
dpc-5027	14	25	,	,	PUNCT
dpc-5027	14	26	facial	facial	ADJ
dpc-5027	14	27	flushing	flushing	NOUN
dpc-5027	14	28	,	,	PUNCT
dpc-5027	14	29	pustules	pustule	NOUN
dpc-5027	14	30	,	,	PUNCT
dpc-5027	14	31	and	and	CCONJ
dpc-5027	14	32	telangiectasia	telangiectasia	NOUN
dpc-5027	14	33	.	.	PUNCT
dpc-5027	15	1	any	any	DET
dpc-5027	15	2	disturbance	disturbance	NOUN
dpc-5027	15	3	in	in	ADP
dpc-5027	15	4	the	the	DET
dpc-5027	15	5	gut	gut	NOUN
dpc-5027	15	6	microbiome	microbiome	NOUN
dpc-5027	15	7	could	could	AUX
dpc-5027	15	8	influence	influence	VERB
dpc-5027	15	9	the	the	DET
dpc-5027	15	10	immune	immune	ADJ
dpc-5027	15	11	system	system	NOUN
dpc-5027	15	12	equilibrium	equilibrium	NOUN
dpc-5027	15	13	in	in	ADP
dpc-5027	15	14	rosacea	rosacea	NOUN
dpc-5027	15	15	by	by	ADP
dpc-5027	15	16	releasing	release	VERB
dpc-5027	15	17	zonulin	zonulin	NOUN
dpc-5027	15	18	,	,	PUNCT
dpc-5027	15	19	leading	lead	VERB
dpc-5027	15	20	to	to	ADP
dpc-5027	15	21	increased	increase	VERB
dpc-5027	15	22	intestinal	intestinal	ADJ
dpc-5027	15	23	permeability	permeability	NOUN
dpc-5027	15	24	and	and	CCONJ
dpc-5027	15	25	the	the	DET
dpc-5027	15	26	passage	passage	NOUN
dpc-5027	15	27	of	of	ADP
dpc-5027	15	28	many	many	ADJ
dpc-5027	15	29	microbes	microbe	NOUN
dpc-5027	15	30	into	into	ADP
dpc-5027	15	31	the	the	DET
dpc-5027	15	32	circulation	circulation	NOUN
dpc-5027	15	33	,	,	PUNCT
dpc-5027	15	34	causing	cause	VERB
dpc-5027	15	35	inflammation	inflammation	NOUN
dpc-5027	15	36	.	.	PUNCT
dpc-5027	16	1	objectives	objective	NOUN
dpc-5027	16	2	:	:	PUNCT
dpc-5027	16	3	we	we	PRON
dpc-5027	16	4	aimed	aim	VERB
dpc-5027	16	5	to	to	PART
dpc-5027	16	6	estimate	estimate	VERB
dpc-5027	16	7	the	the	DET
dpc-5027	16	8	serum	serum	NOUN
dpc-5027	16	9	zonulin	zonulin	PROPN
dpc-5027	16	10	levels	level	NOUN
dpc-5027	16	11	in	in	ADP
dpc-5027	16	12	cases	case	NOUN
dpc-5027	16	13	with	with	ADP
dpc-5027	16	14	rosacea	rosacea	NOUN
dpc-5027	16	15	compared	compare	VERB
dpc-5027	16	16	with	with	ADP
dpc-5027	16	17	healthy	healthy	ADJ
dpc-5027	16	18	controls	control	NOUN
dpc-5027	16	19	.	.	PUNCT
dpc-5027	17	1	some	some	DET
dpc-5027	17	2	fecal	fecal	ADJ
dpc-5027	17	3	bacteria	bacteria	NOUN
dpc-5027	17	4	were	be	AUX
dpc-5027	17	5	investigated	investigate	VERB
dpc-5027	17	6	in	in	ADP
dpc-5027	17	7	an	an	DET
dpc-5027	17	8	attempt	attempt	NOUN
dpc-5027	17	9	to	to	PART
dpc-5027	17	10	find	find	VERB
dpc-5027	17	11	a	a	DET
dpc-5027	17	12	relationship	relationship	NOUN
dpc-5027	17	13	between	between	ADP
dpc-5027	17	14	gut	gut	NOUN
dpc-5027	17	15	microbiome	microbiome	NOUN
dpc-5027	17	16	and	and	CCONJ
dpc-5027	17	17	rosacea	rosacea	NOUN
dpc-5027	17	18	.	.	PUNCT
dpc-5027	18	1	methods	method	NOUN
dpc-5027	18	2	:	:	PUNCT
dpc-5027	18	3	this	this	DET
dpc-5027	18	4	case	case	NOUN
dpc-5027	18	5	-	-	PUNCT
dpc-5027	18	6	control	control	NOUN
dpc-5027	18	7	study	study	NOUN
dpc-5027	18	8	was	be	AUX
dpc-5027	18	9	performed	perform	VERB
dpc-5027	18	10	on	on	ADP
dpc-5027	18	11	42	42	NUM
dpc-5027	18	12	participants	participant	NOUN
dpc-5027	18	13	aged	age	VERB
dpc-5027	18	14	above	above	ADP
dpc-5027	18	15	18	18	NUM
dpc-5027	18	16	years	year	NOUN
dpc-5027	18	17	:	:	PUNCT
dpc-5027	18	18	21	21	NUM
dpc-5027	18	19	patients	patient	NOUN
dpc-5027	18	20	with	with	ADP
dpc-5027	18	21	a	a	DET
dpc-5027	18	22	clinical	clinical	ADJ
dpc-5027	18	23	diagnosis	diagnosis	NOUN
dpc-5027	18	24	of	of	ADP
dpc-5027	18	25	rosacea	rosacea	NOUN
dpc-5027	18	26	approved	approve	VERB
dpc-5027	18	27	by	by	ADP
dpc-5027	18	28	dermoscopy	dermoscopy	NOUN
dpc-5027	18	29	and	and	CCONJ
dpc-5027	18	30	21	21	NUM
dpc-5027	18	31	healthy	healthy	ADJ
dpc-5027	18	32	individuals	individual	NOUN
dpc-5027	18	33	as	as	ADP
dpc-5027	18	34	controls	control	NOUN
dpc-5027	18	35	.	.	PUNCT
dpc-5027	19	1	the	the	DET
dpc-5027	19	2	serum	serum	PROPN
dpc-5027	19	3	zonulin	zonulin	PROPN
dpc-5027	19	4	level	level	NOUN
dpc-5027	19	5	was	be	AUX
dpc-5027	19	6	estimated	estimate	VERB
dpc-5027	19	7	by	by	ADP
dpc-5027	19	8	the	the	DET
dpc-5027	19	9	enzyme	enzyme	NOUN
dpc-5027	19	10	-	-	PUNCT
dpc-5027	19	11	linked	link	VERB
dpc-5027	19	12	immunosorbent	immunosorbent	ADJ
dpc-5027	19	13	assay	assay	NOUN
dpc-5027	19	14	technique	technique	NOUN
dpc-5027	19	15	,	,	PUNCT
dpc-5027	19	16	and	and	CCONJ
dpc-5027	19	17	some	some	DET
dpc-5027	19	18	gut	gut	NOUN
dpc-5027	19	19	microbiomes	microbiome	NOUN
dpc-5027	19	20	were	be	AUX
dpc-5027	19	21	investigated	investigate	VERB
dpc-5027	19	22	using	use	VERB
dpc-5027	19	23	real	real	ADJ
dpc-5027	19	24	-	-	PUNCT
dpc-5027	19	25	time	time	NOUN
dpc-5027	19	26	quantitative	quantitative	ADJ
dpc-5027	19	27	pcr	pcr	NOUN
dpc-5027	19	28	.	.	PUNCT
dpc-5027	20	1	results	result	NOUN
dpc-5027	20	2	:	:	PUNCT
dpc-5027	20	3	there	there	PRON
dpc-5027	20	4	was	be	VERB
dpc-5027	20	5	a	a	DET
dpc-5027	20	6	statistically	statistically	ADV
dpc-5027	20	7	significantly	significantly	ADV
dpc-5027	20	8	higher	high	ADJ
dpc-5027	20	9	serum	serum	NOUN
dpc-5027	20	10	zonulin	zonulin	PROPN
dpc-5027	20	11	level	level	NOUN
dpc-5027	20	12	in	in	ADP
dpc-5027	20	13	rosacea	rosacea	NOUN
dpc-5027	20	14	cases	case	NOUN
dpc-5027	20	15	than	than	ADP
dpc-5027	20	16	in	in	ADP
dpc-5027	20	17	controls	control	NOUN
dpc-5027	20	18	.	.	PUNCT
dpc-5027	21	1	there	there	PRON
dpc-5027	21	2	was	be	VERB
dpc-5027	21	3	a	a	DET
dpc-5027	21	4	statistically	statistically	ADV
dpc-5027	21	5	significant	significant	ADJ
dpc-5027	21	6	elevation	elevation	NOUN
dpc-5027	21	7	in	in	ADP
dpc-5027	21	8	bacteroides	bacteroide	NOUN
dpc-5027	21	9	and	and	CCONJ
dpc-5027	21	10	lactobacillus	lactobacillus	NOUN
dpc-5027	21	11	gut	gut	NOUN
dpc-5027	21	12	microbiomes	microbiome	NOUN
dpc-5027	21	13	in	in	ADP
dpc-5027	21	14	rosacea	rosacea	NOUN
dpc-5027	21	15	patients	patient	NOUN
dpc-5027	21	16	compared	compare	VERB
dpc-5027	21	17	to	to	ADP
dpc-5027	21	18	controls	control	NOUN
dpc-5027	21	19	,	,	PUNCT
dpc-5027	21	20	while	while	SCONJ
dpc-5027	21	21	there	there	PRON
dpc-5027	21	22	was	be	VERB
dpc-5027	21	23	no	no	DET
dpc-5027	21	24	statistically	statistically	ADV
dpc-5027	21	25	significant	significant	ADJ
dpc-5027	21	26	increase	increase	NOUN
dpc-5027	21	27	in	in	ADP
dpc-5027	21	28	fusobacterium	fusobacterium	NOUN
dpc-5027	21	29	microbiome	microbiome	NOUN
dpc-5027	21	30	in	in	ADP
dpc-5027	21	31	patients	patient	NOUN
dpc-5027	21	32	.	.	PUNCT
dpc-5027	22	1	zonulin	zonulin	PROPN
dpc-5027	22	2	levels	level	NOUN
dpc-5027	22	3	did	do	AUX
dpc-5027	22	4	not	not	PART
dpc-5027	22	5	show	show	VERB
dpc-5027	22	6	a	a	DET
dpc-5027	22	7	significant	significant	ADJ
dpc-5027	22	8	correlation	correlation	NOUN
dpc-5027	22	9	with	with	ADP
dpc-5027	22	10	gut	gut	NOUN
dpc-5027	22	11	microbiome	microbiome	NOUN
dpc-5027	22	12	.	.	PUNCT
dpc-5027	23	1	conclusions	conclusion	NOUN
dpc-5027	23	2	:	:	PUNCT
dpc-5027	23	3	serum	serum	PROPN
dpc-5027	23	4	zonulin	zonulin	PROPN
dpc-5027	23	5	measurement	measurement	PROPN
dpc-5027	23	6	can	can	AUX
dpc-5027	23	7	be	be	AUX
dpc-5027	23	8	used	use	VERB
dpc-5027	23	9	as	as	ADP
dpc-5027	23	10	a	a	DET
dpc-5027	23	11	discriminating	discriminate	VERB
dpc-5027	23	12	marker	marker	NOUN
dpc-5027	23	13	between	between	ADP
dpc-5027	23	14	rosacea	rosacea	NOUN
dpc-5027	23	15	and	and	CCONJ
dpc-5027	23	16	healthy	healthy	ADJ
dpc-5027	23	17	controls	control	NOUN
dpc-5027	23	18	,	,	PUNCT
dpc-5027	23	19	due	due	ADJ
dpc-5027	23	20	to	to	ADP
dpc-5027	23	21	getting	get	VERB
dpc-5027	23	22	a	a	DET
dpc-5027	23	23	specific	specific	ADJ
dpc-5027	23	24	cut	cut	NOUN
dpc-5027	23	25	-	-	PUNCT
dpc-5027	23	26	off	off	ADP
dpc-5027	23	27	point	point	NOUN
dpc-5027	23	28	in	in	ADP
dpc-5027	23	29	roc	roc	PROPN
dpc-5027	23	30	analysis	analysis	NOUN
dpc-5027	23	31	with	with	ADP
dpc-5027	23	32	the	the	DET
dpc-5027	23	33	highest	high	ADJ
dpc-5027	23	34	specificity	specificity	NOUN
dpc-5027	23	35	and	and	CCONJ
dpc-5027	23	36	sensitivity	sensitivity	NOUN
dpc-5027	23	37	(	(	PUNCT
dpc-5027	23	38	100	100	NUM
dpc-5027	23	39	%	%	NOUN
dpc-5027	23	40	and	and	CCONJ
dpc-5027	23	41	100	100	NUM
dpc-5027	23	42	%	%	NOUN
dpc-5027	23	43	,	,	PUNCT
dpc-5027	23	44	respectively	respectively	ADV
dpc-5027	23	45	)	)	PUNCT
dpc-5027	23	46	.	.	PUNCT
dpc-5027	24	1	gut	gut	VERB
dpc-5027	24	2	microbial	microbial	ADJ
dpc-5027	24	3	dysbiosis	dysbiosis	NOUN
dpc-5027	24	4	could	could	AUX
dpc-5027	24	5	play	play	VERB
dpc-5027	24	6	a	a	DET
dpc-5027	24	7	valuable	valuable	ADJ
dpc-5027	24	8	role	role	NOUN
dpc-5027	24	9	in	in	ADP
dpc-5027	24	10	the	the	DET
dpc-5027	24	11	disease	disease	NOUN
dpc-5027	24	12	pathogenesis	pathogenesis	NOUN
dpc-5027	24	13	.	.	PUNCT
dpc-5027	25	1	abstract	abstract	ADJ
dpc-5027	25	2	2	2	NUM
dpc-5027	25	3	original	original	ADJ
dpc-5027	25	4	article	article	NOUN
dpc-5027	25	5	|	|	ADV
dpc-5027	25	6	dermatol	dermatol	ADJ
dpc-5027	25	7	pract	pract	NOUN
dpc-5027	25	8	concept	concept	NOUN
dpc-5027	25	9	.	.	PUNCT
dpc-5027	26	1	2025;15(3):5027	2025;15(3):5027	NUM
dpc-5027	26	2	introduction	introduction	NOUN
dpc-5027	26	3	rosacea	rosacea	NOUN
dpc-5027	26	4	is	be	AUX
dpc-5027	26	5	a	a	DET
dpc-5027	26	6	chronic	chronic	ADJ
dpc-5027	26	7	inflammatory	inflammatory	ADJ
dpc-5027	26	8	skin	skin	NOUN
dpc-5027	26	9	disease	disease	NOUN
dpc-5027	26	10	that	that	PRON
dpc-5027	26	11	affects	affect	VERB
dpc-5027	26	12	2–10	2–10	NOUN
dpc-5027	26	13	%	%	NOUN
dpc-5027	26	14	of	of	ADP
dpc-5027	26	15	the	the	DET
dpc-5027	26	16	general	general	ADJ
dpc-5027	26	17	population	population	NOUN
dpc-5027	26	18	.	.	PUNCT
dpc-5027	27	1	it	it	PRON
dpc-5027	27	2	displays	display	VERB
dpc-5027	27	3	erythema	erythema	ADV
dpc-5027	27	4	,	,	PUNCT
dpc-5027	27	5	edema	edema	PROPN
dpc-5027	27	6	,	,	PUNCT
dpc-5027	27	7	flushing	flush	VERB
dpc-5027	27	8	,	,	PUNCT
dpc-5027	27	9	telangiectasia	telangiectasia	NOUN
dpc-5027	27	10	,	,	PUNCT
dpc-5027	27	11	papules	papule	NOUN
dpc-5027	27	12	,	,	PUNCT
dpc-5027	27	13	pustules	pustule	NOUN
dpc-5027	27	14	,	,	PUNCT
dpc-5027	27	15	ocular	ocular	ADJ
dpc-5027	27	16	lesions	lesion	NOUN
dpc-5027	27	17	,	,	PUNCT
dpc-5027	27	18	and	and	CCONJ
dpc-5027	27	19	phymatous	phymatous	ADJ
dpc-5027	27	20	changes	change	NOUN
dpc-5027	27	21	that	that	PRON
dpc-5027	27	22	progress	progress	VERB
dpc-5027	27	23	in	in	ADP
dpc-5027	27	24	the	the	DET
dpc-5027	27	25	centrofacial	centrofacial	ADJ
dpc-5027	27	26	region	region	NOUN
dpc-5027	27	27	alone	alone	ADJ
dpc-5027	27	28	or	or	CCONJ
dpc-5027	27	29	in	in	ADP
dpc-5027	27	30	combination	combination	NOUN
dpc-5027	27	31	[	[	X
dpc-5027	27	32	1	1	NUM
dpc-5027	27	33	]	]	PUNCT
dpc-5027	27	34	.	.	PUNCT
dpc-5027	28	1	rosacea	rosacea	NOUN
dpc-5027	28	2	is	be	AUX
dpc-5027	28	3	clinically	clinically	ADV
dpc-5027	28	4	categorized	categorize	VERB
dpc-5027	28	5	into	into	ADP
dpc-5027	28	6	four	four	NUM
dpc-5027	28	7	subtypes	subtype	NOUN
dpc-5027	28	8	:	:	PUNCT
dpc-5027	28	9	(	(	PUNCT
dpc-5027	28	10	1	1	X
dpc-5027	28	11	)	)	PUNCT
dpc-5027	28	12	papulopustular	papulopustular	ADJ
dpc-5027	28	13	,	,	PUNCT
dpc-5027	28	14	(	(	PUNCT
dpc-5027	28	15	2	2	X
dpc-5027	28	16	)	)	PUNCT
dpc-5027	28	17	erythematotelangiectatic	erythematotelangiectatic	NOUN
dpc-5027	28	18	,	,	PUNCT
dpc-5027	28	19	(	(	PUNCT
dpc-5027	28	20	3	3	X
dpc-5027	28	21	)	)	PUNCT
dpc-5027	28	22	phymatous	phymatous	ADJ
dpc-5027	28	23	,	,	PUNCT
dpc-5027	28	24	and	and	CCONJ
dpc-5027	28	25	(	(	PUNCT
dpc-5027	28	26	4	4	X
dpc-5027	28	27	)	)	PUNCT
dpc-5027	28	28	ocular	ocular	ADJ
dpc-5027	28	29	rosacea	rosacea	NOUN
dpc-5027	29	1	[	[	X
dpc-5027	29	2	2	2	NUM
dpc-5027	29	3	]	]	PUNCT
dpc-5027	29	4	.	.	PUNCT
dpc-5027	30	1	in	in	ADP
dpc-5027	30	2	patients	patient	NOUN
dpc-5027	30	3	with	with	ADP
dpc-5027	30	4	rosacea	rosacea	NOUN
dpc-5027	30	5	,	,	PUNCT
dpc-5027	30	6	there	there	PRON
dpc-5027	30	7	are	be	VERB
dpc-5027	30	8	numerous	numerous	ADJ
dpc-5027	30	9	flare	flare	ADJ
dpc-5027	30	10	triggers	trigger	NOUN
dpc-5027	30	11	,	,	PUNCT
dpc-5027	30	12	such	such	ADJ
dpc-5027	30	13	as	as	ADP
dpc-5027	30	14	exercise	exercise	NOUN
dpc-5027	30	15	,	,	PUNCT
dpc-5027	30	16	hot	hot	ADJ
dpc-5027	30	17	and	and	CCONJ
dpc-5027	30	18	cold	cold	ADJ
dpc-5027	30	19	temperatures	temperature	NOUN
dpc-5027	30	20	,	,	PUNCT
dpc-5027	30	21	ultraviolet	ultraviolet	ADJ
dpc-5027	30	22	radiation	radiation	NOUN
dpc-5027	30	23	,	,	PUNCT
dpc-5027	30	24	spicy	spicy	ADJ
dpc-5027	30	25	foods	food	NOUN
dpc-5027	30	26	,	,	PUNCT
dpc-5027	30	27	and	and	CCONJ
dpc-5027	30	28	alcohol	alcohol	NOUN
dpc-5027	30	29	[	[	X
dpc-5027	30	30	3	3	NUM
dpc-5027	30	31	]	]	PUNCT
dpc-5027	30	32	.	.	PUNCT
dpc-5027	31	1	these	these	DET
dpc-5027	31	2	factors	factor	NOUN
dpc-5027	31	3	can	can	AUX
dpc-5027	31	4	increase	increase	VERB
dpc-5027	31	5	the	the	DET
dpc-5027	31	6	susceptibility	susceptibility	NOUN
dpc-5027	31	7	of	of	ADP
dpc-5027	31	8	patients	patient	NOUN
dpc-5027	31	9	to	to	ADP
dpc-5027	31	10	skin	skin	NOUN
dpc-5027	31	11	disorders	disorder	NOUN
dpc-5027	31	12	by	by	ADP
dpc-5027	31	13	disrupting	disrupt	VERB
dpc-5027	31	14	immune	immune	ADJ
dpc-5027	31	15	function	function	NOUN
dpc-5027	31	16	or	or	CCONJ
dpc-5027	31	17	altering	alter	VERB
dpc-5027	31	18	the	the	DET
dpc-5027	31	19	skin	skin	NOUN
dpc-5027	31	20	’s	’s	PART
dpc-5027	31	21	epidermal	epidermal	ADJ
dpc-5027	31	22	barrier	barrier	NOUN
dpc-5027	31	23	function	function	NOUN
dpc-5027	31	24	[	[	X
dpc-5027	31	25	4	4	NUM
dpc-5027	31	26	]	]	PUNCT
dpc-5027	31	27	.	.	PUNCT
dpc-5027	32	1	rosacea	rosacea	NOUN
dpc-5027	32	2	appears	appear	VERB
dpc-5027	32	3	to	to	PART
dpc-5027	32	4	be	be	AUX
dpc-5027	32	5	the	the	DET
dpc-5027	32	6	result	result	NOUN
dpc-5027	32	7	of	of	ADP
dpc-5027	32	8	the	the	DET
dpc-5027	32	9	innate	innate	ADJ
dpc-5027	32	10	and	and	CCONJ
dpc-5027	32	11	adaptive	adaptive	ADJ
dpc-5027	32	12	immune	immune	ADJ
dpc-5027	32	13	systems	system	NOUN
dpc-5027	32	14	’	'	PUNCT
dpc-5027	32	15	dysregulation	dysregulation	NOUN
dpc-5027	32	16	as	as	ADV
dpc-5027	32	17	well	well	ADV
dpc-5027	32	18	as	as	ADP
dpc-5027	32	19	of	of	ADP
dpc-5027	32	20	neurovascular	neurovascular	ADJ
dpc-5027	32	21	dysfunction	dysfunction	NOUN
dpc-5027	32	22	,	,	PUNCT
dpc-5027	32	23	skin	skin	NOUN
dpc-5027	32	24	barrier	barrier	NOUN
dpc-5027	32	25	dysfunction	dysfunction	NOUN
dpc-5027	32	26	,	,	PUNCT
dpc-5027	32	27	microbial	microbial	ADJ
dpc-5027	32	28	dysbiosis	dysbiosis	NOUN
dpc-5027	32	29	,	,	PUNCT
dpc-5027	32	30	sebaceous	sebaceous	ADJ
dpc-5027	32	31	gland	gland	NOUN
dpc-5027	32	32	dysfunction	dysfunction	NOUN
dpc-5027	32	33	,	,	PUNCT
dpc-5027	32	34	metabolic	metabolic	NOUN
dpc-5027	32	35	dysfunction	dysfunction	NOUN
dpc-5027	32	36	,	,	PUNCT
dpc-5027	32	37	and	and	CCONJ
dpc-5027	32	38	genetic	genetic	ADJ
dpc-5027	32	39	predisposition	predisposition	NOUN
dpc-5027	32	40	[	[	X
dpc-5027	32	41	5	5	NUM
dpc-5027	32	42	]	]	PUNCT
dpc-5027	32	43	.	.	PUNCT
dpc-5027	33	1	the	the	DET
dpc-5027	33	2	protein	protein	NOUN
dpc-5027	33	3	zonulin	zonulin	PROPN
dpc-5027	33	4	was	be	AUX
dpc-5027	33	5	initially	initially	ADV
dpc-5027	33	6	identified	identify	VERB
dpc-5027	33	7	as	as	ADP
dpc-5027	33	8	an	an	DET
dpc-5027	33	9	endogenous	endogenous	ADJ
dpc-5027	33	10	bacterial	bacterial	ADJ
dpc-5027	33	11	enterotoxin	enterotoxin	X
dpc-5027	33	12	human	human	ADJ
dpc-5027	33	13	analogue	analogue	NOUN
dpc-5027	33	14	,	,	PUNCT
dpc-5027	33	15	zonula	zonula	NOUN
dpc-5027	33	16	occludens	occluden	NOUN
dpc-5027	33	17	toxin	toxin	PROPN
dpc-5027	33	18	(	(	PUNCT
dpc-5027	33	19	zot	zot	PROPN
dpc-5027	33	20	)	)	PUNCT
dpc-5027	33	21	,	,	PUNCT
dpc-5027	33	22	which	which	PRON
dpc-5027	33	23	is	be	AUX
dpc-5027	33	24	produced	produce	VERB
dpc-5027	33	25	by	by	ADP
dpc-5027	33	26	the	the	DET
dpc-5027	33	27	intestinal	intestinal	ADJ
dpc-5027	33	28	bacterium	bacterium	NOUN
dpc-5027	33	29	vibrio	vibrio	ADJ
dpc-5027	33	30	cholerae	cholerae	NOUN
dpc-5027	34	1	[	[	X
dpc-5027	34	2	6	6	NUM
dpc-5027	34	3	]	]	PUNCT
dpc-5027	34	4	.	.	PUNCT
dpc-5027	35	1	zonulin	zonulin	PROPN
dpc-5027	35	2	is	be	AUX
dpc-5027	35	3	a	a	DET
dpc-5027	35	4	critical	critical	ADJ
dpc-5027	35	5	regulator	regulator	NOUN
dpc-5027	35	6	of	of	ADP
dpc-5027	35	7	tight	tight	ADJ
dpc-5027	35	8	junctions	junction	NOUN
dpc-5027	35	9	in	in	ADP
dpc-5027	35	10	intestinal	intestinal	ADJ
dpc-5027	35	11	epithelial	epithelial	ADJ
dpc-5027	35	12	cells	cell	NOUN
dpc-5027	35	13	,	,	PUNCT
dpc-5027	35	14	as	as	SCONJ
dpc-5027	35	15	it	it	PRON
dpc-5027	35	16	reversibly	reversibly	ADV
dpc-5027	35	17	opens	open	VERB
dpc-5027	35	18	the	the	DET
dpc-5027	35	19	intercellular	intercellular	ADJ
dpc-5027	35	20	tight	tight	ADJ
dpc-5027	35	21	junctions	junction	NOUN
dpc-5027	35	22	in	in	ADP
dpc-5027	35	23	the	the	DET
dpc-5027	35	24	small	small	ADJ
dpc-5027	35	25	intestine	intestine	NOUN
dpc-5027	35	26	.	.	PUNCT
dpc-5027	36	1	it	it	PRON
dpc-5027	36	2	operates	operate	VERB
dpc-5027	36	3	through	through	ADP
dpc-5027	36	4	par2	par2	PROPN
dpc-5027	36	5	,	,	PUNCT
dpc-5027	36	6	which	which	PRON
dpc-5027	36	7	results	result	VERB
dpc-5027	36	8	in	in	ADP
dpc-5027	36	9	the	the	DET
dpc-5027	36	10	tight	tight	ADJ
dpc-5027	36	11	junction	junction	NOUN
dpc-5027	36	12	proteins	protein	NOUN
dpc-5027	36	13	and	and	CCONJ
dpc-5027	36	14	the	the	DET
dpc-5027	36	15	actin	actin	NOUN
dpc-5027	36	16	filaments	filament	NOUN
dpc-5027	36	17	,	,	PUNCT
dpc-5027	36	18	subsequently	subsequently	ADV
dpc-5027	36	19	increasing	increase	VERB
dpc-5027	36	20	intestinal	intestinal	ADJ
dpc-5027	36	21	permeability	permeability	NOUN
dpc-5027	36	22	[	[	X
dpc-5027	36	23	7	7	NUM
dpc-5027	36	24	]	]	PUNCT
dpc-5027	36	25	.	.	PUNCT
dpc-5027	37	1	this	this	PRON
dpc-5027	37	2	allows	allow	VERB
dpc-5027	37	3	passage	passage	NOUN
dpc-5027	37	4	of	of	ADP
dpc-5027	37	5	macromolecular	macromolecular	ADJ
dpc-5027	37	6	proteins	protein	NOUN
dpc-5027	37	7	,	,	PUNCT
dpc-5027	37	8	toxins	toxin	NOUN
dpc-5027	37	9	,	,	PUNCT
dpc-5027	37	10	microorganisms	microorganism	NOUN
dpc-5027	37	11	,	,	PUNCT
dpc-5027	37	12	and	and	CCONJ
dpc-5027	37	13	inappropriate	inappropriate	ADJ
dpc-5027	37	14	antigens	antigen	NOUN
dpc-5027	37	15	into	into	ADP
dpc-5027	37	16	systemic	systemic	ADJ
dpc-5027	37	17	circulation	circulation	NOUN
dpc-5027	37	18	across	across	ADP
dpc-5027	37	19	the	the	DET
dpc-5027	37	20	mucosa	mucosa	NOUN
dpc-5027	37	21	,	,	PUNCT
dpc-5027	37	22	initiating	initiate	VERB
dpc-5027	37	23	an	an	DET
dpc-5027	37	24	innate	innate	ADJ
dpc-5027	37	25	immune	immune	ADJ
dpc-5027	37	26	response	response	NOUN
dpc-5027	37	27	.	.	PUNCT
dpc-5027	38	1	when	when	SCONJ
dpc-5027	38	2	the	the	DET
dpc-5027	38	3	process	process	NOUN
dpc-5027	38	4	persists	persist	VERB
dpc-5027	38	5	,	,	PUNCT
dpc-5027	38	6	an	an	DET
dpc-5027	38	7	adaptive	adaptive	ADJ
dpc-5027	38	8	immune	immune	ADJ
dpc-5027	38	9	response	response	NOUN
dpc-5027	38	10	begins	begin	VERB
dpc-5027	38	11	,	,	PUNCT
dpc-5027	38	12	producing	produce	VERB
dpc-5027	38	13	pro	pro	ADJ
dpc-5027	38	14	-	-	ADJ
dpc-5027	38	15	inflammatory	inflammatory	ADJ
dpc-5027	38	16	cytokine	cytokine	NOUN
dpc-5027	38	17	.	.	PUNCT
dpc-5027	38	18	 	 	SPACE
dpc-5027	39	1	[	[	X
dpc-5027	39	2	8	8	NUM
dpc-5027	39	3	]	]	PUNCT
dpc-5027	39	4	.	.	PUNCT
dpc-5027	40	1	this	this	DET
dpc-5027	40	2	process	process	NOUN
dpc-5027	40	3	further	far	ADV
dpc-5027	40	4	facilitates	facilitate	VERB
dpc-5027	40	5	the	the	DET
dpc-5027	40	6	passage	passage	NOUN
dpc-5027	40	7	of	of	ADP
dpc-5027	40	8	antigens	antigen	NOUN
dpc-5027	40	9	by	by	ADP
dpc-5027	40	10	opening	open	VERB
dpc-5027	40	11	the	the	DET
dpc-5027	40	12	paracellular	paracellular	ADJ
dpc-5027	40	13	pathway	pathway	NOUN
dpc-5027	40	14	,	,	PUNCT
dpc-5027	40	15	thereby	thereby	ADV
dpc-5027	40	16	establishing	establish	VERB
dpc-5027	40	17	a	a	DET
dpc-5027	40	18	vicious	vicious	ADJ
dpc-5027	40	19	cycle	cycle	NOUN
dpc-5027	40	20	.	.	PUNCT
dpc-5027	41	1	the	the	DET
dpc-5027	41	2	consequence	consequence	NOUN
dpc-5027	41	3	is	be	AUX
dpc-5027	41	4	the	the	DET
dpc-5027	41	5	breakdown	breakdown	NOUN
dpc-5027	41	6	of	of	ADP
dpc-5027	41	7	immune	immune	ADJ
dpc-5027	41	8	tolerance	tolerance	NOUN
dpc-5027	41	9	and	and	CCONJ
dpc-5027	41	10	chronic	chronic	ADJ
dpc-5027	41	11	inflammation	inflammation	NOUN
dpc-5027	41	12	[	[	X
dpc-5027	41	13	8	8	NUM
dpc-5027	41	14	]	]	PUNCT
dpc-5027	41	15	.	.	PUNCT
dpc-5027	42	1	luminal	luminal	ADJ
dpc-5027	42	2	zonulin	zonulin	PROPN
dpc-5027	42	3	release	release	NOUN
dpc-5027	42	4	is	be	AUX
dpc-5027	42	5	induced	induce	VERB
dpc-5027	42	6	by	by	ADP
dpc-5027	42	7	either	either	PRON
dpc-5027	42	8	gliadin	gliadin	VERB
dpc-5027	42	9	exposure	exposure	NOUN
dpc-5027	42	10	or	or	CCONJ
dpc-5027	42	11	microbiome	microbiome	ADJ
dpc-5027	42	12	imbalance	imbalance	NOUN
dpc-5027	42	13	[	[	X
dpc-5027	42	14	9	9	NUM
dpc-5027	42	15	]	]	PUNCT
dpc-5027	42	16	.	.	PUNCT
dpc-5027	43	1	the	the	DET
dpc-5027	43	2	barrier	barrier	NOUN
dpc-5027	43	3	endothelial	endothelial	ADJ
dpc-5027	43	4	and	and	CCONJ
dpc-5027	43	5	epithelial	epithelial	ADJ
dpc-5027	43	6	layers	layer	NOUN
dpc-5027	43	7	function	function	VERB
dpc-5027	43	8	in	in	ADP
dpc-5027	43	9	the	the	DET
dpc-5027	43	10	intestine	intestine	NOUN
dpc-5027	43	11	can	can	AUX
dpc-5027	43	12	be	be	AUX
dpc-5027	43	13	preserved	preserve	VERB
dpc-5027	43	14	by	by	ADP
dpc-5027	43	15	inhibiting	inhibit	VERB
dpc-5027	43	16	the	the	DET
dpc-5027	43	17	zonulin	zonulin	PROPN
dpc-5027	43	18	pathway	pathway	NOUN
dpc-5027	43	19	with	with	ADP
dpc-5027	43	20	zonulin	zonulin	PROPN
dpc-5027	43	21	antagonists	antagonist	NOUN
dpc-5027	43	22	(	(	PUNCT
dpc-5027	43	23	larazotide	larazotide	NOUN
dpc-5027	43	24	acetate	acetate	NOUN
dpc-5027	43	25	)	)	PUNCT
dpc-5027	43	26	,	,	PUNCT
dpc-5027	43	27	epidermal	epidermal	ADJ
dpc-5027	43	28	growth	growth	NOUN
dpc-5027	43	29	factor	factor	NOUN
dpc-5027	43	30	receptors	receptor	NOUN
dpc-5027	43	31	(	(	PUNCT
dpc-5027	43	32	egfr	egfr	X
dpc-5027	43	33	)	)	PUNCT
dpc-5027	43	34	inhibitors	inhibitor	NOUN
dpc-5027	43	35	,	,	PUNCT
dpc-5027	43	36	or	or	CCONJ
dpc-5027	43	37	par2	par2	NOUN
dpc-5027	43	38	modulators	modulator	NOUN
dpc-5027	43	39	[	[	X
dpc-5027	43	40	10	10	NUM
dpc-5027	43	41	]	]	PUNCT
dpc-5027	43	42	.	.	PUNCT
dpc-5027	44	1	a	a	DET
dpc-5027	44	2	previous	previous	ADJ
dpc-5027	44	3	study	study	NOUN
dpc-5027	44	4	revealed	reveal	VERB
dpc-5027	44	5	a	a	DET
dpc-5027	44	6	significant	significant	ADJ
dpc-5027	44	7	increase	increase	NOUN
dpc-5027	44	8	in	in	ADP
dpc-5027	44	9	serum	serum	PROPN
dpc-5027	44	10	zonulin	zonulin	PROPN
dpc-5027	44	11	levels	level	NOUN
dpc-5027	44	12	in	in	ADP
dpc-5027	44	13	rosacea	rosacea	NOUN
dpc-5027	44	14	patients	patient	NOUN
dpc-5027	44	15	compared	compare	VERB
dpc-5027	44	16	to	to	ADP
dpc-5027	44	17	healthy	healthy	ADJ
dpc-5027	44	18	controls	control	NOUN
dpc-5027	44	19	[	[	X
dpc-5027	44	20	11	11	NUM
dpc-5027	44	21	]	]	PUNCT
dpc-5027	44	22	.	.	PUNCT
dpc-5027	45	1	the	the	DET
dpc-5027	45	2	link	link	NOUN
dpc-5027	45	3	between	between	ADP
dpc-5027	45	4	gut	gut	NOUN
dpc-5027	45	5	microbiome	microbiome	NOUN
dpc-5027	45	6	and	and	CCONJ
dpc-5027	45	7	rosacea	rosacea	NOUN
dpc-5027	45	8	has	have	AUX
dpc-5027	45	9	been	be	AUX
dpc-5027	45	10	reported	report	VERB
dpc-5027	45	11	[	[	X
dpc-5027	45	12	12	12	NUM
dpc-5027	45	13	]	]	PUNCT
dpc-5027	45	14	.	.	PUNCT
dpc-5027	46	1	the	the	DET
dpc-5027	46	2	human	human	ADJ
dpc-5027	46	3	microbiome	microbiome	NOUN
dpc-5027	46	4	is	be	AUX
dpc-5027	46	5	a	a	DET
dpc-5027	46	6	diverse	diverse	ADJ
dpc-5027	46	7	collection	collection	NOUN
dpc-5027	46	8	of	of	ADP
dpc-5027	46	9	microorganisms	microorganism	NOUN
dpc-5027	46	10	,	,	PUNCT
dpc-5027	46	11	including	include	VERB
dpc-5027	46	12	bacteria	bacteria	NOUN
dpc-5027	46	13	,	,	PUNCT
dpc-5027	46	14	that	that	PRON
dpc-5027	46	15	are	be	AUX
dpc-5027	46	16	both	both	CCONJ
dpc-5027	46	17	internal	internal	ADJ
dpc-5027	46	18	and	and	CCONJ
dpc-5027	46	19	external	external	ADJ
dpc-5027	46	20	to	to	ADP
dpc-5027	46	21	the	the	DET
dpc-5027	46	22	human	human	ADJ
dpc-5027	46	23	body	body	NOUN
dpc-5027	46	24	.	.	PUNCT
dpc-5027	47	1	intestinal	intestinal	ADJ
dpc-5027	47	2	flora	flora	NOUN
dpc-5027	47	3	is	be	AUX
dpc-5027	47	4	one	one	NUM
dpc-5027	47	5	of	of	ADP
dpc-5027	47	6	the	the	DET
dpc-5027	47	7	human	human	ADJ
dpc-5027	47	8	microbiota	microbiota	NOUN
dpc-5027	47	9	ecosystems	ecosystem	NOUN
dpc-5027	47	10	that	that	PRON
dpc-5027	47	11	has	have	VERB
dpc-5027	47	12	a	a	DET
dpc-5027	47	13	significant	significant	ADJ
dpc-5027	47	14	impact	impact	NOUN
dpc-5027	47	15	on	on	ADP
dpc-5027	47	16	our	our	PRON
dpc-5027	47	17	health	health	NOUN
dpc-5027	47	18	[	[	X
dpc-5027	47	19	13	13	NUM
dpc-5027	47	20	]	]	PUNCT
dpc-5027	47	21	.	.	PUNCT
dpc-5027	48	1	an	an	DET
dpc-5027	48	2	inflammatory	inflammatory	ADJ
dpc-5027	48	3	response	response	NOUN
dpc-5027	48	4	may	may	AUX
dpc-5027	48	5	be	be	AUX
dpc-5027	48	6	initiated	initiate	VERB
dpc-5027	48	7	by	by	ADP
dpc-5027	48	8	any	any	DET
dpc-5027	48	9	quantitative	quantitative	ADJ
dpc-5027	48	10	or	or	CCONJ
dpc-5027	48	11	qualitative	qualitative	ADJ
dpc-5027	48	12	alterations	alteration	NOUN
dpc-5027	48	13	to	to	ADP
dpc-5027	48	14	the	the	DET
dpc-5027	48	15	intestinal	intestinal	PROPN
dpc-5027	48	16	microbiomes	microbiomes	PROPN
dpc-5027	48	17	,	,	PUNCT
dpc-5027	48	18	which	which	PRON
dpc-5027	48	19	may	may	AUX
dpc-5027	48	20	be	be	AUX
dpc-5027	48	21	followed	follow	VERB
dpc-5027	48	22	by	by	ADP
dpc-5027	48	23	autoimmune	autoimmune	ADJ
dpc-5027	48	24	processes	process	NOUN
dpc-5027	48	25	or	or	CCONJ
dpc-5027	48	26	tissue	tissue	NOUN
dpc-5027	48	27	damage	damage	NOUN
dpc-5027	48	28	[	[	X
dpc-5027	48	29	14	14	NUM
dpc-5027	48	30	]	]	PUNCT
dpc-5027	48	31	.	.	PUNCT
dpc-5027	49	1	these	these	DET
dpc-5027	49	2	modifications	modification	NOUN
dpc-5027	49	3	,	,	PUNCT
dpc-5027	49	4	which	which	PRON
dpc-5027	49	5	encompass	encompass	VERB
dpc-5027	49	6	a	a	DET
dpc-5027	49	7	variety	variety	NOUN
dpc-5027	49	8	of	of	ADP
dpc-5027	49	9	dietary	dietary	ADJ
dpc-5027	49	10	components	component	NOUN
dpc-5027	49	11	,	,	PUNCT
dpc-5027	49	12	illnesses	illness	NOUN
dpc-5027	49	13	,	,	PUNCT
dpc-5027	49	14	lifestyles	lifestyle	NOUN
dpc-5027	49	15	,	,	PUNCT
dpc-5027	49	16	prebiotics	prebiotic	NOUN
dpc-5027	49	17	,	,	PUNCT
dpc-5027	49	18	probiotics	probiotic	NOUN
dpc-5027	49	19	,	,	PUNCT
dpc-5027	49	20	antibiotics	antibiotic	NOUN
dpc-5027	49	21	,	,	PUNCT
dpc-5027	49	22	and	and	CCONJ
dpc-5027	49	23	novel	novel	ADJ
dpc-5027	49	24	biologic	biologic	NOUN
dpc-5027	49	25	medications	medication	NOUN
dpc-5027	49	26	,	,	PUNCT
dpc-5027	49	27	have	have	VERB
dpc-5027	49	28	the	the	DET
dpc-5027	49	29	potential	potential	NOUN
dpc-5027	49	30	to	to	PART
dpc-5027	49	31	modify	modify	VERB
dpc-5027	49	32	gut	gut	NOUN
dpc-5027	49	33	microbial	microbial	ADJ
dpc-5027	49	34	communities	community	NOUN
dpc-5027	49	35	.	.	PUNCT
dpc-5027	50	1	these	these	DET
dpc-5027	50	2	modifications	modification	NOUN
dpc-5027	50	3	can	can	AUX
dpc-5027	50	4	result	result	VERB
dpc-5027	50	5	in	in	ADP
dpc-5027	50	6	dysbiosis	dysbiosis	NOUN
dpc-5027	50	7	,	,	PUNCT
dpc-5027	50	8	which	which	PRON
dpc-5027	50	9	can	can	AUX
dpc-5027	50	10	further	far	ADV
dpc-5027	50	11	reduce	reduce	VERB
dpc-5027	50	12	the	the	DET
dpc-5027	50	13	gut	gut	NOUN
dpc-5027	50	14	mucus	mucus	NOUN
dpc-5027	50	15	layer	layer	NOUN
dpc-5027	50	16	integrity	integrity	NOUN
dpc-5027	50	17	,	,	PUNCT
dpc-5027	50	18	allow	allow	VERB
dpc-5027	50	19	microbes	microbe	NOUN
dpc-5027	50	20	to	to	PART
dpc-5027	50	21	pass	pass	VERB
dpc-5027	50	22	through	through	ADP
dpc-5027	50	23	the	the	DET
dpc-5027	50	24	intestinal	intestinal	ADJ
dpc-5027	50	25	barrier	barrier	NOUN
dpc-5027	50	26	,	,	PUNCT
dpc-5027	50	27	induce	induce	VERB
dpc-5027	50	28	harmful	harmful	ADJ
dpc-5027	50	29	effects	effect	NOUN
dpc-5027	50	30	by	by	ADP
dpc-5027	50	31	neurotransmitters	neurotransmitter	NOUN
dpc-5027	50	32	of	of	ADP
dpc-5027	50	33	the	the	DET
dpc-5027	50	34	gut	gut	NOUN
dpc-5027	50	35	microbes	microbe	NOUN
dpc-5027	50	36	or	or	CCONJ
dpc-5027	50	37	the	the	DET
dpc-5027	50	38	host	host	NOUN
dpc-5027	50	39	,	,	PUNCT
dpc-5027	50	40	produce	produce	VERB
dpc-5027	50	41	toxic	toxic	ADJ
dpc-5027	50	42	products	product	NOUN
dpc-5027	50	43	,	,	PUNCT
dpc-5027	50	44	produce	produce	VERB
dpc-5027	50	45	b	b	NOUN
dpc-5027	50	46	cell	cell	NOUN
dpc-5027	50	47	hyperresponsiveness	hyperresponsiveness	NOUN
dpc-5027	50	48	,	,	PUNCT
dpc-5027	50	49	impair	impair	NOUN
dpc-5027	50	50	t	t	NOUN
dpc-5027	50	51	cell	cell	NOUN
dpc-5027	50	52	differentiation	differentiation	NOUN
dpc-5027	50	53	,	,	PUNCT
dpc-5027	50	54	and	and	CCONJ
dpc-5027	50	55	create	create	VERB
dpc-5027	50	56	low	low	ADJ
dpc-5027	50	57	iga	iga	PROPN
dpc-5027	50	58	secretion	secretion	NOUN
dpc-5027	50	59	levels	level	NOUN
dpc-5027	50	60	[	[	X
dpc-5027	50	61	15	15	NUM
dpc-5027	50	62	]	]	PUNCT
dpc-5027	50	63	.	.	PUNCT
dpc-5027	51	1	in	in	ADP
dpc-5027	51	2	the	the	DET
dpc-5027	51	3	process	process	NOUN
dpc-5027	51	4	of	of	ADP
dpc-5027	51	5	passing	pass	VERB
dpc-5027	51	6	through	through	ADP
dpc-5027	51	7	the	the	DET
dpc-5027	51	8	circulatory	circulatory	ADJ
dpc-5027	51	9	system	system	NOUN
dpc-5027	51	10	,	,	PUNCT
dpc-5027	51	11	all	all	DET
dpc-5027	51	12	these	these	DET
dpc-5027	51	13	substances	substance	NOUN
dpc-5027	51	14	transform	transform	VERB
dpc-5027	51	15	the	the	DET
dpc-5027	51	16	state	state	NOUN
dpc-5027	51	17	of	of	ADP
dpc-5027	51	18	the	the	DET
dpc-5027	51	19	skin	skin	NOUN
dpc-5027	51	20	from	from	ADP
dpc-5027	51	21	healthy	healthy	ADJ
dpc-5027	51	22	to	to	ADP
dpc-5027	51	23	dysbiotic	dysbiotic	NOUN
dpc-5027	51	24	[	[	X
dpc-5027	51	25	15	15	NUM
dpc-5027	51	26	]	]	PUNCT
dpc-5027	51	27	.	.	PUNCT
dpc-5027	52	1	objectives	objective	VERB
dpc-5027	52	2	the	the	DET
dpc-5027	52	3	present	present	ADJ
dpc-5027	52	4	study	study	NOUN
dpc-5027	52	5	aimed	aim	VERB
dpc-5027	52	6	to	to	PART
dpc-5027	52	7	estimate	estimate	VERB
dpc-5027	52	8	the	the	DET
dpc-5027	52	9	serum	serum	NOUN
dpc-5027	52	10	zonulin	zonulin	PROPN
dpc-5027	52	11	level	level	NOUN
dpc-5027	52	12	in	in	ADP
dpc-5027	52	13	patients	patient	NOUN
dpc-5027	52	14	with	with	ADP
dpc-5027	52	15	rosacea	rosacea	NOUN
dpc-5027	52	16	compared	compare	VERB
dpc-5027	52	17	with	with	ADP
dpc-5027	52	18	healthy	healthy	ADJ
dpc-5027	52	19	controls	control	NOUN
dpc-5027	52	20	.	.	PUNCT
dpc-5027	53	1	in	in	ADP
dpc-5027	53	2	addition	addition	NOUN
dpc-5027	53	3	,	,	PUNCT
dpc-5027	53	4	some	some	DET
dpc-5027	53	5	fecal	fecal	ADJ
dpc-5027	53	6	bacteria	bacteria	NOUN
dpc-5027	53	7	were	be	AUX
dpc-5027	53	8	investigated	investigate	VERB
dpc-5027	53	9	and	and	CCONJ
dpc-5027	53	10	correlated	correlate	VERB
dpc-5027	53	11	with	with	ADP
dpc-5027	53	12	the	the	DET
dpc-5027	53	13	disease	disease	NOUN
dpc-5027	53	14	severity	severity	NOUN
dpc-5027	53	15	in	in	ADP
dpc-5027	53	16	an	an	DET
dpc-5027	53	17	attempt	attempt	NOUN
dpc-5027	53	18	to	to	PART
dpc-5027	53	19	find	find	VERB
dpc-5027	53	20	a	a	DET
dpc-5027	53	21	relationship	relationship	NOUN
dpc-5027	53	22	between	between	ADP
dpc-5027	53	23	rosacea	rosacea	NOUN
dpc-5027	53	24	and	and	CCONJ
dpc-5027	53	25	gut	gut	NOUN
dpc-5027	53	26	microbiome	microbiome	NOUN
dpc-5027	53	27	.	.	PUNCT
dpc-5027	54	1	methods	method	NOUN
dpc-5027	54	2	this	this	DET
dpc-5027	54	3	case	case	NOUN
dpc-5027	54	4	-	-	PUNCT
dpc-5027	54	5	control	control	NOUN
dpc-5027	54	6	research	research	NOUN
dpc-5027	54	7	was	be	AUX
dpc-5027	54	8	carried	carry	VERB
dpc-5027	54	9	out	out	ADP
dpc-5027	54	10	on	on	ADP
dpc-5027	54	11	a	a	DET
dpc-5027	54	12	total	total	NOUN
dpc-5027	54	13	of	of	ADP
dpc-5027	54	14	42	42	NUM
dpc-5027	54	15	individuals	individual	NOUN
dpc-5027	54	16	:	:	PUNCT
dpc-5027	54	17	21	21	NUM
dpc-5027	54	18	rosacea	rosacea	NOUN
dpc-5027	54	19	cases	case	NOUN
dpc-5027	54	20	and	and	CCONJ
dpc-5027	54	21	21	21	NUM
dpc-5027	54	22	healthy	healthy	ADJ
dpc-5027	54	23	sexand	sexand	NOUN
dpc-5027	54	24	agematched	agematche	VERB
dpc-5027	54	25	individuals	individual	NOUN
dpc-5027	54	26	.	.	PUNCT
dpc-5027	55	1	they	they	PRON
dpc-5027	55	2	were	be	AUX
dpc-5027	55	3	randomly	randomly	ADV
dpc-5027	55	4	chosen	choose	VERB
dpc-5027	55	5	from	from	ADP
dpc-5027	55	6	the	the	DET
dpc-5027	55	7	dermatology	dermatology	NOUN
dpc-5027	55	8	outpatient	outpatient	NOUN
dpc-5027	55	9	clinic	clinic	NOUN
dpc-5027	55	10	in	in	ADP
dpc-5027	55	11	al	al	PROPN
dpc-5027	55	12	zahraa	zahraa	PROPN
dpc-5027	55	13	university	university	PROPN
dpc-5027	55	14	hospital	hospital	PROPN
dpc-5027	55	15	and	and	CCONJ
dpc-5027	55	16	damanhour	damanhour	PROPN
dpc-5027	55	17	medical	medical	PROPN
dpc-5027	55	18	national	national	PROPN
dpc-5027	55	19	institute	institute	PROPN
dpc-5027	55	20	during	during	ADP
dpc-5027	55	21	the	the	DET
dpc-5027	55	22	period	period	NOUN
dpc-5027	55	23	from	from	ADP
dpc-5027	55	24	february	february	PROPN
dpc-5027	55	25	2021	2021	NUM
dpc-5027	55	26	to	to	ADP
dpc-5027	55	27	december	december	PROPN
dpc-5027	55	28	2022	2022	NUM
dpc-5027	55	29	.	.	PUNCT
dpc-5027	56	1	the	the	DET
dpc-5027	56	2	ethics	ethics	PROPN
dpc-5027	56	3	committee	committee	PROPN
dpc-5027	56	4	of	of	ADP
dpc-5027	56	5	the	the	DET
dpc-5027	56	6	faculty	faculty	NOUN
dpc-5027	56	7	of	of	ADP
dpc-5027	56	8	medicine	medicine	NOUN
dpc-5027	56	9	for	for	ADP
dpc-5027	56	10	girls	girl	NOUN
dpc-5027	56	11	at	at	ADP
dpc-5027	56	12	al	al	PROPN
dpc-5027	56	13	-	-	PUNCT
dpc-5027	56	14	azhar	azhar	PROPN
dpc-5027	56	15	university	university	PROPN
dpc-5027	56	16	,	,	PUNCT
dpc-5027	56	17	egypt	egypt	PROPN
dpc-5027	56	18	,	,	PUNCT
dpc-5027	56	19	approved	approve	VERB
dpc-5027	56	20	this	this	DET
dpc-5027	56	21	research	research	NOUN
dpc-5027	56	22	.	.	PUNCT
dpc-5027	57	1	irb	irb	PROPN
dpc-5027	57	2	(	(	PUNCT
dpc-5027	57	3	202102652	202102652	NUM
dpc-5027	57	4	)	)	PUNCT
dpc-5027	57	5	.	.	PUNCT
dpc-5027	58	1	the	the	DET
dpc-5027	58	2	sample	sample	NOUN
dpc-5027	58	3	size	size	NOUN
dpc-5027	58	4	was	be	AUX
dpc-5027	58	5	determined	determine	VERB
dpc-5027	58	6	using	use	VERB
dpc-5027	58	7	the	the	DET
dpc-5027	58	8	epi	epi	NOUN
dpc-5027	58	9	-	-	NOUN
dpc-5027	58	10	info	info	ADJ
dpc-5027	58	11	statistical	statistical	ADJ
dpc-5027	58	12	application	application	NOUN
dpc-5027	58	13	developed	develop	VERB
dpc-5027	58	14	by	by	ADP
dpc-5027	58	15	the	the	DET
dpc-5027	58	16	world	world	PROPN
dpc-5027	58	17	health	health	PROPN
dpc-5027	58	18	organization	organization	NOUN
dpc-5027	58	19	and	and	CCONJ
dpc-5027	58	20	the	the	DET
dpc-5027	58	21	centers	center	NOUN
dpc-5027	58	22	for	for	ADP
dpc-5027	58	23	disease	disease	NOUN
dpc-5027	58	24	control	control	NOUN
dpc-5027	58	25	and	and	CCONJ
dpc-5027	58	26	prevention	prevention	NOUN
dpc-5027	58	27	in	in	ADP
dpc-5027	58	28	atlanta	atlanta	PROPN
dpc-5027	58	29	,	,	PUNCT
dpc-5027	58	30	georgia	georgia	PROPN
dpc-5027	58	31	,	,	PUNCT
dpc-5027	58	32	usa	usa	PROPN
dpc-5027	58	33	,	,	PUNCT
dpc-5027	58	34	in	in	ADP
dpc-5027	58	35	2002	2002	NUM
dpc-5027	58	36	.	.	PUNCT
dpc-5027	59	1	the	the	DET
dpc-5027	59	2	study	study	NOUN
dpc-5027	59	3	’s	’s	PART
dpc-5027	59	4	power	power	NOUN
dpc-5027	59	5	was	be	AUX
dpc-5027	59	6	calculated	calculate	VERB
dpc-5027	59	7	at	at	ADP
dpc-5027	59	8	84	84	NUM
dpc-5027	59	9	%	%	NOUN
dpc-5027	59	10	,	,	PUNCT
dpc-5027	59	11	with	with	ADP
dpc-5027	59	12	a	a	DET
dpc-5027	59	13	5	5	NUM
dpc-5027	59	14	%	%	NOUN
dpc-5027	59	15	accepted	accept	VERB
dpc-5027	59	16	error	error	NOUN
dpc-5027	59	17	and	and	CCONJ
dpc-5027	59	18	a	a	DET
dpc-5027	59	19	95	95	NUM
dpc-5027	59	20	%	%	NOUN
dpc-5027	59	21	confidence	confidence	NOUN
dpc-5027	59	22	limit	limit	NOUN
dpc-5027	59	23	.	.	PUNCT
dpc-5027	60	1	the	the	DET
dpc-5027	60	2	annual	annual	ADJ
dpc-5027	60	3	influx	influx	NOUN
dpc-5027	60	4	into	into	ADP
dpc-5027	60	5	the	the	DET
dpc-5027	60	6	hospital	hospital	NOUN
dpc-5027	60	7	ranged	range	VERB
dpc-5027	60	8	from	from	ADP
dpc-5027	60	9	30	30	NUM
dpc-5027	60	10	to	to	PART
dpc-5027	60	11	50	50	NUM
dpc-5027	60	12	cases	case	NOUN
dpc-5027	60	13	.	.	PUNCT
dpc-5027	61	1	accordingly	accordingly	ADV
dpc-5027	61	2	,	,	PUNCT
dpc-5027	61	3	the	the	DET
dpc-5027	61	4	minimum	minimum	ADJ
dpc-5027	61	5	estimated	estimate	VERB
dpc-5027	61	6	sample	sample	NOUN
dpc-5027	61	7	size	size	NOUN
dpc-5027	61	8	constituted	constitute	VERB
dpc-5027	61	9	21	21	NUM
dpc-5027	61	10	cases	case	NOUN
dpc-5027	61	11	and	and	CCONJ
dpc-5027	61	12	21	21	NUM
dpc-5027	61	13	healthy	healthy	ADJ
dpc-5027	61	14	controls	control	NOUN
dpc-5027	61	15	.	.	PUNCT
dpc-5027	62	1	patients	patient	NOUN
dpc-5027	62	2	of	of	ADP
dpc-5027	62	3	both	both	DET
dpc-5027	62	4	sexes	sex	NOUN
dpc-5027	62	5	aged	age	VERB
dpc-5027	62	6	above	above	ADP
dpc-5027	62	7	18	18	NUM
dpc-5027	62	8	years	year	NOUN
dpc-5027	62	9	with	with	ADP
dpc-5027	62	10	any	any	DET
dpc-5027	62	11	subtype	subtype	NOUN
dpc-5027	62	12	of	of	ADP
dpc-5027	62	13	rosacea	rosacea	NOUN
dpc-5027	62	14	were	be	AUX
dpc-5027	62	15	involved	involve	VERB
dpc-5027	62	16	in	in	ADP
dpc-5027	62	17	the	the	DET
dpc-5027	62	18	research	research	NOUN
dpc-5027	62	19	.	.	PUNCT
dpc-5027	63	1	exclusion	exclusion	NOUN
dpc-5027	63	2	criteria	criterion	NOUN
dpc-5027	63	3	included	include	VERB
dpc-5027	63	4	patients	patient	NOUN
dpc-5027	63	5	with	with	ADP
dpc-5027	63	6	systemic	systemic	ADJ
dpc-5027	63	7	diseases	disease	NOUN
dpc-5027	63	8	or	or	CCONJ
dpc-5027	63	9	autoimmune	autoimmune	ADJ
dpc-5027	63	10	diseases	disease	NOUN
dpc-5027	63	11	known	know	VERB
dpc-5027	63	12	to	to	PART
dpc-5027	63	13	affect	affect	VERB
dpc-5027	63	14	levels	level	NOUN
dpc-5027	63	15	of	of	ADP
dpc-5027	63	16	zonulin	zonulin	PROPN
dpc-5027	63	17	,	,	PUNCT
dpc-5027	63	18	for	for	ADP
dpc-5027	63	19	example	example	NOUN
dpc-5027	63	20	(	(	PUNCT
dpc-5027	63	21	type	type	NOUN
dpc-5027	63	22	1	1	NUM
dpc-5027	63	23	diabetes	diabetes	NOUN
dpc-5027	63	24	,	,	PUNCT
dpc-5027	63	25	coeliac	coeliac	NOUN
dpc-5027	63	26	disease	disease	NOUN
dpc-5027	63	27	,	,	PUNCT
dpc-5027	63	28	rheumatoid	rheumatoid	NOUN
dpc-5027	63	29	arthritis	arthritis	NOUN
dpc-5027	63	30	,	,	PUNCT
dpc-5027	63	31	multiple	multiple	ADJ
dpc-5027	63	32	sclerosis	sclerosis	NOUN
dpc-5027	63	33	,	,	PUNCT
dpc-5027	63	34	autoimmune	autoimmune	ADJ
dpc-5027	63	35	goiter	goiter	NOUN
dpc-5027	63	36	,	,	PUNCT
dpc-5027	63	37	and	and	CCONJ
dpc-5027	63	38	inflammatory	inflammatory	ADJ
dpc-5027	63	39	bowel	bowel	NOUN
dpc-5027	63	40	disease	disease	NOUN
dpc-5027	63	41	)	)	PUNCT
dpc-5027	63	42	,	,	PUNCT
dpc-5027	63	43	patients	patient	NOUN
dpc-5027	63	44	who	who	PRON
dpc-5027	63	45	were	be	AUX
dpc-5027	63	46	taking	take	VERB
dpc-5027	63	47	antibiotics	antibiotic	NOUN
dpc-5027	63	48	,	,	PUNCT
dpc-5027	63	49	including	include	VERB
dpc-5027	63	50	tetracycline	tetracycline	NOUN
dpc-5027	63	51	and	and	CCONJ
dpc-5027	63	52	probiotics	probiotic	NOUN
dpc-5027	63	53	,	,	PUNCT
dpc-5027	63	54	within	within	ADP
dpc-5027	63	55	six	six	NUM
dpc-5027	63	56	weeks	week	NOUN
dpc-5027	63	57	before	before	ADP
dpc-5027	63	58	the	the	DET
dpc-5027	63	59	study	study	NOUN
dpc-5027	63	60	that	that	PRON
dpc-5027	63	61	might	might	AUX
dpc-5027	63	62	have	have	AUX
dpc-5027	63	63	influenced	influence	VERB
dpc-5027	63	64	the	the	DET
dpc-5027	63	65	gut	gut	NOUN
dpc-5027	63	66	environment	environment	NOUN
dpc-5027	63	67	,	,	PUNCT
dpc-5027	63	68	use	use	NOUN
dpc-5027	63	69	of	of	ADP
dpc-5027	63	70	antibiotics	antibiotic	NOUN
dpc-5027	63	71	within	within	ADP
dpc-5027	63	72	four	four	NUM
dpc-5027	63	73	weeks	week	NOUN
dpc-5027	63	74	before	before	ADP
dpc-5027	63	75	the	the	DET
dpc-5027	63	76	study	study	NOUN
dpc-5027	63	77	in	in	ADP
dpc-5027	63	78	the	the	DET
dpc-5027	63	79	control	control	NOUN
dpc-5027	63	80	group	group	NOUN
dpc-5027	63	81	,	,	PUNCT
dpc-5027	63	82	patients	patient	NOUN
dpc-5027	63	83	who	who	PRON
dpc-5027	63	84	were	be	AUX
dpc-5027	63	85	undergoing	undergo	VERB
dpc-5027	63	86	radiotherapy	radiotherapy	NOUN
dpc-5027	63	87	and	and	CCONJ
dpc-5027	63	88	chemotherapy	chemotherapy	NOUN
dpc-5027	63	89	,	,	PUNCT
dpc-5027	63	90	and	and	CCONJ
dpc-5027	63	91	original	original	ADJ
dpc-5027	63	92	article	article	NOUN
dpc-5027	63	93	|	|	ADV
dpc-5027	63	94	dermatol	dermatol	ADJ
dpc-5027	63	95	pract	pract	NOUN
dpc-5027	63	96	concept	concept	NOUN
dpc-5027	63	97	.	.	PUNCT
dpc-5027	64	1	2025;15(3):5027	2025;15(3):5027	NUM
dpc-5027	64	2	3	3	NUM
dpc-5027	64	3	patients	patient	NOUN
dpc-5027	64	4	with	with	ADP
dpc-5027	64	5	dermatological	dermatological	ADJ
dpc-5027	64	6	diseases	disease	NOUN
dpc-5027	64	7	,	,	PUNCT
dpc-5027	64	8	for	for	ADP
dpc-5027	64	9	example	example	NOUN
dpc-5027	64	10	,	,	PUNCT
dpc-5027	64	11	psoriasis	psoriasis	NOUN
dpc-5027	64	12	,	,	PUNCT
dpc-5027	64	13	lichen	lichen	NOUN
dpc-5027	64	14	planus	planus	NOUN
dpc-5027	64	15	,	,	PUNCT
dpc-5027	64	16	and	and	CCONJ
dpc-5027	64	17	atopic	atopic	NOUN
dpc-5027	64	18	dermatitis	dermatitis	NOUN
dpc-5027	64	19	.	.	PUNCT
dpc-5027	65	1	clinical	clinical	ADJ
dpc-5027	65	2	assessment	assessment	NOUN
dpc-5027	65	3	a	a	DET
dpc-5027	65	4	general	general	ADJ
dpc-5027	65	5	and	and	CCONJ
dpc-5027	65	6	dermatological	dermatological	ADJ
dpc-5027	65	7	examination	examination	NOUN
dpc-5027	65	8	was	be	AUX
dpc-5027	65	9	performed	perform	VERB
dpc-5027	65	10	on	on	ADP
dpc-5027	65	11	each	each	DET
dpc-5027	65	12	patient	patient	NOUN
dpc-5027	65	13	to	to	PART
dpc-5027	65	14	rule	rule	VERB
dpc-5027	65	15	out	out	ADP
dpc-5027	65	16	the	the	DET
dpc-5027	65	17	presence	presence	NOUN
dpc-5027	65	18	of	of	ADP
dpc-5027	65	19	any	any	DET
dpc-5027	65	20	additional	additional	ADJ
dpc-5027	65	21	systemic	systemic	ADJ
dpc-5027	65	22	or	or	CCONJ
dpc-5027	65	23	related	related	ADJ
dpc-5027	65	24	dermatologic	dermatologic	ADJ
dpc-5027	65	25	conditions	condition	NOUN
dpc-5027	65	26	.	.	PUNCT
dpc-5027	66	1	we	we	PRON
dpc-5027	66	2	used	use	VERB
dpc-5027	66	3	metric	metric	ADJ
dpc-5027	66	4	units	unit	NOUN
dpc-5027	66	5	to	to	PART
dpc-5027	66	6	measure	measure	VERB
dpc-5027	66	7	the	the	DET
dpc-5027	66	8	body	body	NOUN
dpc-5027	66	9	mass	mass	NOUN
dpc-5027	66	10	index	index	NOUN
dpc-5027	66	11	(	(	PUNCT
dpc-5027	66	12	bmi	bmi	PROPN
dpc-5027	66	13	)	)	PUNCT
dpc-5027	66	14	.	.	PUNCT
dpc-5027	67	1	the	the	DET
dpc-5027	67	2	presence	presence	NOUN
dpc-5027	67	3	of	of	ADP
dpc-5027	67	4	either	either	DET
dpc-5027	67	5	one	one	NUM
dpc-5027	67	6	of	of	ADP
dpc-5027	67	7	the	the	DET
dpc-5027	67	8	diagnostic	diagnostic	ADJ
dpc-5027	67	9	phenotypes	phenotype	NOUN
dpc-5027	67	10	,	,	PUNCT
dpc-5027	67	11	including	include	VERB
dpc-5027	67	12	phymatous	phymatous	ADJ
dpc-5027	67	13	changes	change	NOUN
dpc-5027	67	14	or	or	CCONJ
dpc-5027	67	15	centrofacial	centrofacial	ADJ
dpc-5027	67	16	persistent	persistent	ADJ
dpc-5027	67	17	erythema	erythema	NOUN
dpc-5027	67	18	in	in	ADP
dpc-5027	67	19	a	a	DET
dpc-5027	67	20	characteristic	characteristic	ADJ
dpc-5027	67	21	pattern	pattern	NOUN
dpc-5027	67	22	that	that	PRON
dpc-5027	67	23	could	could	AUX
dpc-5027	67	24	periodically	periodically	ADV
dpc-5027	67	25	intensify	intensify	VERB
dpc-5027	67	26	was	be	AUX
dpc-5027	67	27	the	the	DET
dpc-5027	67	28	basis	basis	NOUN
dpc-5027	67	29	for	for	ADP
dpc-5027	67	30	a	a	DET
dpc-5027	67	31	diagnosis	diagnosis	NOUN
dpc-5027	67	32	of	of	ADP
dpc-5027	67	33	rosacea	rosacea	NOUN
dpc-5027	67	34	[	[	X
dpc-5027	67	35	16	16	NUM
dpc-5027	67	36	]	]	PUNCT
dpc-5027	67	37	.	.	PUNCT
dpc-5027	68	1	in	in	ADP
dpc-5027	68	2	the	the	DET
dpc-5027	68	3	absence	absence	NOUN
dpc-5027	68	4	of	of	ADP
dpc-5027	68	5	these	these	DET
dpc-5027	68	6	features	feature	NOUN
dpc-5027	68	7	,	,	PUNCT
dpc-5027	68	8	the	the	DET
dpc-5027	68	9	diagnosis	diagnosis	NOUN
dpc-5027	68	10	was	be	AUX
dpc-5027	68	11	established	establish	VERB
dpc-5027	68	12	by	by	ADP
dpc-5027	68	13	the	the	DET
dpc-5027	68	14	presence	presence	NOUN
dpc-5027	68	15	of	of	ADP
dpc-5027	68	16	any	any	DET
dpc-5027	68	17	two	two	NUM
dpc-5027	68	18	of	of	ADP
dpc-5027	68	19	the	the	DET
dpc-5027	68	20	following	follow	VERB
dpc-5027	68	21	major	major	ADJ
dpc-5027	68	22	features	feature	NOUN
dpc-5027	68	23	–	–	PUNCT
dpc-5027	68	24	telangiectasia	telangiectasia	NOUN
dpc-5027	68	25	,	,	PUNCT
dpc-5027	68	26	flushing/	flushing/	ADJ
dpc-5027	68	27	transient	transient	NOUN
dpc-5027	68	28	erythema	erythema	NOUN
dpc-5027	68	29	,	,	PUNCT
dpc-5027	68	30	papules	papule	NOUN
dpc-5027	68	31	,	,	PUNCT
dpc-5027	68	32	or	or	CCONJ
dpc-5027	68	33	pustules	pustule	NOUN
dpc-5027	68	34	–	–	PUNCT
dpc-5027	68	35	and	and	CCONJ
dpc-5027	68	36	the	the	DET
dpc-5027	68	37	following	follow	VERB
dpc-5027	68	38	ocular	ocular	ADJ
dpc-5027	68	39	manifestations	manifestation	NOUN
dpc-5027	68	40	:	:	PUNCT
dpc-5027	68	41	lid	lid	NOUN
dpc-5027	68	42	margin	margin	NOUN
dpc-5027	68	43	telangiectasia	telangiectasia	NOUN
dpc-5027	68	44	,	,	PUNCT
dpc-5027	68	45	interpalpebral	interpalpebral	ADJ
dpc-5027	68	46	conjunctival	conjunctival	NOUN
dpc-5027	68	47	injection	injection	NOUN
dpc-5027	68	48	,	,	PUNCT
dpc-5027	68	49	spade	spade	NOUN
dpc-5027	68	50	-	-	PUNCT
dpc-5027	68	51	shaped	shape	VERB
dpc-5027	68	52	infiltrates	infiltrate	NOUN
dpc-5027	68	53	in	in	ADP
dpc-5027	68	54	the	the	DET
dpc-5027	68	55	cornea	cornea	NOUN
dpc-5027	68	56	,	,	PUNCT
dpc-5027	68	57	scleritis	scleritis	NOUN
dpc-5027	68	58	,	,	PUNCT
dpc-5027	68	59	and	and	CCONJ
dpc-5027	68	60	sclerokeratitis	sclerokeratitis	NOUN
dpc-5027	69	1	[	[	X
dpc-5027	69	2	16	16	NUM
dpc-5027	69	3	,	,	PUNCT
dpc-5027	69	4	17	17	NUM
dpc-5027	69	5	]	]	PUNCT
dpc-5027	69	6	,	,	PUNCT
dpc-5027	69	7	in	in	ADP
dpc-5027	69	8	accordance	accordance	NOUN
dpc-5027	69	9	with	with	ADP
dpc-5027	69	10	the	the	DET
dpc-5027	69	11	recommendations	recommendation	NOUN
dpc-5027	69	12	of	of	ADP
dpc-5027	69	13	the	the	DET
dpc-5027	69	14	global	global	ADJ
dpc-5027	69	15	rosacea	rosacea	PROPN
dpc-5027	69	16	consensus	consensus	PROPN
dpc-5027	69	17	(	(	PUNCT
dpc-5027	69	18	rosco	rosco	PROPN
dpc-5027	69	19	)	)	PUNCT
dpc-5027	69	20	panel	panel	NOUN
dpc-5027	70	1	[	[	X
dpc-5027	70	2	16	16	NUM
dpc-5027	70	3	]	]	PUNCT
dpc-5027	70	4	.	.	PUNCT
dpc-5027	71	1	dermoscopic	dermoscopic	PROPN
dpc-5027	71	2	examination	examination	NOUN
dpc-5027	71	3	was	be	AUX
dpc-5027	71	4	done	do	VERB
dpc-5027	71	5	by	by	ADP
dpc-5027	71	6	using	use	VERB
dpc-5027	71	7	a	a	DET
dpc-5027	71	8	dermlite	dermlite	ADJ
dpc-5027	71	9	(	(	PUNCT
dpc-5027	71	10	dl4w	dl4w	PROPN
dpc-5027	71	11	)	)	PUNCT
dpc-5027	71	12	polarized	polarize	VERB
dpc-5027	71	13	dermatoscope	dermatoscope	NOUN
dpc-5027	71	14	to	to	PART
dpc-5027	71	15	confirm	confirm	VERB
dpc-5027	71	16	the	the	DET
dpc-5027	71	17	diagnosis	diagnosis	NOUN
dpc-5027	71	18	of	of	ADP
dpc-5027	71	19	rosacea	rosacea	NOUN
dpc-5027	71	20	.	.	PUNCT
dpc-5027	72	1	the	the	DET
dpc-5027	72	2	diagnostic	diagnostic	ADJ
dpc-5027	72	3	patterns	pattern	NOUN
dpc-5027	72	4	of	of	ADP
dpc-5027	72	5	rosacea	rosacea	NOUN
dpc-5027	72	6	included	include	VERB
dpc-5027	72	7	orange	orange	ADJ
dpc-5027	72	8	-	-	PUNCT
dpc-5027	72	9	yellow	yellow	ADJ
dpc-5027	72	10	colored	colored	ADJ
dpc-5027	72	11	areas	area	NOUN
dpc-5027	72	12	,	,	PUNCT
dpc-5027	72	13	polygonal	polygonal	ADJ
dpc-5027	72	14	blood	blood	NOUN
dpc-5027	72	15	vessels	vessel	NOUN
dpc-5027	72	16	,	,	PUNCT
dpc-5027	72	17	a	a	DET
dpc-5027	72	18	pinkish	pinkish	ADJ
dpc-5027	72	19	background	background	NOUN
dpc-5027	72	20	,	,	PUNCT
dpc-5027	72	21	superficial	superficial	ADJ
dpc-5027	72	22	white	white	ADJ
dpc-5027	72	23	scales	scale	NOUN
dpc-5027	72	24	,	,	PUNCT
dpc-5027	72	25	vellus	vellus	ADJ
dpc-5027	72	26	hair	hair	NOUN
dpc-5027	72	27	,	,	PUNCT
dpc-5027	72	28	follicular	follicular	ADJ
dpc-5027	72	29	plugs	plug	NOUN
dpc-5027	72	30	,	,	PUNCT
dpc-5027	72	31	pustules	pustule	NOUN
dpc-5027	72	32	,	,	PUNCT
dpc-5027	72	33	perifollicular	perifollicular	ADJ
dpc-5027	72	34	white	white	ADJ
dpc-5027	72	35	coloration	coloration	NOUN
dpc-5027	72	36	,	,	PUNCT
dpc-5027	72	37	follicular	follicular	ADJ
dpc-5027	72	38	yellow	yellow	ADJ
dpc-5027	72	39	clods	clod	NOUN
dpc-5027	72	40	,	,	PUNCT
dpc-5027	72	41	and	and	CCONJ
dpc-5027	72	42	sebaceous	sebaceous	ADJ
dpc-5027	72	43	hyperplasia	hyperplasia	NOUN
dpc-5027	72	44	(	(	PUNCT
dpc-5027	72	45	figure	figure	NOUN
dpc-5027	72	46	1	1	NUM
dpc-5027	72	47	)	)	PUNCT
dpc-5027	72	48	.	.	PUNCT
dpc-5027	73	1	some	some	DET
dpc-5027	73	2	clinical	clinical	ADJ
dpc-5027	73	3	and	and	CCONJ
dpc-5027	73	4	dermoscopic	dermoscopic	ADJ
dpc-5027	73	5	photos	photo	NOUN
dpc-5027	73	6	of	of	ADP
dpc-5027	73	7	our	our	PRON
dpc-5027	73	8	patients	patient	NOUN
dpc-5027	73	9	with	with	ADP
dpc-5027	73	10	different	different	ADJ
dpc-5027	73	11	subtypes	subtype	NOUN
dpc-5027	73	12	of	of	ADP
dpc-5027	73	13	rosacea	rosacea	NOUN
dpc-5027	73	14	are	be	AUX
dpc-5027	73	15	illustrated	illustrate	VERB
dpc-5027	73	16	in	in	ADP
dpc-5027	73	17	figure	figure	NOUN
dpc-5027	73	18	2	2	NUM
dpc-5027	73	19	.	.	PUNCT
dpc-5027	73	20	laboratory	laboratory	NOUN
dpc-5027	73	21	assessment	assessment	NOUN
dpc-5027	73	22	serum	serum	PROPN
dpc-5027	73	23	zonulin	zonulin	PROPN
dpc-5027	73	24	level	level	PROPN
dpc-5027	73	25	measurement	measurement	NOUN
dpc-5027	73	26	:	:	PUNCT
dpc-5027	73	27	10	10	NUM
dpc-5027	73	28	ml	ml	NOUN
dpc-5027	73	29	of	of	ADP
dpc-5027	73	30	blood	blood	NOUN
dpc-5027	73	31	was	be	AUX
dpc-5027	73	32	collected	collect	VERB
dpc-5027	73	33	from	from	ADP
dpc-5027	73	34	all	all	DET
dpc-5027	73	35	participant	participant	ADJ
dpc-5027	73	36	groups	group	NOUN
dpc-5027	73	37	after	after	ADP
dpc-5027	73	38	12	12	NUM
dpc-5027	73	39	hours	hour	NOUN
dpc-5027	73	40	of	of	ADP
dpc-5027	73	41	fasting	fast	VERB
dpc-5027	73	42	and	and	CCONJ
dpc-5027	73	43	deposited	deposit	VERB
dpc-5027	73	44	in	in	ADP
dpc-5027	73	45	gel	gel	NOUN
dpc-5027	73	46	vacuum	vacuum	PROPN
dpc-5027	73	47	biochemistry	biochemistry	PROPN
dpc-5027	73	48	tubes	tube	NOUN
dpc-5027	73	49	.	.	PUNCT
dpc-5027	74	1	the	the	DET
dpc-5027	74	2	serum	serum	NOUN
dpc-5027	74	3	was	be	AUX
dpc-5027	74	4	separated	separate	VERB
dpc-5027	74	5	by	by	ADP
dpc-5027	74	6	centrifugation	centrifugation	NOUN
dpc-5027	74	7	at	at	ADP
dpc-5027	74	8	3,000	3,000	NUM
dpc-5027	74	9	rpm	rpm	NOUN
dpc-5027	74	10	for	for	ADP
dpc-5027	74	11	20	20	NUM
dpc-5027	74	12	minutes	minute	NOUN
dpc-5027	74	13	after	after	ADP
dpc-5027	74	14	coagulation	coagulation	NOUN
dpc-5027	74	15	for	for	ADP
dpc-5027	74	16	10–20	10–20	NUM
dpc-5027	74	17	minutes	minute	NOUN
dpc-5027	74	18	.	.	PUNCT
dpc-5027	75	1	the	the	DET
dpc-5027	75	2	serum	serum	NOUN
dpc-5027	75	3	that	that	PRON
dpc-5027	75	4	was	be	AUX
dpc-5027	75	5	separated	separate	VERB
dpc-5027	75	6	was	be	AUX
dpc-5027	75	7	maintained	maintain	VERB
dpc-5027	75	8	at	at	ADP
dpc-5027	75	9	–	–	PUNCT
dpc-5027	75	10	80	80	NUM
dpc-5027	75	11	°	°	NUM
dpc-5027	75	12	c	c	NOUN
dpc-5027	75	13	until	until	SCONJ
dpc-5027	75	14	it	it	PRON
dpc-5027	75	15	was	be	AUX
dpc-5027	75	16	analyzed	analyze	VERB
dpc-5027	75	17	.	.	PUNCT
dpc-5027	76	1	a	a	DET
dpc-5027	76	2	double	double	ADJ
dpc-5027	76	3	-	-	PUNCT
dpc-5027	76	4	antibody	antibody	NOUN
dpc-5027	76	5	sandwich	sandwich	NOUN
dpc-5027	76	6	enzyme	enzyme	NOUN
dpc-5027	76	7	-	-	PUNCT
dpc-5027	76	8	linked	link	VERB
dpc-5027	76	9	immunosorbent	immunosorbent	NOUN
dpc-5027	76	10	assay	assay	PROPN
dpc-5027	76	11	(	(	PUNCT
dpc-5027	76	12	elisa	elisa	NOUN
dpc-5027	76	13	)	)	PUNCT
dpc-5027	76	14	reagent	reagent	NOUN
dpc-5027	76	15	(	(	PUNCT
dpc-5027	76	16	shanghai	shanghai	PROPN
dpc-5027	76	17	sunred	sunre	VERB
dpc-5027	76	18	biological	biological	ADJ
dpc-5027	76	19	technology	technology	NOUN
dpc-5027	76	20	company	company	NOUN
dpc-5027	76	21	)	)	PUNCT
dpc-5027	76	22	was	be	AUX
dpc-5027	76	23	employed	employ	VERB
dpc-5027	76	24	to	to	PART
dpc-5027	76	25	conduct	conduct	VERB
dpc-5027	76	26	the	the	DET
dpc-5027	76	27	zonulin	zonulin	PROPN
dpc-5027	76	28	test	test	NOUN
dpc-5027	76	29	.	.	PUNCT
dpc-5027	77	1	the	the	DET
dpc-5027	77	2	kit	kit	PROPN
dpc-5027	77	3	’s	’s	PART
dpc-5027	77	4	measurement	measurement	NOUN
dpc-5027	77	5	range	range	NOUN
dpc-5027	77	6	was	be	AUX
dpc-5027	77	7	0.25	0.25	NUM
dpc-5027	77	8	-	-	PUNCT
dpc-5027	77	9	70ng	70ng	NOUN
dpc-5027	77	10	/	/	SYM
dpc-5027	77	11	ml	ml	NOUN
dpc-5027	77	12	.	.	PUNCT
dpc-5027	77	13	measurement	measurement	NOUN
dpc-5027	77	14	of	of	ADP
dpc-5027	77	15	the	the	DET
dpc-5027	77	16	gut	gut	NOUN
dpc-5027	77	17	microbiome	microbiome	NOUN
dpc-5027	77	18	:	:	PUNCT
dpc-5027	77	19	we	we	PRON
dpc-5027	77	20	collected	collect	VERB
dpc-5027	77	21	the	the	DET
dpc-5027	77	22	stool	stool	NOUN
dpc-5027	77	23	specimen	speciman	NOUN
dpc-5027	77	24	24	24	NUM
dpc-5027	77	25	hours	hour	NOUN
dpc-5027	77	26	prior	prior	ADV
dpc-5027	77	27	to	to	ADP
dpc-5027	77	28	the	the	DET
dpc-5027	77	29	sampling	sampling	NOUN
dpc-5027	77	30	visit	visit	NOUN
dpc-5027	77	31	.	.	PUNCT
dpc-5027	78	1	specimens	specimen	NOUN
dpc-5027	78	2	were	be	AUX
dpc-5027	78	3	transported	transport	VERB
dpc-5027	78	4	to	to	ADP
dpc-5027	78	5	the	the	DET
dpc-5027	78	6	laboratory	laboratory	NOUN
dpc-5027	78	7	using	use	VERB
dpc-5027	78	8	cooler	cooler	ADJ
dpc-5027	78	9	bags	bag	NOUN
dpc-5027	78	10	and	and	CCONJ
dpc-5027	78	11	stored	store	VERB
dpc-5027	78	12	at	at	ADP
dpc-5027	78	13	–	–	PUNCT
dpc-5027	78	14	20	20	NUM
dpc-5027	78	15	°	°	NUM
dpc-5027	78	16	c	c	NOUN
dpc-5027	78	17	until	until	ADP
dpc-5027	78	18	analysis	analysis	NOUN
dpc-5027	78	19	.	.	PUNCT
dpc-5027	79	1	real	real	ADJ
dpc-5027	79	2	-	-	PUNCT
dpc-5027	79	3	time	time	NOUN
dpc-5027	79	4	quantitative	quantitative	ADJ
dpc-5027	79	5	polymerase	polymerase	NOUN
dpc-5027	79	6	chain	chain	NOUN
dpc-5027	79	7	reaction	reaction	NOUN
dpc-5027	79	8	(	(	PUNCT
dpc-5027	79	9	qpcr	qpcr	ADV
dpc-5027	79	10	)	)	PUNCT
dpc-5027	79	11	was	be	AUX
dpc-5027	79	12	conducted	conduct	VERB
dpc-5027	79	13	using	use	VERB
dpc-5027	79	14	specific	specific	ADJ
dpc-5027	79	15	primers	primer	NOUN
dpc-5027	79	16	targeting	target	VERB
dpc-5027	79	17	the	the	DET
dpc-5027	79	18	following	following	ADJ
dpc-5027	79	19	bacterial	bacterial	ADJ
dpc-5027	79	20	taxa	taxa	NOUN
dpc-5027	79	21	:	:	PUNCT
dpc-5027	79	22	bacteroides	bacteroides	PROPN
dpc-5027	79	23	(	(	PUNCT
dpc-5027	79	24	gram	gram	NOUN
dpc-5027	79	25	-	-	PUNCT
dpc-5027	79	26	negative	negative	ADJ
dpc-5027	79	27	,	,	PUNCT
dpc-5027	79	28	non	non	ADJ
dpc-5027	79	29	-	-	ADJ
dpc-5027	79	30	spore	spore	ADJ
dpc-5027	79	31	-	-	PUNCT
dpc-5027	79	32	forming	form	VERB
dpc-5027	79	33	bacteria	bacteria	NOUN
dpc-5027	79	34	in	in	ADP
dpc-5027	79	35	the	the	DET
dpc-5027	79	36	phylum	phylum	NOUN
dpc-5027	79	37	bacteroidetes	bacteroidete	NOUN
dpc-5027	79	38	)	)	PUNCT
dpc-5027	79	39	,	,	PUNCT
dpc-5027	79	40	lactobacillales	lactobacillale	NOUN
dpc-5027	79	41	(	(	PUNCT
dpc-5027	79	42	gram	gram	NOUN
dpc-5027	79	43	-	-	PUNCT
dpc-5027	79	44	positive	positive	ADJ
dpc-5027	79	45	,	,	PUNCT
dpc-5027	79	46	nonspore	nonspore	NOUN
dpc-5027	79	47	-	-	PUNCT
dpc-5027	79	48	forming	form	VERB
dpc-5027	79	49	bacteria	bacteria	NOUN
dpc-5027	79	50	in	in	ADP
dpc-5027	79	51	the	the	DET
dpc-5027	79	52	phylum	phylum	NOUN
dpc-5027	79	53	firmicutes	firmicute	NOUN
dpc-5027	79	54	)	)	PUNCT
dpc-5027	79	55	,	,	PUNCT
dpc-5027	79	56	and	and	CCONJ
dpc-5027	79	57	fusobacterium	fusobacterium	NOUN
dpc-5027	79	58	(	(	PUNCT
dpc-5027	79	59	anaerobic	anaerobic	NOUN
dpc-5027	79	60	,	,	PUNCT
dpc-5027	79	61	gram	gram	NOUN
dpc-5027	79	62	-	-	PUNCT
dpc-5027	79	63	negative	negative	ADJ
dpc-5027	79	64	bacteria	bacteria	NOUN
dpc-5027	79	65	in	in	ADP
dpc-5027	79	66	the	the	DET
dpc-5027	79	67	phylum	phylum	NOUN
dpc-5027	79	68	fusobacteria	fusobacteria	NOUN
dpc-5027	79	69	)	)	PUNCT
dpc-5027	79	70	.	.	PUNCT
dpc-5027	80	1	briefly	briefly	NOUN
dpc-5027	80	2	,	,	PUNCT
dpc-5027	80	3	dna	dna	PROPN
dpc-5027	80	4	was	be	AUX
dpc-5027	80	5	extracted	extract	VERB
dpc-5027	80	6	from	from	ADP
dpc-5027	80	7	stool	stool	NOUN
dpc-5027	80	8	samples	sample	NOUN
dpc-5027	80	9	using	use	VERB
dpc-5027	80	10	the	the	DET
dpc-5027	80	11	qiaamp	qiaamp	NOUN
dpc-5027	80	12	®	®	NOUN
dpc-5027	80	13	fast	fast	ADJ
dpc-5027	80	14	dna	dna	PROPN
dpc-5027	80	15	stool	stool	NOUN
dpc-5027	80	16	mini	mini	NOUN
dpc-5027	80	17	kit	kit	NOUN
dpc-5027	80	18	protocol	protocol	NOUN
dpc-5027	80	19	according	accord	VERB
dpc-5027	80	20	to	to	ADP
dpc-5027	80	21	the	the	DET
dpc-5027	80	22	manufacturer	manufacturer	NOUN
dpc-5027	80	23	’s	’s	PART
dpc-5027	80	24	instructions	instruction	NOUN
dpc-5027	80	25	.	.	PUNCT
dpc-5027	81	1	real	real	ADJ
dpc-5027	81	2	-	-	PUNCT
dpc-5027	81	3	time	time	NOUN
dpc-5027	81	4	qpcr	qpcr	ADJ
dpc-5027	81	5	experiments	experiment	NOUN
dpc-5027	81	6	were	be	AUX
dpc-5027	81	7	performed	perform	VERB
dpc-5027	81	8	with	with	ADP
dpc-5027	81	9	the	the	DET
dpc-5027	81	10	step	step	NOUN
dpc-5027	81	11	one	one	NUM
dpc-5027	81	12	plus	plus	CCONJ
dpc-5027	81	13	applied	apply	VERB
dpc-5027	81	14	biosystems	biosystem	NOUN
dpc-5027	81	15	using	use	VERB
dpc-5027	81	16	the	the	DET
dpc-5027	81	17	faststart	faststart	NOUN
dpc-5027	81	18	dna	dna	PROPN
dpc-5027	81	19	master	master	PROPN
dpc-5027	81	20	sybr	sybr	PROPN
dpc-5027	81	21	green	green	PROPN
dpc-5027	81	22	kit	kit	PROPN
dpc-5027	81	23	(	(	PUNCT
dpc-5027	81	24	roche	roche	NOUN
dpc-5027	81	25	diagnostics	diagnostic	NOUN
dpc-5027	81	26	,	,	PUNCT
dpc-5027	81	27	indianapolis	indianapolis	PROPN
dpc-5027	81	28	,	,	PUNCT
dpc-5027	81	29	in	in	ADP
dpc-5027	81	30	)	)	PUNCT
dpc-5027	81	31	.	.	PUNCT
dpc-5027	82	1	the	the	DET
dpc-5027	82	2	thermal	thermal	ADJ
dpc-5027	82	3	cycling	cycling	NOUN
dpc-5027	82	4	conditions	condition	NOUN
dpc-5027	82	5	used	use	VERB
dpc-5027	82	6	were	be	AUX
dpc-5027	82	7	as	as	SCONJ
dpc-5027	82	8	follows	follow	VERB
dpc-5027	82	9	:	:	PUNCT
dpc-5027	82	10	an	an	DET
dpc-5027	82	11	initial	initial	ADJ
dpc-5027	82	12	dna	dna	NOUN
dpc-5027	82	13	denaturation	denaturation	NOUN
dpc-5027	82	14	step	step	NOUN
dpc-5027	82	15	at	at	ADP
dpc-5027	82	16	95	95	NUM
dpc-5027	82	17	°	°	NOUN
dpc-5027	82	18	c	c	NOUN
dpc-5027	82	19	for	for	ADP
dpc-5027	82	20	10	10	NUM
dpc-5027	82	21	minutes	minute	NOUN
dpc-5027	82	22	,	,	PUNCT
dpc-5027	82	23	followed	follow	VERB
dpc-5027	82	24	by	by	ADP
dpc-5027	82	25	45	45	NUM
dpc-5027	82	26	cycles	cycle	NOUN
dpc-5027	82	27	of	of	ADP
dpc-5027	82	28	denaturation	denaturation	NOUN
dpc-5027	82	29	at	at	ADP
dpc-5027	82	30	95	95	NUM
dpc-5027	82	31	°	°	NOUN
dpc-5027	82	32	c	c	NOUN
dpc-5027	82	33	for	for	ADP
dpc-5027	82	34	10	10	NUM
dpc-5027	82	35	s	s	NOUN
dpc-5027	82	36	,	,	PUNCT
dpc-5027	82	37	primer	primer	NOUN
dpc-5027	82	38	annealing	annealing	NOUN
dpc-5027	82	39	at	at	ADP
dpc-5027	82	40	optimal	optimal	ADJ
dpc-5027	82	41	temperature	temperature	NOUN
dpc-5027	82	42	for	for	ADP
dpc-5027	82	43	20	20	NUM
dpc-5027	82	44	s	s	NOUN
dpc-5027	82	45	,	,	PUNCT
dpc-5027	82	46	and	and	CCONJ
dpc-5027	82	47	extension	extension	NOUN
dpc-5027	82	48	at	at	ADP
dpc-5027	82	49	72	72	NUM
dpc-5027	82	50	°	°	ADP
dpc-5027	82	51	c	c	NOUN
dpc-5027	82	52	for	for	ADP
dpc-5027	82	53	15	15	NUM
dpc-5027	82	54	s.	s.	PROPN
dpc-5027	82	55	finally	finally	ADV
dpc-5027	82	56	,	,	PUNCT
dpc-5027	82	57	the	the	DET
dpc-5027	82	58	bacterial	bacterial	ADJ
dpc-5027	82	59	concentration	concentration	NOUN
dpc-5027	82	60	from	from	ADP
dpc-5027	82	61	each	each	DET
dpc-5027	82	62	fecal	fecal	ADJ
dpc-5027	82	63	sample	sample	NOUN
dpc-5027	82	64	was	be	AUX
dpc-5027	82	65	calculated	calculate	VERB
dpc-5027	82	66	by	by	ADP
dpc-5027	82	67	comparing	compare	VERB
dpc-5027	82	68	the	the	DET
dpc-5027	82	69	ct	ct	PROPN
dpc-5027	82	70	values	value	NOUN
dpc-5027	82	71	obtained	obtain	VERB
dpc-5027	82	72	from	from	ADP
dpc-5027	82	73	the	the	DET
dpc-5027	82	74	standard	standard	ADJ
dpc-5027	82	75	curves	curve	NOUN
dpc-5027	82	76	with	with	ADP
dpc-5027	82	77	applied	apply	VERB
dpc-5027	82	78	biosystems	biosystems	PROPN
dpc-5027	82	79	software	software	NOUN
dpc-5027	82	80	.	.	PUNCT
dpc-5027	83	1	standard	standard	ADJ
dpc-5027	83	2	curves	curve	NOUN
dpc-5027	83	3	were	be	AUX
dpc-5027	83	4	constructed	construct	VERB
dpc-5027	83	5	for	for	ADP
dpc-5027	83	6	each	each	DET
dpc-5027	83	7	experiment	experiment	NOUN
dpc-5027	83	8	using	use	VERB
dpc-5027	83	9	serial	serial	ADJ
dpc-5027	83	10	tenfold	tenfold	ADJ
dpc-5027	83	11	dilutions	dilution	NOUN
dpc-5027	83	12	of	of	ADP
dpc-5027	83	13	bacterial	bacterial	ADJ
dpc-5027	83	14	genomic	genomic	ADJ
dpc-5027	83	15	dna	dna	NOUN
dpc-5027	83	16	(	(	PUNCT
dpc-5027	83	17	of	of	ADP
dpc-5027	83	18	known	know	VERB
dpc-5027	83	19	concentration	concentration	NOUN
dpc-5027	83	20	)	)	PUNCT
dpc-5027	83	21	from	from	ADP
dpc-5027	83	22	pure	pure	ADJ
dpc-5027	83	23	cultures	culture	NOUN
dpc-5027	83	24	,	,	PUNCT
dpc-5027	83	25	corresponding	correspond	VERB
dpc-5027	83	26	to	to	ADP
dpc-5027	83	27	1x106	1x106	NUM
dpc-5027	83	28	to	to	ADP
dpc-5027	83	29	1x	1x	PROPN
dpc-5027	83	30	107	107	NUM
dpc-5027	83	31	16s	16	NOUN
dpc-5027	83	32	rrna	rrna	PROPN
dpc-5027	83	33	gene	gene	NOUN
dpc-5027	83	34	copies	copy	NOUN
dpc-5027	83	35	/	/	SYM
dpc-5027	83	36	gram	gram	NOUN
dpc-5027	83	37	of	of	ADP
dpc-5027	83	38	feces	fece	NOUN
dpc-5027	83	39	.	.	PUNCT
dpc-5027	84	1	standard	standard	ADJ
dpc-5027	84	2	curves	curve	NOUN
dpc-5027	84	3	were	be	AUX
dpc-5027	84	4	normalized	normalize	VERB
dpc-5027	84	5	to	to	ADP
dpc-5027	84	6	the	the	DET
dpc-5027	84	7	copy	copy	NOUN
dpc-5027	84	8	number	number	NOUN
dpc-5027	84	9	of	of	ADP
dpc-5027	84	10	the	the	DET
dpc-5027	84	11	16s	16s	PROPN
dpc-5027	84	12	rrna	rrna	PROPN
dpc-5027	84	13	gene	gene	NOUN
dpc-5027	84	14	for	for	ADP
dpc-5027	84	15	each	each	PRON
dpc-5027	84	16	.	.	PUNCT
dpc-5027	85	1	statistical	statistical	ADJ
dpc-5027	85	2	analysis	analysis	NOUN
dpc-5027	85	3	the	the	DET
dpc-5027	85	4	statistical	statistical	ADJ
dpc-5027	85	5	program	program	NOUN
dpc-5027	85	6	for	for	ADP
dpc-5027	85	7	social	social	ADJ
dpc-5027	85	8	science	science	NOUN
dpc-5027	85	9	(	(	PUNCT
dpc-5027	85	10	spss	spss	PROPN
dpc-5027	85	11	version	version	PROPN
dpc-5027	85	12	24.0	24.0	NUM
dpc-5027	85	13	)	)	PUNCT
dpc-5027	85	14	was	be	AUX
dpc-5027	85	15	employed	employ	VERB
dpc-5027	85	16	to	to	PART
dpc-5027	85	17	analyze	analyze	VERB
dpc-5027	85	18	the	the	DET
dpc-5027	85	19	data	datum	NOUN
dpc-5027	85	20	.	.	PUNCT
dpc-5027	86	1	the	the	DET
dpc-5027	86	2	mean±standard	mean±standard	NOUN
dpc-5027	86	3	figure	figure	NOUN
dpc-5027	86	4	1	1	NUM
dpc-5027	86	5	.	.	PUNCT
dpc-5027	86	6	dermoscopic	dermoscopic	PROPN
dpc-5027	86	7	findings	finding	NOUN
dpc-5027	86	8	of	of	ADP
dpc-5027	86	9	the	the	DET
dpc-5027	86	10	rosacea	rosacea	NOUN
dpc-5027	86	11	group	group	NOUN
dpc-5027	86	12	.	.	PUNCT
dpc-5027	87	1	4	4	NUM
dpc-5027	87	2	original	original	ADJ
dpc-5027	87	3	article	article	NOUN
dpc-5027	87	4	|	|	ADV
dpc-5027	87	5	dermatol	dermatol	ADJ
dpc-5027	87	6	pract	pract	NOUN
dpc-5027	87	7	concept	concept	NOUN
dpc-5027	87	8	.	.	PUNCT
dpc-5027	88	1	2025;15(3):5027	2025;15(3):5027	NUM
dpc-5027	88	2	deviation	deviation	NOUN
dpc-5027	88	3	(	(	PUNCT
dpc-5027	88	4	sd	sd	NOUN
dpc-5027	88	5	)	)	PUNCT
dpc-5027	88	6	was	be	AUX
dpc-5027	88	7	utilized	utilize	VERB
dpc-5027	88	8	to	to	PART
dpc-5027	88	9	represent	represent	VERB
dpc-5027	88	10	the	the	DET
dpc-5027	88	11	parametric	parametric	ADJ
dpc-5027	88	12	quantitative	quantitative	ADJ
dpc-5027	88	13	data	datum	NOUN
dpc-5027	88	14	.	.	PUNCT
dpc-5027	89	1	median	median	NOUN
dpc-5027	89	2	and	and	CCONJ
dpc-5027	89	3	interquartile	interquartile	ADJ
dpc-5027	89	4	range	range	NOUN
dpc-5027	89	5	(	(	PUNCT
dpc-5027	89	6	iqr	iqr	NOUN
dpc-5027	89	7	)	)	PUNCT
dpc-5027	89	8	were	be	AUX
dpc-5027	89	9	utilized	utilize	VERB
dpc-5027	89	10	to	to	PART
dpc-5027	89	11	represent	represent	VERB
dpc-5027	89	12	the	the	DET
dpc-5027	89	13	non	non	ADJ
dpc-5027	89	14	-	-	ADJ
dpc-5027	89	15	parametric	parametric	ADJ
dpc-5027	89	16	data	datum	NOUN
dpc-5027	89	17	.	.	PUNCT
dpc-5027	90	1	frequency	frequency	NOUN
dpc-5027	90	2	and	and	CCONJ
dpc-5027	90	3	percentage	percentage	NOUN
dpc-5027	90	4	were	be	AUX
dpc-5027	90	5	the	the	DET
dpc-5027	90	6	metrics	metric	NOUN
dpc-5027	90	7	employed	employ	VERB
dpc-5027	90	8	to	to	PART
dpc-5027	90	9	represent	represent	VERB
dpc-5027	90	10	qualitative	qualitative	ADJ
dpc-5027	90	11	data	datum	NOUN
dpc-5027	90	12	.	.	PUNCT
dpc-5027	91	1	when	when	SCONJ
dpc-5027	91	2	comparing	compare	VERB
dpc-5027	91	3	two	two	NUM
dpc-5027	91	4	means	mean	NOUN
dpc-5027	91	5	,	,	PUNCT
dpc-5027	91	6	an	an	DET
dpc-5027	91	7	independent	independent	ADJ
dpc-5027	91	8	-	-	PUNCT
dpc-5027	91	9	samples	sample	NOUN
dpc-5027	91	10	t	t	NOUN
dpc-5027	91	11	-	-	PUNCT
dpc-5027	91	12	test	test	NOUN
dpc-5027	91	13	of	of	ADP
dpc-5027	91	14	significance	significance	NOUN
dpc-5027	91	15	was	be	AUX
dpc-5027	91	16	employed	employ	VERB
dpc-5027	91	17	.	.	PUNCT
dpc-5027	92	1	when	when	SCONJ
dpc-5027	92	2	contrasting	contrast	VERB
dpc-5027	92	3	more	more	ADJ
dpc-5027	92	4	than	than	ADP
dpc-5027	92	5	two	two	NUM
dpc-5027	92	6	means	mean	NOUN
dpc-5027	92	7	,	,	PUNCT
dpc-5027	92	8	a	a	DET
dpc-5027	92	9	one	one	NUM
dpc-5027	92	10	-	-	PUNCT
dpc-5027	92	11	way	way	NOUN
dpc-5027	92	12	analysis	analysis	NOUN
dpc-5027	92	13	of	of	ADP
dpc-5027	92	14	variance	variance	NOUN
dpc-5027	92	15	(	(	PUNCT
dpc-5027	92	16	anova	anova	PROPN
dpc-5027	92	17	)	)	PUNCT
dpc-5027	92	18	was	be	AUX
dpc-5027	92	19	employed	employ	VERB
dpc-5027	92	20	.	.	PUNCT
dpc-5027	93	1	for	for	ADP
dpc-5027	93	2	multiple	multiple	ADJ
dpc-5027	93	3	comparisons	comparison	NOUN
dpc-5027	93	4	among	among	ADP
dpc-5027	93	5	various	various	ADJ
dpc-5027	93	6	variables	variable	NOUN
dpc-5027	93	7	,	,	PUNCT
dpc-5027	93	8	the	the	DET
dpc-5027	93	9	post	post	X
dpc-5027	93	10	hoc	hoc	X
dpc-5027	93	11	test	test	NOUN
dpc-5027	93	12	was	be	AUX
dpc-5027	93	13	used	use	VERB
dpc-5027	93	14	.	.	PUNCT
dpc-5027	94	1	to	to	PART
dpc-5027	94	2	contrast	contrast	VERB
dpc-5027	94	3	the	the	DET
dpc-5027	94	4	proportions	proportion	NOUN
dpc-5027	94	5	of	of	ADP
dpc-5027	94	6	two	two	NUM
dpc-5027	94	7	qualitative	qualitative	ADJ
dpc-5027	94	8	parameters	parameter	NOUN
dpc-5027	94	9	,	,	PUNCT
dpc-5027	94	10	the	the	DET
dpc-5027	94	11	chi	chi	NOUN
dpc-5027	94	12	-	-	PUNCT
dpc-5027	94	13	squared	square	VERB
dpc-5027	94	14	(	(	PUNCT
dpc-5027	94	15	χ2	χ2	PROPN
dpc-5027	94	16	)	)	PUNCT
dpc-5027	94	17	test	test	NOUN
dpc-5027	94	18	of	of	ADP
dpc-5027	94	19	significance	significance	NOUN
dpc-5027	94	20	was	be	AUX
dpc-5027	94	21	used	use	VERB
dpc-5027	94	22	.	.	PUNCT
dpc-5027	95	1	the	the	DET
dpc-5027	95	2	data	datum	NOUN
dpc-5027	95	3	was	be	AUX
dpc-5027	95	4	correlated	correlate	VERB
dpc-5027	95	5	using	use	VERB
dpc-5027	95	6	pearson	pearson	PROPN
dpc-5027	95	7	’s	’s	PART
dpc-5027	95	8	correlation	correlation	NOUN
dpc-5027	95	9	coefficient	coefficient	NOUN
dpc-5027	95	10	(	(	PUNCT
dpc-5027	95	11	r	r	NOUN
dpc-5027	95	12	)	)	PUNCT
dpc-5027	95	13	test	test	NOUN
dpc-5027	95	14	.	.	PUNCT
dpc-5027	96	1	to	to	PART
dpc-5027	96	2	determine	determine	VERB
dpc-5027	96	3	the	the	DET
dpc-5027	96	4	best	good	ADJ
dpc-5027	96	5	cut	cut	NOUN
dpc-5027	96	6	-	-	PUNCT
dpc-5027	96	7	off	off	ADP
dpc-5027	96	8	point	point	NOUN
dpc-5027	96	9	for	for	ADP
dpc-5027	96	10	this	this	DET
dpc-5027	96	11	marker	marker	NOUN
dpc-5027	96	12	,	,	PUNCT
dpc-5027	96	13	we	we	PRON
dpc-5027	96	14	calculated	calculate	VERB
dpc-5027	96	15	its	its	PRON
dpc-5027	96	16	positive	positive	ADJ
dpc-5027	96	17	predictive	predictive	ADJ
dpc-5027	96	18	value	value	NOUN
dpc-5027	96	19	(	(	PUNCT
dpc-5027	96	20	ppv	ppv	NOUN
dpc-5027	96	21	)	)	PUNCT
dpc-5027	96	22	,	,	PUNCT
dpc-5027	96	23	sensitivity	sensitivity	NOUN
dpc-5027	96	24	,	,	PUNCT
dpc-5027	96	25	specificity	specificity	NOUN
dpc-5027	96	26	,	,	PUNCT
dpc-5027	96	27	negative	negative	ADJ
dpc-5027	96	28	predictive	predictive	ADJ
dpc-5027	96	29	value	value	NOUN
dpc-5027	96	30	(	(	PUNCT
dpc-5027	96	31	npv	npv	NOUN
dpc-5027	96	32	)	)	PUNCT
dpc-5027	96	33	,	,	PUNCT
dpc-5027	96	34	and	and	CCONJ
dpc-5027	96	35	area	area	NOUN
dpc-5027	96	36	under	under	ADP
dpc-5027	96	37	the	the	DET
dpc-5027	96	38	curve	curve	NOUN
dpc-5027	96	39	(	(	PUNCT
dpc-5027	96	40	auc	auc	NOUN
dpc-5027	96	41	)	)	PUNCT
dpc-5027	96	42	utilizing	utilize	VERB
dpc-5027	96	43	a	a	DET
dpc-5027	96	44	receiver	receiver	ADJ
dpc-5027	96	45	operating	operate	VERB
dpc-5027	96	46	figure	figure	NOUN
dpc-5027	96	47	2	2	NUM
dpc-5027	96	48	.	.	PUNCT
dpc-5027	96	49	clinical	clinical	ADJ
dpc-5027	96	50	and	and	CCONJ
dpc-5027	96	51	dermoscopic	dermoscopic	ADJ
dpc-5027	96	52	photos	photo	NOUN
dpc-5027	96	53	of	of	ADP
dpc-5027	96	54	patients	patient	NOUN
dpc-5027	96	55	with	with	ADP
dpc-5027	96	56	different	different	ADJ
dpc-5027	96	57	subtypes	subtype	NOUN
dpc-5027	96	58	of	of	ADP
dpc-5027	96	59	rosacea	rosacea	NOUN
dpc-5027	96	60	.	.	PUNCT
dpc-5027	97	1	a.	a.	NOUN
dpc-5027	97	2	39	39	NUM
dpc-5027	97	3	-	-	PUNCT
dpc-5027	97	4	year	year	NOUN
dpc-5027	97	5	-	-	PUNCT
dpc-5027	97	6	old	old	ADJ
dpc-5027	97	7	female	female	ADJ
dpc-5027	97	8	patient	patient	NOUN
dpc-5027	97	9	,	,	PUNCT
dpc-5027	97	10	bmi=27.7	bmi=27.7	ADJ
dpc-5027	97	11	kg	kg	PROPN
dpc-5027	97	12	/	/	SYM
dpc-5027	97	13	m2	m2	PROPN
dpc-5027	97	14	with	with	ADP
dpc-5027	97	15	moderate	moderate	ADJ
dpc-5027	97	16	erythematotelangiectatic	erythematotelangiectatic	ADJ
dpc-5027	97	17	rosacea	rosacea	NOUN
dpc-5027	97	18	as	as	ADP
dpc-5027	97	19	of	of	ADP
dpc-5027	97	20	one	one	NUM
dpc-5027	97	21	year	year	NOUN
dpc-5027	97	22	affecting	affect	VERB
dpc-5027	97	23	both	both	DET
dpc-5027	97	24	cheeks	cheek	NOUN
dpc-5027	97	25	,	,	PUNCT
dpc-5027	97	26	chin	chin	NOUN
dpc-5027	97	27	,	,	PUNCT
dpc-5027	97	28	and	and	CCONJ
dpc-5027	97	29	nose	nose	NOUN
dpc-5027	97	30	(	(	PUNCT
dpc-5027	97	31	telangiectasia	telangiectasia	NOUN
dpc-5027	97	32	score	score	VERB
dpc-5027	97	33	2	2	NUM
dpc-5027	97	34	,	,	PUNCT
dpc-5027	97	35	erythema	erythema	ADV
dpc-5027	97	36	score	score	NOUN
dpc-5027	97	37	2	2	NUM
dpc-5027	97	38	)	)	PUNCT
dpc-5027	97	39	;	;	PUNCT
dpc-5027	97	40	b.	b.	PROPN
dpc-5027	97	41	dermoscopic	dermoscopic	PROPN
dpc-5027	97	42	photo	photo	PROPN
dpc-5027	97	43	showing	show	VERB
dpc-5027	97	44	polygonal	polygonal	ADJ
dpc-5027	97	45	blood	blood	NOUN
dpc-5027	97	46	vessels	vessel	NOUN
dpc-5027	97	47	with	with	ADP
dpc-5027	97	48	pinkish	pinkish	ADJ
dpc-5027	97	49	background	background	NOUN
dpc-5027	97	50	.	.	PUNCT
dpc-5027	98	1	c.	c.	NOUN
dpc-5027	98	2	55	55	NUM
dpc-5027	98	3	-	-	PUNCT
dpc-5027	98	4	year	year	NOUN
dpc-5027	98	5	-	-	PUNCT
dpc-5027	98	6	old	old	ADJ
dpc-5027	98	7	female	female	ADJ
dpc-5027	98	8	patient	patient	NOUN
dpc-5027	98	9	,	,	PUNCT
dpc-5027	98	10	bmi=29	bmi=29	PROPN
dpc-5027	98	11	kg	kg	PROPN
dpc-5027	98	12	/	/	SYM
dpc-5027	98	13	m2	m2	PROPN
dpc-5027	98	14	with	with	ADP
dpc-5027	98	15	moderate	moderate	ADJ
dpc-5027	98	16	papulopustular	papulopustular	ADJ
dpc-5027	98	17	rosacea	rosacea	NOUN
dpc-5027	98	18	as	as	ADP
dpc-5027	98	19	of	of	ADP
dpc-5027	98	20	two	two	NUM
dpc-5027	98	21	months	month	NOUN
dpc-5027	98	22	affecting	affect	VERB
dpc-5027	98	23	both	both	DET
dpc-5027	98	24	cheeks	cheek	NOUN
dpc-5027	98	25	and	and	CCONJ
dpc-5027	98	26	nose	nose	NOUN
dpc-5027	98	27	(	(	PUNCT
dpc-5027	98	28	inflammatory	inflammatory	ADJ
dpc-5027	98	29	score	score	NOUN
dpc-5027	98	30	2	2	NUM
dpc-5027	98	31	,	,	PUNCT
dpc-5027	98	32	telangiectasia	telangiectasia	NOUN
dpc-5027	98	33	score	score	VERB
dpc-5027	98	34	2	2	NUM
dpc-5027	98	35	)	)	PUNCT
dpc-5027	98	36	(	(	PUNCT
dpc-5027	98	37	erythema	erythema	ADV
dpc-5027	98	38	score	score	NOUN
dpc-5027	98	39	is	be	AUX
dpc-5027	98	40	1	1	NUM
dpc-5027	98	41	)	)	PUNCT
dpc-5027	98	42	;	;	PUNCT
dpc-5027	98	43	d.	d.	PROPN
dpc-5027	98	44	dermoscopic	dermoscopic	PROPN
dpc-5027	98	45	photo	photo	PROPN
dpc-5027	98	46	showing	show	VERB
dpc-5027	98	47	follicular	follicular	ADJ
dpc-5027	98	48	pustules	pustule	NOUN
dpc-5027	98	49	with	with	ADP
dpc-5027	98	50	orange	orange	ADJ
dpc-5027	98	51	-	-	PUNCT
dpc-5027	98	52	colored	color	VERB
dpc-5027	98	53	areas	area	NOUN
dpc-5027	98	54	and	and	CCONJ
dpc-5027	98	55	linear	linear	ADJ
dpc-5027	98	56	vessels	vessel	NOUN
dpc-5027	98	57	forming	form	VERB
dpc-5027	98	58	incomplete	incomplete	ADJ
dpc-5027	98	59	polygons	polygon	NOUN
dpc-5027	98	60	.	.	PUNCT
dpc-5027	99	1	e	e	X
dpc-5027	99	2	:	:	PUNCT
dpc-5027	99	3	55	55	NUM
dpc-5027	99	4	-	-	PUNCT
dpc-5027	99	5	year	year	NOUN
dpc-5027	99	6	-	-	PUNCT
dpc-5027	99	7	old	old	ADJ
dpc-5027	99	8	male	male	ADJ
dpc-5027	99	9	patient	patient	NOUN
dpc-5027	99	10	,	,	PUNCT
dpc-5027	99	11	bmi=29.6	bmi=29.6	VERB
dpc-5027	99	12	kg	kg	PROPN
dpc-5027	99	13	/	/	SYM
dpc-5027	99	14	m2	m2	PROPN
dpc-5027	99	15	with	with	ADP
dpc-5027	99	16	rhinophyma	rhinophyma	NOUN
dpc-5027	99	17	as	as	ADP
dpc-5027	99	18	of	of	ADP
dpc-5027	99	19	one	one	NUM
dpc-5027	99	20	year	year	NOUN
dpc-5027	99	21	;	;	PUNCT
dpc-5027	100	1	f	f	X
dpc-5027	100	2	:	:	PUNCT
dpc-5027	100	3	dermoscopic	dermoscopic	ADJ
dpc-5027	100	4	image	image	NOUN
dpc-5027	100	5	showing	show	VERB
dpc-5027	100	6	sebaceous	sebaceous	ADJ
dpc-5027	100	7	hyperplasia	hyperplasia	NOUN
dpc-5027	100	8	characterized	characterize	VERB
dpc-5027	100	9	by	by	ADP
dpc-5027	100	10	follicular	follicular	ADJ
dpc-5027	100	11	yellow	yellow	ADJ
dpc-5027	100	12	clods	clod	NOUN
dpc-5027	100	13	(	(	PUNCT
dpc-5027	100	14	black	black	ADJ
dpc-5027	100	15	arrow	arrow	NOUN
dpc-5027	100	16	)	)	PUNCT
dpc-5027	100	17	.	.	PUNCT
dpc-5027	101	1	original	original	ADJ
dpc-5027	101	2	article	article	NOUN
dpc-5027	101	3	|	|	ADV
dpc-5027	101	4	dermatol	dermatol	ADJ
dpc-5027	101	5	pract	pract	NOUN
dpc-5027	101	6	concept	concept	NOUN
dpc-5027	101	7	.	.	PUNCT
dpc-5027	102	1	2025;15(3):5027	2025;15(3):5027	NUM
dpc-5027	102	2	5	5	NUM
dpc-5027	102	3	table	table	NOUN
dpc-5027	102	4	1	1	NUM
dpc-5027	102	5	.	.	PUNCT
dpc-5027	102	6	demographic	demographic	ADJ
dpc-5027	102	7	data	datum	NOUN
dpc-5027	102	8	of	of	ADP
dpc-5027	102	9	all	all	DET
dpc-5027	102	10	participants	participant	NOUN
dpc-5027	102	11	and	and	CCONJ
dpc-5027	102	12	clinical	clinical	ADJ
dpc-5027	102	13	characteristics	characteristic	NOUN
dpc-5027	102	14	of	of	ADP
dpc-5027	102	15	rosacea	rosacea	NOUN
dpc-5027	102	16	patients	patient	NOUN
dpc-5027	102	17	.	.	PUNCT
dpc-5027	103	1	variables	variable	NOUN
dpc-5027	103	2	cases	case	NOUN
dpc-5027	103	3	(	(	PUNCT
dpc-5027	103	4	n=21	n=21	NOUN
dpc-5027	103	5	)	)	PUNCT
dpc-5027	103	6	controls	control	NOUN
dpc-5027	103	7	(	(	PUNCT
dpc-5027	103	8	n=21	n=21	NOUN
dpc-5027	103	9	)	)	PUNCT
dpc-5027	103	10	test	test	NOUN
dpc-5027	103	11	p	p	NOUN
dpc-5027	103	12	-	-	PUNCT
dpc-5027	103	13	value	value	NOUN
dpc-5027	103	14	age	age	NOUN
dpc-5027	103	15	(	(	PUNCT
dpc-5027	103	16	year	year	NOUN
dpc-5027	103	17	)	)	PUNCT
dpc-5027	103	18	range	range	NOUN
dpc-5027	103	19	19	19	NUM
dpc-5027	103	20	–	–	SYM
dpc-5027	103	21	58	58	NUM
dpc-5027	103	22	25	25	NUM
dpc-5027	103	23	–	–	PUNCT
dpc-5027	103	24	50	50	NUM
dpc-5027	103	25	t	t	NOUN
dpc-5027	103	26	:	:	PUNCT
dpc-5027	103	27	1.055	1.055	NUM
dpc-5027	103	28	0.298	0.298	NUM
dpc-5027	103	29	mean	mean	NOUN
dpc-5027	103	30	±	±	NUM
dpc-5027	103	31	sd	sd	ADP
dpc-5027	103	32	39.52	39.52	NUM
dpc-5027	103	33	±	±	NUM
dpc-5027	103	34	10.73	10.73	NUM
dpc-5027	103	35	36.57±7.03	36.57±7.03	NUM
dpc-5027	103	36	bmi	bmi	NOUN
dpc-5027	103	37	range	range	VERB
dpc-5027	103	38	22	22	NUM
dpc-5027	103	39	–	–	PUNCT
dpc-5027	103	40	34.4	34.4	NUM
dpc-5027	103	41	22.7	22.7	NUM
dpc-5027	103	42	–	–	PUNCT
dpc-5027	103	43	33.3	33.3	NUM
dpc-5027	103	44	t	t	NOUN
dpc-5027	103	45	:	:	PUNCT
dpc-5027	103	46	0.078	0.078	NUM
dpc-5027	103	47	0.939	0.939	NUM
dpc-5027	103	48	mean	mean	NOUN
dpc-5027	103	49	±	±	NUM
dpc-5027	103	50	sd	sd	ADP
dpc-5027	103	51	27.45	27.45	NUM
dpc-5027	103	52	±	±	NUM
dpc-5027	103	53	3.29	3.29	NUM
dpc-5027	103	54	27.52±3.07	27.52±3.07	NUM
dpc-5027	103	55	sex	sex	NOUN
dpc-5027	103	56	male	male	NOUN
dpc-5027	103	57	n	n	CCONJ
dpc-5027	103	58	3	3	NUM
dpc-5027	103	59	3	3	NUM
dpc-5027	103	60	x2:0.0	x2:0.0	PROPN
dpc-5027	103	61	1.0	1.0	NUM
dpc-5027	103	62	%	%	NOUN
dpc-5027	103	63	14.3	14.3	NUM
dpc-5027	103	64	%	%	NOUN
dpc-5027	103	65	14.3	14.3	NUM
dpc-5027	103	66	%	%	NOUN
dpc-5027	103	67	female	female	ADJ
dpc-5027	103	68	n	n	CCONJ
dpc-5027	103	69	18	18	NUM
dpc-5027	103	70	18	18	NUM
dpc-5027	103	71	%	%	NOUN
dpc-5027	103	72	85.7	85.7	NUM
dpc-5027	103	73	%	%	NOUN
dpc-5027	103	74	85.7	85.7	NUM
dpc-5027	103	75	%	%	NOUN
dpc-5027	103	76	occupation	occupation	NOUN
dpc-5027	103	77	non	non	PROPN
dpc-5027	103	78	worker	worker	PROPN
dpc-5027	103	79	n	n	PROPN
dpc-5027	103	80	17	17	NUM
dpc-5027	103	81	18	18	NUM
dpc-5027	103	82	x2	x2	NOUN
dpc-5027	103	83	:	:	PUNCT
dpc-5027	103	84	0.171	0.171	NUM
dpc-5027	103	85	0.679	0.679	NUM
dpc-5027	103	86	%	%	NOUN
dpc-5027	103	87	81.0	81.0	NUM
dpc-5027	103	88	%	%	NOUN
dpc-5027	103	89	85.7	85.7	NUM
dpc-5027	103	90	%	%	NOUN
dpc-5027	103	91	worker	worker	NOUN
dpc-5027	103	92	n	n	CCONJ
dpc-5027	103	93	4	4	NUM
dpc-5027	103	94	3	3	NUM
dpc-5027	103	95	%	%	NOUN
dpc-5027	103	96	19.0	19.0	NUM
dpc-5027	103	97	%	%	NOUN
dpc-5027	103	98	14.3	14.3	NUM
dpc-5027	103	99	%	%	NOUN
dpc-5027	103	100	residence	residence	NOUN
dpc-5027	103	101	urban	urban	ADJ
dpc-5027	103	102	n	n	PROPN
dpc-5027	103	103	7	7	NUM
dpc-5027	103	104	6	6	NUM
dpc-5027	103	105	x2	x2	NOUN
dpc-5027	103	106	:	:	PUNCT
dpc-5027	103	107	0.111	0.111	NUM
dpc-5027	103	108	0.739	0.739	NUM
dpc-5027	103	109	%	%	NOUN
dpc-5027	103	110	33.3	33.3	NUM
dpc-5027	103	111	%	%	NOUN
dpc-5027	103	112	28.6	28.6	NUM
dpc-5027	103	113	%	%	NOUN
dpc-5027	103	114	rural	rural	ADJ
dpc-5027	103	115	n	n	CCONJ
dpc-5027	103	116	14	14	NUM
dpc-5027	103	117	15	15	NUM
dpc-5027	103	118	%	%	NOUN
dpc-5027	103	119	66.7	66.7	NUM
dpc-5027	103	120	%	%	NOUN
dpc-5027	103	121	71.4	71.4	NUM
dpc-5027	103	122	%	%	NOUN
dpc-5027	103	123	clinical	clinical	ADJ
dpc-5027	103	124	data	datum	NOUN
dpc-5027	103	125	n	n	PRON
dpc-5027	103	126	%	%	NOUN
dpc-5027	103	127	subtype	subtype	NOUN
dpc-5027	103	128	of	of	ADP
dpc-5027	103	129	rosacea	rosacea	NOUN
dpc-5027	103	130	erythematotelangiectatic	erythematotelangiectatic	PROPN
dpc-5027	103	131	14	14	NUM
dpc-5027	103	132	66.7	66.7	NUM
dpc-5027	103	133	papulopustular	papulopustular	ADJ
dpc-5027	103	134	5	5	NUM
dpc-5027	103	135	23.8	23.8	NUM
dpc-5027	103	136	rhinophyma	rhinophyma	NOUN
dpc-5027	103	137	2	2	NUM
dpc-5027	103	138	9.5	9.5	NUM
dpc-5027	103	139	degree	degree	NOUN
dpc-5027	103	140	of	of	ADP
dpc-5027	103	141	severity	severity	NOUN
dpc-5027	103	142	mild	mild	ADJ
dpc-5027	103	143	4	4	NUM
dpc-5027	103	144	19.0	19.0	NUM
dpc-5027	103	145	moderate	moderate	ADJ
dpc-5027	103	146	12	12	NUM
dpc-5027	103	147	57.1	57.1	NUM
dpc-5027	103	148	severe	severe	ADJ
dpc-5027	103	149	5	5	NUM
dpc-5027	103	150	23.8	23.8	NUM
dpc-5027	103	151	bowel	bowel	NOUN
dpc-5027	103	152	habits	habit	NOUN
dpc-5027	103	153	normal	normal	ADJ
dpc-5027	103	154	19	19	NUM
dpc-5027	103	155	90.5	90.5	NUM
dpc-5027	103	156	diarrhea	diarrhea	NOUN
dpc-5027	103	157	1	1	NUM
dpc-5027	103	158	4.8	4.8	NUM
dpc-5027	103	159	constipation	constipation	NOUN
dpc-5027	103	160	1	1	NUM
dpc-5027	103	161	4.8	4.8	NUM
dpc-5027	103	162	food	food	NOUN
dpc-5027	103	163	habits	habit	NOUN
dpc-5027	103	164	not	not	PART
dpc-5027	103	165	increased	increase	VERB
dpc-5027	103	166	6	6	NUM
dpc-5027	103	167	28.6	28.6	NUM
dpc-5027	103	168	increased	increase	VERB
dpc-5027	103	169	with	with	ADP
dpc-5027	103	170	spicy	spicy	ADJ
dpc-5027	103	171	8	8	NUM
dpc-5027	103	172	38.1	38.1	NUM
dpc-5027	103	173	increased	increase	VERB
dpc-5027	103	174	with	with	ADP
dpc-5027	103	175	hot	hot	ADJ
dpc-5027	103	176	liquid	liquid	ADJ
dpc-5027	103	177	5	5	NUM
dpc-5027	103	178	23.8	23.8	NUM
dpc-5027	103	179	increased	increase	VERB
dpc-5027	103	180	with	with	ADP
dpc-5027	103	181	both	both	DET
dpc-5027	103	182	2	2	NUM
dpc-5027	103	183	9.5	9.5	NUM
dpc-5027	103	184	duration	duration	NOUN
dpc-5027	103	185	range	range	NOUN
dpc-5027	103	186	1	1	NUM
dpc-5027	103	187	–	–	SYM
dpc-5027	103	188	72	72	NUM
dpc-5027	103	189	m	m	NOUN
dpc-5027	103	190	median	median	NOUN
dpc-5027	103	191	12	12	NUM
dpc-5027	103	192	m	m	PROPN
dpc-5027	103	193	data	datum	NOUN
dpc-5027	103	194	are	be	AUX
dpc-5027	103	195	presented	present	VERB
dpc-5027	103	196	as	as	ADP
dpc-5027	103	197	mean	mean	NOUN
dpc-5027	103	198	±	±	NUM
dpc-5027	103	199	sd	sd	NOUN
dpc-5027	103	200	,	,	PUNCT
dpc-5027	103	201	or	or	CCONJ
dpc-5027	103	202	number	number	NOUN
dpc-5027	103	203	(	(	PUNCT
dpc-5027	103	204	%	%	NOUN
dpc-5027	103	205	)	)	PUNCT
dpc-5027	103	206	,	,	PUNCT
dpc-5027	103	207	t	t	PROPN
dpc-5027	103	208	:	:	PUNCT
dpc-5027	103	209	student	student	NOUN
dpc-5027	103	210	test	test	NOUN
dpc-5027	103	211	,	,	PUNCT
dpc-5027	103	212	χ2	χ2	PROPN
dpc-5027	103	213	:	:	PUNCT
dpc-5027	103	214	chi	chi	ADJ
dpc-5027	103	215	-	-	PUNCT
dpc-5027	103	216	square	square	PROPN
dpc-5027	103	217	test	test	NOUN
dpc-5027	103	218	,	,	PUNCT
dpc-5027	103	219	bmi	bmi	NOUN
dpc-5027	103	220	=	=	SYM
dpc-5027	103	221	body	body	PROPN
dpc-5027	103	222	mass	mass	PROPN
dpc-5027	103	223	index	index	NOUN
dpc-5027	103	224	;	;	PUNCT
dpc-5027	103	225	sd	sd	NOUN
dpc-5027	103	226	=	=	SYM
dpc-5027	103	227	standard	standard	ADJ
dpc-5027	103	228	deviation	deviation	NOUN
dpc-5027	103	229	.	.	PUNCT
dpc-5027	104	1	characteristic	characteristic	ADJ
dpc-5027	104	2	(	(	PUNCT
dpc-5027	104	3	roc	roc	PROPN
dpc-5027	104	4	)	)	PUNCT
dpc-5027	104	5	curve	curve	NOUN
dpc-5027	104	6	.	.	PUNCT
dpc-5027	105	1	a	a	DET
dpc-5027	105	2	95	95	NUM
dpc-5027	105	3	%	%	NOUN
dpc-5027	105	4	confidence	confidence	NOUN
dpc-5027	105	5	level	level	NOUN
dpc-5027	105	6	was	be	AUX
dpc-5027	105	7	used	use	VERB
dpc-5027	105	8	,	,	PUNCT
dpc-5027	105	9	and	and	CCONJ
dpc-5027	105	10	a	a	DET
dpc-5027	105	11	5	5	NUM
dpc-5027	105	12	%	%	NOUN
dpc-5027	105	13	tolerance	tolerance	NOUN
dpc-5027	105	14	for	for	ADP
dpc-5027	105	15	error	error	NOUN
dpc-5027	105	16	was	be	AUX
dpc-5027	105	17	allowed	allow	VERB
dpc-5027	105	18	.	.	PUNCT
dpc-5027	106	1	assuming	assume	VERB
dpc-5027	106	2	a	a	DET
dpc-5027	106	3	significance	significance	NOUN
dpc-5027	106	4	level	level	NOUN
dpc-5027	106	5	of	of	ADP
dpc-5027	106	6	p	p	NOUN
dpc-5027	106	7	<	<	X
dpc-5027	106	8	0.05	0.05	NUM
dpc-5027	106	9	,	,	PUNCT
dpc-5027	106	10	the	the	DET
dpc-5027	106	11	results	result	NOUN
dpc-5027	106	12	indicated	indicate	VERB
dpc-5027	106	13	statistical	statistical	ADJ
dpc-5027	106	14	significance	significance	NOUN
dpc-5027	106	15	.	.	PUNCT
dpc-5027	107	1	results	result	VERB
dpc-5027	107	2	both	both	DET
dpc-5027	107	3	groups	group	NOUN
dpc-5027	107	4	were	be	AUX
dpc-5027	107	5	ageand	ageand	NOUN
dpc-5027	107	6	sex	sex	NOUN
dpc-5027	107	7	-	-	PUNCT
dpc-5027	107	8	matched	match	VERB
dpc-5027	107	9	.	.	PUNCT
dpc-5027	108	1	the	the	DET
dpc-5027	108	2	age	age	NOUN
dpc-5027	108	3	differed	differ	VERB
dpc-5027	108	4	insignificantly	insignificantly	ADV
dpc-5027	108	5	between	between	ADP
dpc-5027	108	6	both	both	DET
dpc-5027	108	7	groups	group	NOUN
dpc-5027	108	8	,	,	PUNCT
dpc-5027	108	9	ranging	range	VERB
dpc-5027	108	10	from	from	ADP
dpc-5027	108	11	18	18	NUM
dpc-5027	108	12	to	to	PART
dpc-5027	108	13	58	58	NUM
dpc-5027	108	14	years	year	NOUN
dpc-5027	108	15	(	(	PUNCT
dpc-5027	108	16	mean	mean	NOUN
dpc-5027	108	17	±	±	NUM
dpc-5027	108	18	sd	sd	ADP
dpc-5027	108	19	=	=	SYM
dpc-5027	108	20	39.52	39.52	NUM
dpc-5027	108	21	±	±	NUM
dpc-5027	108	22	10.73	10.73	NUM
dpc-5027	108	23	years	year	NOUN
dpc-5027	108	24	for	for	ADP
dpc-5027	108	25	the	the	DET
dpc-5027	108	26	rosacea	rosacea	NOUN
dpc-5027	108	27	group	group	NOUN
dpc-5027	108	28	and	and	CCONJ
dpc-5027	108	29	36.57	36.57	NUM
dpc-5027	108	30	±	±	NOUN
dpc-5027	108	31	7.03	7.03	NUM
dpc-5027	108	32	years	year	NOUN
dpc-5027	108	33	for	for	ADP
dpc-5027	108	34	the	the	DET
dpc-5027	108	35	control	control	NOUN
dpc-5027	108	36	group	group	NOUN
dpc-5027	108	37	;	;	PUNCT
dpc-5027	108	38	p	p	X
dpc-5027	108	39	=	=	PROPN
dpc-5027	108	40	0.298	0.298	NUM
dpc-5027	108	41	)	)	PUNCT
dpc-5027	108	42	.	.	PUNCT
dpc-5027	109	1	rosacea	rosacea	NOUN
dpc-5027	109	2	duration	duration	NOUN
dpc-5027	109	3	ranged	range	VERB
dpc-5027	109	4	from	from	ADP
dpc-5027	109	5	1	1	NUM
dpc-5027	109	6	to	to	PART
dpc-5027	109	7	72	72	NUM
dpc-5027	109	8	months	month	NOUN
dpc-5027	109	9	(	(	PUNCT
dpc-5027	109	10	median=12	median=12	NOUN
dpc-5027	109	11	months	month	NOUN
dpc-5027	109	12	)	)	PUNCT
dpc-5027	109	13	.	.	PUNCT
dpc-5027	110	1	the	the	DET
dpc-5027	110	2	demographic	demographic	ADJ
dpc-5027	110	3	data	datum	NOUN
dpc-5027	110	4	of	of	ADP
dpc-5027	110	5	all	all	DET
dpc-5027	110	6	participants	participant	NOUN
dpc-5027	110	7	and	and	CCONJ
dpc-5027	110	8	rosacea	rosacea	NOUN
dpc-5027	110	9	patients	patient	NOUN
dpc-5027	110	10	’	'	PUNCT
dpc-5027	110	11	clinical	clinical	ADJ
dpc-5027	110	12	characteristics	characteristic	NOUN
dpc-5027	110	13	were	be	AUX
dpc-5027	110	14	determined	determine	VERB
dpc-5027	110	15	in	in	ADP
dpc-5027	110	16	table	table	NOUN
dpc-5027	110	17	1	1	NUM
dpc-5027	110	18	.	.	PUNCT
dpc-5027	111	1	the	the	DET
dpc-5027	111	2	patient	patient	ADJ
dpc-5027	111	3	group	group	NOUN
dpc-5027	111	4	had	have	VERB
dpc-5027	111	5	a	a	DET
dpc-5027	111	6	significantly	significantly	ADV
dpc-5027	111	7	greater	great	ADJ
dpc-5027	111	8	zonulin	zonulin	NOUN
dpc-5027	111	9	level	level	NOUN
dpc-5027	111	10	compared	compare	VERB
dpc-5027	111	11	to	to	ADP
dpc-5027	111	12	the	the	DET
dpc-5027	111	13	control	control	NOUN
dpc-5027	111	14	group	group	NOUN
dpc-5027	111	15	(	(	PUNCT
dpc-5027	111	16	p=0.001	p=0.001	NUM
dpc-5027	111	17	)	)	PUNCT
dpc-5027	112	1	(	(	PUNCT
dpc-5027	112	2	mean	mean	VERB
dpc-5027	112	3	±	±	NUM
dpc-5027	112	4	sd	sd	ADP
dpc-5027	112	5	=	=	SYM
dpc-5027	112	6	33.71	33.71	NUM
dpc-5027	112	7	±	±	NUM
dpc-5027	112	8	10.77	10.77	NUM
dpc-5027	112	9	ng	ng	PROPN
dpc-5027	112	10	/	/	SYM
dpc-5027	112	11	ml	ml	X
dpc-5027	112	12	for	for	ADP
dpc-5027	112	13	the	the	DET
dpc-5027	112	14	rosacea	rosacea	NOUN
dpc-5027	112	15	group	group	NOUN
dpc-5027	112	16	and	and	CCONJ
dpc-5027	112	17	10.59	10.59	NUM
dpc-5027	112	18	±	±	NUM
dpc-5027	112	19	2.17	2.17	NUM
dpc-5027	112	20	ng	ng	PROPN
dpc-5027	112	21	/	/	SYM
dpc-5027	112	22	ml	ml	X
dpc-5027	112	23	for	for	ADP
dpc-5027	112	24	the	the	DET
dpc-5027	112	25	control	control	NOUN
dpc-5027	112	26	group	group	NOUN
dpc-5027	112	27	)	)	PUNCT
dpc-5027	112	28	.	.	PUNCT
dpc-5027	113	1	the	the	DET
dpc-5027	113	2	zonulin	zonulin	PROPN
dpc-5027	113	3	roc	roc	PROPN
dpc-5027	113	4	curve	curve	NOUN
dpc-5027	113	5	in	in	ADP
dpc-5027	113	6	rosacea	rosacea	NOUN
dpc-5027	113	7	patients	patient	NOUN
dpc-5027	113	8	at	at	ADP
dpc-5027	113	9	a	a	DET
dpc-5027	113	10	cut	cut	VERB
dpc-5027	113	11	-	-	PUNCT
dpc-5027	113	12	off	off	ADP
dpc-5027	113	13	point	point	NOUN
dpc-5027	113	14	>	>	PROPN
dpc-5027	113	15	16.25	16.25	NUM
dpc-5027	113	16	ng	ng	NOUN
dpc-5027	113	17	/	/	SYM
dpc-5027	113	18	ml	ml	PROPN
dpc-5027	113	19	demonstrated	demonstrate	VERB
dpc-5027	113	20	100	100	NUM
dpc-5027	113	21	%	%	NOUN
dpc-5027	113	22	specificity	specificity	NOUN
dpc-5027	113	23	and	and	CCONJ
dpc-5027	113	24	100	100	NUM
dpc-5027	113	25	%	%	NOUN
dpc-5027	113	26	sensitivity	sensitivity	NOUN
dpc-5027	113	27	of	of	ADP
dpc-5027	113	28	zonulin	zonulin	NOUN
dpc-5027	113	29	(	(	PUNCT
dpc-5027	113	30	tables	table	NOUN
dpc-5027	113	31	2–3	2–3	NUM
dpc-5027	113	32	;	;	PUNCT
dpc-5027	113	33	figure	figure	NOUN
dpc-5027	113	34	3	3	NUM
dpc-5027	113	35	)	)	PUNCT
dpc-5027	113	36	.	.	PUNCT
dpc-5027	114	1	6	6	NUM
dpc-5027	114	2	original	original	ADJ
dpc-5027	114	3	article	article	NOUN
dpc-5027	114	4	|	|	ADV
dpc-5027	114	5	dermatol	dermatol	ADJ
dpc-5027	114	6	pract	pract	NOUN
dpc-5027	114	7	concept	concept	NOUN
dpc-5027	114	8	.	.	PUNCT
dpc-5027	115	1	2025;15(3):5027	2025;15(3):5027	NUM
dpc-5027	115	2	figure	figure	NOUN
dpc-5027	115	3	3	3	NUM
dpc-5027	115	4	.	.	PUNCT
dpc-5027	116	1	roc	roc	PROPN
dpc-5027	116	2	curve	curve	NOUN
dpc-5027	116	3	for	for	ADP
dpc-5027	116	4	serum	serum	NOUN
dpc-5027	116	5	zonulin	zonulin	PROPN
dpc-5027	116	6	to	to	PART
dpc-5027	116	7	predict	predict	VERB
dpc-5027	116	8	cases	case	NOUN
dpc-5027	116	9	versus	versus	ADP
dpc-5027	116	10	controls	control	NOUN
dpc-5027	116	11	.	.	PUNCT
dpc-5027	117	1	table	table	NOUN
dpc-5027	117	2	2	2	NUM
dpc-5027	117	3	.	.	X
dpc-5027	117	4	zonulin	zonulin	PROPN
dpc-5027	117	5	level	level	PROPN
dpc-5027	117	6	comparison	comparison	NOUN
dpc-5027	117	7	in	in	ADP
dpc-5027	117	8	rosacea	rosacea	NOUN
dpc-5027	117	9	cases	case	NOUN
dpc-5027	117	10	and	and	CCONJ
dpc-5027	117	11	controls	control	NOUN
dpc-5027	117	12	.	.	PUNCT
dpc-5027	118	1	cases	case	NOUN
dpc-5027	118	2	(	(	PUNCT
dpc-5027	118	3	n=21	n=21	NOUN
dpc-5027	118	4	)	)	PUNCT
dpc-5027	118	5	controls	control	NOUN
dpc-5027	118	6	(	(	PUNCT
dpc-5027	118	7	n=21	n=21	NOUN
dpc-5027	118	8	)	)	PUNCT
dpc-5027	118	9	t.	t.	NOUN
dpc-5027	118	10	p	p	NOUN
dpc-5027	118	11	-	-	PUNCT
dpc-5027	118	12	value	value	NOUN
dpc-5027	118	13	serum	serum	NOUN
dpc-5027	118	14	zonulin	zonulin	PROPN
dpc-5027	118	15	(	(	PUNCT
dpc-5027	118	16	ng	ng	PROPN
dpc-5027	118	17	/	/	SYM
dpc-5027	118	18	ml	ml	NOUN
dpc-5027	118	19	)	)	PUNCT
dpc-5027	118	20	range	range	NOUN
dpc-5027	118	21	17.3	17.3	NUM
dpc-5027	118	22	–	–	PUNCT
dpc-5027	118	23	49.2	49.2	NUM
dpc-5027	118	24	7.5	7.5	NUM
dpc-5027	118	25	–	–	PUNCT
dpc-5027	118	26	15.2	15.2	NUM
dpc-5027	118	27	9.650	9.650	NUM
dpc-5027	118	28	0.001	0.001	NUM
dpc-5027	118	29	*	*	PUNCT
dpc-5027	118	30	mean±sd	mean±sd	ADP
dpc-5027	118	31	33.71	33.71	NUM
dpc-5027	118	32	±	±	NUM
dpc-5027	118	33	10.77	10.77	NUM
dpc-5027	118	34	10.59	10.59	NUM
dpc-5027	118	35	±	±	NUM
dpc-5027	118	36	2.17	2.17	NUM
dpc-5027	118	37	data	datum	NOUN
dpc-5027	118	38	are	be	AUX
dpc-5027	118	39	presented	present	VERB
dpc-5027	118	40	as	as	ADP
dpc-5027	118	41	mean	mean	NOUN
dpc-5027	118	42	±	±	NUM
dpc-5027	118	43	sd	sd	NOUN
dpc-5027	118	44	.	.	PUNCT
dpc-5027	119	1	p<0.05	p<0.05	NOUN
dpc-5027	119	2	statistically	statistically	ADV
dpc-5027	119	3	significant	significant	ADJ
dpc-5027	119	4	.	.	PUNCT
dpc-5027	120	1	p≥0.05	p≥0.05	NOUN
dpc-5027	120	2	statistically	statistically	ADV
dpc-5027	120	3	not	not	PART
dpc-5027	120	4	significant	significant	ADJ
dpc-5027	120	5	.	.	PUNCT
dpc-5027	121	1	abbreviations	abbreviation	NOUN
dpc-5027	121	2	:	:	PUNCT
dpc-5027	121	3	sd	sd	NUM
dpc-5027	121	4	:	:	PUNCT
dpc-5027	121	5	standard	standard	ADJ
dpc-5027	121	6	deviation	deviation	NOUN
dpc-5027	121	7	;	;	PUNCT
dpc-5027	121	8	t	t	NUM
dpc-5027	121	9	:	:	PUNCT
dpc-5027	121	10	student	student	NOUN
dpc-5027	121	11	t	t	PROPN
dpc-5027	121	12	test	test	NOUN
dpc-5027	121	13	.	.	PUNCT
dpc-5027	122	1	table	table	NOUN
dpc-5027	122	2	3	3	NUM
dpc-5027	122	3	.	.	PUNCT
dpc-5027	123	1	roc	roc	NOUN
dpc-5027	123	2	analysis	analysis	NOUN
dpc-5027	123	3	of	of	ADP
dpc-5027	123	4	serum	serum	NOUN
dpc-5027	123	5	zonulin	zonulin	PROPN
dpc-5027	123	6	showing	show	VERB
dpc-5027	123	7	auc	auc	NOUN
dpc-5027	123	8	,	,	PUNCT
dpc-5027	123	9	best	good	ADJ
dpc-5027	123	10	cut	cut	VERB
dpc-5027	123	11	-	-	PUNCT
dpc-5027	123	12	off	off	ADP
dpc-5027	123	13	point	point	NOUN
dpc-5027	123	14	,	,	PUNCT
dpc-5027	123	15	sensitivity	sensitivity	NOUN
dpc-5027	123	16	,	,	PUNCT
dpc-5027	123	17	and	and	CCONJ
dpc-5027	123	18	specificity	specificity	NOUN
dpc-5027	123	19	for	for	ADP
dpc-5027	123	20	zonulin	zonulin	PROPN
dpc-5027	123	21	to	to	PART
dpc-5027	123	22	predict	predict	VERB
dpc-5027	123	23	cases	case	NOUN
dpc-5027	123	24	vs.	vs.	ADP
dpc-5027	123	25	controls	control	NOUN
dpc-5027	123	26	.	.	PUNCT
dpc-5027	124	1	cut	cut	VERB
dpc-5027	124	2	-	-	PUNCT
dpc-5027	124	3	off	off	ADP
dpc-5027	124	4	point	point	NOUN
dpc-5027	124	5	sensitivity	sensitivity	NOUN
dpc-5027	124	6	%	%	NOUN
dpc-5027	124	7	specificity	specificity	NOUN
dpc-5027	124	8	%	%	NOUN
dpc-5027	124	9	ppv	ppv	NOUN
dpc-5027	124	10	npv	npv	NOUN
dpc-5027	124	11	auc	auc	NOUN
dpc-5027	124	12	p	p	NOUN
dpc-5027	124	13	-	-	PUNCT
dpc-5027	124	14	value	value	NOUN
dpc-5027	124	15	95	95	NUM
dpc-5027	124	16	%	%	NOUN
dpc-5027	124	17	ci	ci	NOUN
dpc-5027	124	18	16.25	16.25	NUM
dpc-5027	124	19	(	(	PUNCT
dpc-5027	124	20	ng	ng	PROPN
dpc-5027	124	21	/	/	SYM
dpc-5027	124	22	ml	ml	NOUN
dpc-5027	124	23	)	)	PUNCT
dpc-5027	124	24	100	100	NUM
dpc-5027	124	25	100	100	NUM
dpc-5027	124	26	100	100	NUM
dpc-5027	124	27	100	100	NUM
dpc-5027	124	28	1.000	1.000	NUM
dpc-5027	124	29	<	<	NOUN
dpc-5027	124	30	0.001	0.001	NUM
dpc-5027	124	31	1.000	1.000	NUM
dpc-5027	124	32	1.000	1.000	NUM
dpc-5027	124	33	abbreviations	abbreviation	NOUN
dpc-5027	124	34	:	:	PUNCT
dpc-5027	124	35	auc	auc	NOUN
dpc-5027	124	36	:	:	PUNCT
dpc-5027	124	37	area	area	NOUN
dpc-5027	124	38	under	under	ADP
dpc-5027	124	39	the	the	DET
dpc-5027	124	40	curve	curve	NOUN
dpc-5027	124	41	;	;	PUNCT
dpc-5027	124	42	ci	ci	NOUN
dpc-5027	124	43	:	:	PUNCT
dpc-5027	124	44	confidence	confidence	NOUN
dpc-5027	124	45	interval	interval	NOUN
dpc-5027	124	46	;	;	PUNCT
dpc-5027	124	47	npv	npv	NOUN
dpc-5027	124	48	:	:	PUNCT
dpc-5027	124	49	negative	negative	ADJ
dpc-5027	124	50	predictive	predictive	ADJ
dpc-5027	124	51	value	value	NOUN
dpc-5027	124	52	;	;	PUNCT
dpc-5027	124	53	ppv	ppv	NOUN
dpc-5027	124	54	:	:	PUNCT
dpc-5027	124	55	positive	positive	ADJ
dpc-5027	124	56	predictive	predictive	ADJ
dpc-5027	124	57	value	value	NOUN
dpc-5027	124	58	;	;	PUNCT
dpc-5027	124	59	roc	roc	NOUN
dpc-5027	124	60	:	:	PUNCT
dpc-5027	124	61	receiver	receiver	ADJ
dpc-5027	124	62	operating	operate	VERB
dpc-5027	124	63	curve	curve	NOUN
dpc-5027	124	64	.	.	PUNCT
dpc-5027	125	1	zonulin	zonulin	PROPN
dpc-5027	125	2	levels	level	NOUN
dpc-5027	125	3	did	do	AUX
dpc-5027	125	4	not	not	PART
dpc-5027	125	5	show	show	VERB
dpc-5027	125	6	a	a	DET
dpc-5027	125	7	significant	significant	ADJ
dpc-5027	125	8	correlation	correlation	NOUN
dpc-5027	125	9	with	with	ADP
dpc-5027	125	10	the	the	DET
dpc-5027	125	11	age	age	NOUN
dpc-5027	125	12	of	of	ADP
dpc-5027	125	13	the	the	DET
dpc-5027	125	14	patient	patient	NOUN
dpc-5027	125	15	,	,	PUNCT
dpc-5027	125	16	bmi	bmi	NOUN
dpc-5027	125	17	,	,	PUNCT
dpc-5027	125	18	duration	duration	NOUN
dpc-5027	125	19	of	of	ADP
dpc-5027	125	20	disease	disease	NOUN
dpc-5027	125	21	,	,	PUNCT
dpc-5027	125	22	or	or	CCONJ
dpc-5027	125	23	gut	gut	PROPN
dpc-5027	125	24	microbiomes	microbiome	NOUN
dpc-5027	125	25	(	(	PUNCT
dpc-5027	125	26	bacteroides	bacteroide	NOUN
dpc-5027	125	27	,	,	PUNCT
dpc-5027	125	28	lactobacillus	lactobacillus	NOUN
dpc-5027	125	29	,	,	PUNCT
dpc-5027	125	30	and	and	CCONJ
dpc-5027	125	31	fusobacterium	fusobacterium	NOUN
dpc-5027	125	32	)	)	PUNCT
dpc-5027	125	33	,	,	PUNCT
dpc-5027	125	34	nor	nor	CCONJ
dpc-5027	125	35	a	a	DET
dpc-5027	125	36	significant	significant	ADJ
dpc-5027	125	37	relation	relation	NOUN
dpc-5027	125	38	with	with	ADP
dpc-5027	125	39	sex	sex	NOUN
dpc-5027	125	40	,	,	PUNCT
dpc-5027	125	41	occupation	occupation	NOUN
dpc-5027	125	42	,	,	PUNCT
dpc-5027	125	43	residency	residency	NOUN
dpc-5027	125	44	,	,	PUNCT
dpc-5027	125	45	subtypes	subtype	NOUN
dpc-5027	125	46	of	of	ADP
dpc-5027	125	47	rosacea	rosacea	NOUN
dpc-5027	125	48	,	,	PUNCT
dpc-5027	125	49	degree	degree	NOUN
dpc-5027	125	50	of	of	ADP
dpc-5027	125	51	severity	severity	NOUN
dpc-5027	125	52	,	,	PUNCT
dpc-5027	125	53	or	or	CCONJ
dpc-5027	125	54	food	food	NOUN
dpc-5027	125	55	habits	habit	NOUN
dpc-5027	125	56	in	in	ADP
dpc-5027	125	57	the	the	DET
dpc-5027	125	58	rosacea	rosacea	NOUN
dpc-5027	125	59	group	group	NOUN
dpc-5027	125	60	.	.	PUNCT
dpc-5027	126	1	the	the	DET
dpc-5027	126	2	rosacea	rosacea	NOUN
dpc-5027	126	3	group	group	NOUN
dpc-5027	126	4	had	have	VERB
dpc-5027	126	5	a	a	DET
dpc-5027	126	6	significant	significant	ADJ
dpc-5027	126	7	increase	increase	NOUN
dpc-5027	126	8	in	in	ADP
dpc-5027	126	9	bacteroides	bacteroide	NOUN
dpc-5027	126	10	and	and	CCONJ
dpc-5027	126	11	lactobacillus	lactobacillus	NOUN
dpc-5027	126	12	gut	gut	NOUN
dpc-5027	126	13	microbiomes	microbiome	NOUN
dpc-5027	126	14	compared	compare	VERB
dpc-5027	126	15	to	to	ADP
dpc-5027	126	16	controls	control	NOUN
dpc-5027	126	17	(	(	PUNCT
dpc-5027	126	18	mean	mean	NOUN
dpc-5027	126	19	±	±	NUM
dpc-5027	126	20	sd	sd	ADP
dpc-5027	126	21	=	=	NOUN
dpc-5027	126	22	8.49±	8.49±	NUM
dpc-5027	126	23	0.58	0.58	NUM
dpc-5027	126	24	for	for	ADP
dpc-5027	126	25	bacteroides	bacteroide	NOUN
dpc-5027	126	26	in	in	ADP
dpc-5027	126	27	the	the	DET
dpc-5027	126	28	rosacea	rosacea	NOUN
dpc-5027	126	29	group	group	NOUN
dpc-5027	126	30	and	and	CCONJ
dpc-5027	126	31	8.14	8.14	NUM
dpc-5027	126	32	±	±	NUM
dpc-5027	126	33	0.46	0.46	NUM
dpc-5027	126	34	for	for	ADP
dpc-5027	126	35	the	the	DET
dpc-5027	126	36	control	control	NOUN
dpc-5027	126	37	group	group	NOUN
dpc-5027	126	38	,	,	PUNCT
dpc-5027	126	39	p=0.041	p=0.041	NOUN
dpc-5027	126	40	)	)	PUNCT
dpc-5027	126	41	,	,	PUNCT
dpc-5027	126	42	(	(	PUNCT
dpc-5027	126	43	mean	mean	INTJ
dpc-5027	126	44	±	±	NUM
dpc-5027	126	45	sd	sd	ADP
dpc-5027	126	46	=	=	NOUN
dpc-5027	126	47	11.21	11.21	NUM
dpc-5027	126	48	±	±	NUM
dpc-5027	126	49	1.20	1.20	NUM
dpc-5027	126	50	for	for	ADP
dpc-5027	126	51	lactobacillus	lactobacillus	NOUN
dpc-5027	126	52	in	in	ADP
dpc-5027	126	53	the	the	DET
dpc-5027	126	54	rosacea	rosacea	NOUN
dpc-5027	126	55	group	group	NOUN
dpc-5027	126	56	and	and	CCONJ
dpc-5027	126	57	9.89	9.89	NUM
dpc-5027	126	58	±	±	NUM
dpc-5027	126	59	0.52	0.52	NUM
dpc-5027	126	60	for	for	ADP
dpc-5027	126	61	the	the	DET
dpc-5027	126	62	control	control	NOUN
dpc-5027	126	63	group	group	NOUN
dpc-5027	126	64	,	,	PUNCT
dpc-5027	126	65	p=0.001	p=0.001	NUM
dpc-5027	126	66	)	)	PUNCT
dpc-5027	126	67	.	.	PUNCT
dpc-5027	127	1	in	in	ADP
dpc-5027	127	2	contrast	contrast	NOUN
dpc-5027	127	3	,	,	PUNCT
dpc-5027	127	4	fusobacterium	fusobacterium	NOUN
dpc-5027	127	5	did	do	AUX
dpc-5027	127	6	not	not	PART
dpc-5027	127	7	show	show	VERB
dpc-5027	127	8	a	a	DET
dpc-5027	127	9	significant	significant	ADJ
dpc-5027	127	10	difference	difference	NOUN
dpc-5027	127	11	between	between	ADP
dpc-5027	127	12	rosacea	rosacea	PROPN
dpc-5027	127	13	group	group	NOUN
dpc-5027	127	14	and	and	CCONJ
dpc-5027	127	15	controls	control	NOUN
dpc-5027	127	16	(	(	PUNCT
dpc-5027	127	17	p=	p=	NOUN
dpc-5027	127	18	0.842	0.842	NUM
dpc-5027	127	19	)	)	PUNCT
dpc-5027	127	20	(	(	PUNCT
dpc-5027	127	21	table	table	NOUN
dpc-5027	127	22	4	4	NUM
dpc-5027	127	23	)	)	PUNCT
dpc-5027	127	24	.	.	PUNCT
dpc-5027	128	1	bacteroides	bacteroide	NOUN
dpc-5027	128	2	and	and	CCONJ
dpc-5027	128	3	fusobacterium	fusobacterium	NOUN
dpc-5027	128	4	gut	gut	NOUN
dpc-5027	128	5	microbiomes	microbiome	NOUN
dpc-5027	128	6	showed	show	VERB
dpc-5027	128	7	statistically	statistically	ADV
dpc-5027	128	8	significant	significant	ADJ
dpc-5027	128	9	relations	relation	NOUN
dpc-5027	128	10	with	with	ADP
dpc-5027	128	11	subtypes	subtype	NOUN
dpc-5027	128	12	of	of	ADP
dpc-5027	128	13	rosacea	rosacea	NOUN
dpc-5027	128	14	,	,	PUNCT
dpc-5027	128	15	while	while	SCONJ
dpc-5027	128	16	lactobacillus	lactobacillus	NOUN
dpc-5027	128	17	showed	show	VERB
dpc-5027	128	18	no	no	DET
dpc-5027	128	19	significant	significant	ADJ
dpc-5027	128	20	relation	relation	NOUN
dpc-5027	128	21	with	with	ADP
dpc-5027	128	22	subtypes	subtype	NOUN
dpc-5027	128	23	of	of	ADP
dpc-5027	128	24	rosacea	rosacea	NOUN
dpc-5027	128	25	.	.	PUNCT
dpc-5027	129	1	the	the	DET
dpc-5027	129	2	strongest	strong	ADJ
dpc-5027	129	3	significant	significant	ADJ
dpc-5027	129	4	relation	relation	NOUN
dpc-5027	129	5	was	be	AUX
dpc-5027	129	6	found	find	VERB
dpc-5027	129	7	between	between	ADP
dpc-5027	129	8	papulopustular	papulopustular	ADJ
dpc-5027	129	9	and	and	CCONJ
dpc-5027	129	10	rhinophyma	rhinophyma	NOUN
dpc-5027	129	11	subtypes	subtype	NOUN
dpc-5027	129	12	regarding	regard	VERB
dpc-5027	129	13	bacteroides	bacteroide	NOUN
dpc-5027	129	14	and	and	CCONJ
dpc-5027	129	15	fusobacterium	fusobacterium	NOUN
dpc-5027	129	16	(	(	PUNCT
dpc-5027	129	17	p=0.007	p=0.007	X
dpc-5027	129	18	and	and	CCONJ
dpc-5027	129	19	p=0.004	p=0.004	NOUN
dpc-5027	129	20	,	,	PUNCT
dpc-5027	129	21	respectively	respectively	ADV
dpc-5027	129	22	)	)	PUNCT
dpc-5027	129	23	.	.	PUNCT
dpc-5027	130	1	a	a	DET
dpc-5027	130	2	less	less	ADV
dpc-5027	130	3	significant	significant	ADJ
dpc-5027	130	4	relation	relation	NOUN
dpc-5027	130	5	was	be	AUX
dpc-5027	130	6	detected	detect	VERB
dpc-5027	130	7	between	between	ADP
dpc-5027	130	8	erythematotelangiectatic	erythematotelangiectatic	ADJ
dpc-5027	130	9	and	and	CCONJ
dpc-5027	130	10	rhinophyma	rhinophyma	NOUN
dpc-5027	130	11	subtypes	subtype	NOUN
dpc-5027	130	12	regarding	regard	VERB
dpc-5027	130	13	bacteroides	bacteroide	NOUN
dpc-5027	130	14	(	(	PUNCT
dpc-5027	130	15	p=0.022	p=0.022	NOUN
dpc-5027	130	16	)	)	PUNCT
dpc-5027	130	17	,	,	PUNCT
dpc-5027	130	18	with	with	ADP
dpc-5027	130	19	a	a	DET
dpc-5027	130	20	less	less	ADV
dpc-5027	130	21	significant	significant	ADJ
dpc-5027	130	22	relation	relation	NOUN
dpc-5027	130	23	between	between	ADP
dpc-5027	130	24	erythematotelangiectatic	erythematotelangiectatic	ADJ
dpc-5027	130	25	and	and	CCONJ
dpc-5027	130	26	papulopustular	papulopustular	ADJ
dpc-5027	130	27	subtypes	subtype	NOUN
dpc-5027	130	28	regarding	regard	VERB
dpc-5027	130	29	fusobacterium	fusobacterium	NOUN
dpc-5027	130	30	(	(	PUNCT
dpc-5027	130	31	p=0.015	p=0.015	NOUN
dpc-5027	130	32	)	)	PUNCT
dpc-5027	130	33	(	(	PUNCT
dpc-5027	130	34	tables	table	NOUN
dpc-5027	130	35	5–6	5–6	VERB
dpc-5027	130	36	)	)	PUNCT
dpc-5027	130	37	.	.	PUNCT
dpc-5027	131	1	lactobacillus	lactobacillus	NOUN
dpc-5027	131	2	gut	gut	NOUN
dpc-5027	131	3	microbiome	microbiome	NOUN
dpc-5027	131	4	showed	show	VERB
dpc-5027	131	5	a	a	DET
dpc-5027	131	6	significant	significant	ADJ
dpc-5027	131	7	relation	relation	NOUN
dpc-5027	131	8	with	with	ADP
dpc-5027	131	9	degree	degree	NOUN
dpc-5027	131	10	of	of	ADP
dpc-5027	131	11	severity	severity	NOUN
dpc-5027	131	12	,	,	PUNCT
dpc-5027	131	13	with	with	ADP
dpc-5027	131	14	the	the	DET
dpc-5027	131	15	highest	high	ADJ
dpc-5027	131	16	significant	significant	ADJ
dpc-5027	131	17	relation	relation	NOUN
dpc-5027	131	18	found	find	VERB
dpc-5027	131	19	in	in	ADP
dpc-5027	131	20	patients	patient	NOUN
dpc-5027	131	21	with	with	ADP
dpc-5027	131	22	mild	mild	ADJ
dpc-5027	131	23	and	and	CCONJ
dpc-5027	131	24	moderate	moderate	ADJ
dpc-5027	131	25	disease	disease	NOUN
dpc-5027	131	26	(	(	PUNCT
dpc-5027	131	27	p=0.014	p=0.014	X
dpc-5027	131	28	)	)	PUNCT
dpc-5027	131	29	(	(	PUNCT
dpc-5027	131	30	table	table	NOUN
dpc-5027	131	31	7	7	NUM
dpc-5027	131	32	)	)	PUNCT
dpc-5027	131	33	,	,	PUNCT
dpc-5027	131	34	while	while	SCONJ
dpc-5027	131	35	there	there	PRON
dpc-5027	131	36	was	be	VERB
dpc-5027	131	37	no	no	DET
dpc-5027	131	38	statistically	statistically	ADV
dpc-5027	131	39	significant	significant	ADJ
dpc-5027	131	40	relation	relation	NOUN
dpc-5027	131	41	between	between	ADP
dpc-5027	131	42	fusobacterium	fusobacterium	NOUN
dpc-5027	131	43	or	or	CCONJ
dpc-5027	131	44	bacteroides	bacteroide	VERB
dpc-5027	131	45	gut	gut	PROPN
dpc-5027	131	46	microbiomes	microbiome	NOUN
dpc-5027	131	47	and	and	CCONJ
dpc-5027	131	48	degree	degree	NOUN
dpc-5027	131	49	of	of	ADP
dpc-5027	131	50	severity	severity	NOUN
dpc-5027	131	51	in	in	ADP
dpc-5027	131	52	rosacea	rosacea	NOUN
dpc-5027	131	53	patients	patient	NOUN
dpc-5027	131	54	.	.	PUNCT
dpc-5027	132	1	discussion	discussion	NOUN
dpc-5027	132	2	this	this	DET
dpc-5027	132	3	study	study	NOUN
dpc-5027	132	4	detected	detect	VERB
dpc-5027	132	5	a	a	DET
dpc-5027	132	6	statistically	statistically	ADV
dpc-5027	132	7	significant	significant	ADJ
dpc-5027	132	8	higher	high	ADJ
dpc-5027	132	9	serum	serum	NOUN
dpc-5027	132	10	zonulin	zonulin	PROPN
dpc-5027	132	11	level	level	NOUN
dpc-5027	132	12	in	in	ADP
dpc-5027	132	13	rosacea	rosacea	NOUN
dpc-5027	132	14	cases	case	NOUN
dpc-5027	132	15	than	than	ADP
dpc-5027	132	16	in	in	ADP
dpc-5027	132	17	controls	control	NOUN
dpc-5027	132	18	.	.	PUNCT
dpc-5027	133	1	our	our	PRON
dpc-5027	133	2	finding	finding	NOUN
dpc-5027	133	3	confirms	confirm	VERB
dpc-5027	133	4	the	the	DET
dpc-5027	133	5	results	result	NOUN
dpc-5027	133	6	of	of	ADP
dpc-5027	133	7	a	a	DET
dpc-5027	133	8	previous	previous	ADJ
dpc-5027	133	9	study	study	NOUN
dpc-5027	133	10	done	do	VERB
dpc-5027	133	11	by	by	ADP
dpc-5027	133	12	yüksel	yüksel	PROPN
dpc-5027	133	13	and	and	CCONJ
dpc-5027	133	14	ülfer	ülfer	VERB
dpc-5027	133	15	[	[	X
dpc-5027	133	16	11	11	NUM
dpc-5027	133	17	]	]	PUNCT
dpc-5027	133	18	,	,	PUNCT
dpc-5027	133	19	who	who	PRON
dpc-5027	133	20	revealed	reveal	VERB
dpc-5027	133	21	a	a	DET
dpc-5027	133	22	significant	significant	ADJ
dpc-5027	133	23	elevation	elevation	NOUN
dpc-5027	133	24	in	in	ADP
dpc-5027	133	25	serum	serum	PROPN
dpc-5027	133	26	zonulin	zonulin	PROPN
dpc-5027	133	27	levels	level	NOUN
dpc-5027	133	28	in	in	ADP
dpc-5027	133	29	rosacea	rosacea	NOUN
dpc-5027	133	30	patients	patient	NOUN
dpc-5027	133	31	compared	compare	VERB
dpc-5027	133	32	to	to	ADP
dpc-5027	133	33	healthy	healthy	ADJ
dpc-5027	133	34	controls	control	NOUN
dpc-5027	133	35	.	.	PUNCT
dpc-5027	134	1	original	original	ADJ
dpc-5027	134	2	article	article	NOUN
dpc-5027	134	3	|	|	ADV
dpc-5027	134	4	dermatol	dermatol	ADJ
dpc-5027	134	5	pract	pract	NOUN
dpc-5027	134	6	concept	concept	NOUN
dpc-5027	134	7	.	.	PUNCT
dpc-5027	135	1	2025;15(3):5027	2025;15(3):5027	NUM
dpc-5027	135	2	7	7	NUM
dpc-5027	135	3	table	table	NOUN
dpc-5027	135	4	4	4	NUM
dpc-5027	135	5	.	.	PUNCT
dpc-5027	135	6	comparison	comparison	NOUN
dpc-5027	135	7	between	between	ADP
dpc-5027	135	8	rosacea	rosacea	NOUN
dpc-5027	135	9	cases	case	NOUN
dpc-5027	135	10	and	and	CCONJ
dpc-5027	135	11	controls	control	NOUN
dpc-5027	135	12	regarding	regard	VERB
dpc-5027	135	13	gut	gut	PROPN
dpc-5027	135	14	microbiomes	microbiome	NOUN
dpc-5027	135	15	(	(	PUNCT
dpc-5027	135	16	bacteroid	bacteroid	NOUN
dpc-5027	135	17	,	,	PUNCT
dpc-5027	135	18	lactobacillus	lactobacillus	NOUN
dpc-5027	135	19	,	,	PUNCT
dpc-5027	135	20	and	and	CCONJ
dpc-5027	135	21	fusobacterium	fusobacterium	NOUN
dpc-5027	135	22	)	)	PUNCT
dpc-5027	135	23	.	.	PUNCT
dpc-5027	136	1	variables	variable	NOUN
dpc-5027	136	2	cases	case	NOUN
dpc-5027	136	3	(	(	PUNCT
dpc-5027	136	4	n=21	n=21	NOUN
dpc-5027	136	5	)	)	PUNCT
dpc-5027	136	6	controls	control	NOUN
dpc-5027	136	7	(	(	PUNCT
dpc-5027	136	8	n=21	n=21	NOUN
dpc-5027	136	9	)	)	PUNCT
dpc-5027	136	10	t.	t.	NOUN
dpc-5027	136	11	p	p	NOUN
dpc-5027	136	12	-	-	PUNCT
dpc-5027	136	13	value	value	NOUN
dpc-5027	136	14	bacteroide	bacteroide	NOUN
dpc-5027	136	15	range	range	VERB
dpc-5027	136	16	7.2	7.2	NUM
dpc-5027	136	17	–	–	PUNCT
dpc-5027	136	18	9.5	9.5	NUM
dpc-5027	136	19	7.3	7.3	NUM
dpc-5027	136	20	–	–	PUNCT
dpc-5027	136	21	8.9	8.9	NUM
dpc-5027	136	22	2.108	2.108	NUM
dpc-5027	136	23	0.041	0.041	NUM
dpc-5027	136	24	*	*	PUNCT
dpc-5027	136	25	mean	mean	NOUN
dpc-5027	136	26	±	±	NUM
dpc-5027	136	27	sd	sd	ADP
dpc-5027	136	28	8.49	8.49	NUM
dpc-5027	136	29	±	±	NUM
dpc-5027	137	1	0.58	0.58	NUM
dpc-5027	137	2	8.14	8.14	NUM
dpc-5027	137	3	±	±	NUM
dpc-5027	137	4	0.46	0.46	NUM
dpc-5027	137	5	lactobacillus	lactobacillus	NOUN
dpc-5027	137	6	range	range	VERB
dpc-5027	137	7	9.1	9.1	NUM
dpc-5027	137	8	–	–	PUNCT
dpc-5027	137	9	12.9	12.9	NUM
dpc-5027	137	10	9.08	9.08	NUM
dpc-5027	137	11	–	–	PUNCT
dpc-5027	137	12	10.8	10.8	NUM
dpc-5027	137	13	4.645	4.645	NUM
dpc-5027	137	14	0.001	0.001	NUM
dpc-5027	137	15	*	*	PUNCT
dpc-5027	137	16	mean	mean	NOUN
dpc-5027	137	17	±	±	NUM
dpc-5027	137	18	sd	sd	ADP
dpc-5027	137	19	11.21	11.21	NUM
dpc-5027	137	20	±	±	NUM
dpc-5027	137	21	1.20	1.20	NUM
dpc-5027	137	22	9.89	9.89	NUM
dpc-5027	137	23	±	±	NUM
dpc-5027	137	24	0.52	0.52	NUM
dpc-5027	137	25	fusobacterium	fusobacterium	NOUN
dpc-5027	137	26	range	range	NOUN
dpc-5027	137	27	5.1	5.1	NUM
dpc-5027	137	28	–	–	PUNCT
dpc-5027	137	29	8.02	8.02	NUM
dpc-5027	137	30	5.1	5.1	NUM
dpc-5027	137	31	–	–	PUNCT
dpc-5027	137	32	7.9	7.9	NUM
dpc-5027	137	33	0.200	0.200	NUM
dpc-5027	137	34	0.842	0.842	NUM
dpc-5027	137	35	mean	mean	NOUN
dpc-5027	137	36	±	±	NUM
dpc-5027	137	37	sd	sd	ADP
dpc-5027	137	38	6.41	6.41	NUM
dpc-5027	137	39	±	±	NUM
dpc-5027	137	40	1.00	1.00	NUM
dpc-5027	137	41	6.34	6.34	NUM
dpc-5027	137	42	±	±	NUM
dpc-5027	137	43	1.08	1.08	NUM
dpc-5027	137	44	data	datum	NOUN
dpc-5027	137	45	are	be	AUX
dpc-5027	137	46	presented	present	VERB
dpc-5027	137	47	as	as	ADP
dpc-5027	137	48	mean	mean	NOUN
dpc-5027	137	49	±	±	NUM
dpc-5027	137	50	sd	sd	NOUN
dpc-5027	137	51	.	.	PUNCT
dpc-5027	138	1	p<0.05	p<0.05	NOUN
dpc-5027	138	2	statistically	statistically	ADV
dpc-5027	138	3	significant	significant	ADJ
dpc-5027	138	4	.	.	PUNCT
dpc-5027	139	1	p≥0.05	p≥0.05	NOUN
dpc-5027	139	2	statistically	statistically	ADV
dpc-5027	139	3	not	not	PART
dpc-5027	139	4	significant	significant	ADJ
dpc-5027	139	5	.	.	PUNCT
dpc-5027	140	1	abbreviations	abbreviation	NOUN
dpc-5027	140	2	:	:	PUNCT
dpc-5027	140	3	sd	sd	NUM
dpc-5027	140	4	:	:	PUNCT
dpc-5027	140	5	standard	standard	ADJ
dpc-5027	140	6	deviation	deviation	NOUN
dpc-5027	140	7	;	;	PUNCT
dpc-5027	140	8	t	t	NUM
dpc-5027	140	9	:	:	PUNCT
dpc-5027	140	10	student	student	NOUN
dpc-5027	140	11	t	t	PROPN
dpc-5027	140	12	test	test	NOUN
dpc-5027	140	13	.	.	PUNCT
dpc-5027	141	1	table	table	NOUN
dpc-5027	141	2	5	5	NUM
dpc-5027	141	3	.	.	X
dpc-5027	141	4	relationship	relationship	NOUN
dpc-5027	141	5	between	between	ADP
dpc-5027	141	6	bacteroid	bacteroid	NOUN
dpc-5027	141	7	gut	gut	NOUN
dpc-5027	141	8	microbiome	microbiome	NOUN
dpc-5027	141	9	and	and	CCONJ
dpc-5027	141	10	subtypes	subtype	NOUN
dpc-5027	141	11	of	of	ADP
dpc-5027	141	12	rosacea	rosacea	NOUN
dpc-5027	141	13	in	in	ADP
dpc-5027	141	14	the	the	DET
dpc-5027	141	15	case	case	NOUN
dpc-5027	141	16	group	group	NOUN
dpc-5027	141	17	.	.	PUNCT
dpc-5027	142	1	bacteroide	bacteroide	NOUN
dpc-5027	142	2	subtype	subtype	NOUN
dpc-5027	142	3	of	of	ADP
dpc-5027	142	4	rosacea	rosacea	NOUN
dpc-5027	142	5	erythematotelangiectatic	erythematotelangiectatic	ADJ
dpc-5027	142	6	papulopustular	papulopustular	ADJ
dpc-5027	142	7	rhinophyma	rhinophyma	NOUN
dpc-5027	142	8	range	range	NOUN
dpc-5027	142	9	7.5	7.5	NUM
dpc-5027	142	10	–	–	PUNCT
dpc-5027	142	11	9.06	9.06	NUM
dpc-5027	142	12	8.01	8.01	NUM
dpc-5027	142	13	–	–	PUNCT
dpc-5027	142	14	9.5	9.5	NUM
dpc-5027	142	15	7.2	7.2	NUM
dpc-5027	142	16	–	–	PUNCT
dpc-5027	142	17	7.9	7.9	NUM
dpc-5027	142	18	mean	mean	NOUN
dpc-5027	142	19	±	±	NUM
dpc-5027	142	20	sd	sd	ADP
dpc-5027	142	21	8.50	8.50	NUM
dpc-5027	142	22	±	±	NUM
dpc-5027	142	23	0.42	0.42	NUM
dpc-5027	142	24	8.82	8.82	NUM
dpc-5027	142	25	±	±	NUM
dpc-5027	142	26	0.71	0.71	NUM
dpc-5027	142	27	7.55	7.55	NUM
dpc-5027	142	28	±	±	NUM
dpc-5027	142	29	0.49	0.49	NUM
dpc-5027	142	30	f.	f.	PROPN
dpc-5027	142	31	test	test	NOUN
dpc-5027	142	32	4.617	4.617	NUM
dpc-5027	142	33	p	p	NOUN
dpc-5027	142	34	-	-	PUNCT
dpc-5027	142	35	value	value	NOUN
dpc-5027	142	36	0.024	0.024	NUM
dpc-5027	142	37	*	*	PUNCT
dpc-5027	142	38	erythematotelangiectatic	erythematotelangiectatic	ADJ
dpc-5027	142	39	and	and	CCONJ
dpc-5027	142	40	papulopustular	papulopustular	ADJ
dpc-5027	142	41	erythematotelangiectatic	erythematotelangiectatic	NOUN
dpc-5027	142	42	and	and	CCONJ
dpc-5027	142	43	rhinophyma	rhinophyma	NOUN
dpc-5027	142	44	papulopustular	papulopustular	ADJ
dpc-5027	142	45	and	and	CCONJ
dpc-5027	142	46	rhinophyma	rhinophyma	NOUN
dpc-5027	142	47	0.232	0.232	NUM
dpc-5027	142	48	0.022	0.022	NUM
dpc-5027	142	49	*	*	SYM
dpc-5027	142	50	0.007	0.007	NUM
dpc-5027	142	51	*	*	NOUN
dpc-5027	142	52	data	datum	NOUN
dpc-5027	142	53	are	be	AUX
dpc-5027	142	54	presented	present	VERB
dpc-5027	142	55	as	as	ADP
dpc-5027	142	56	mean	mean	NOUN
dpc-5027	142	57	±	±	NUM
dpc-5027	142	58	sd	sd	NOUN
dpc-5027	142	59	.	.	PUNCT
dpc-5027	143	1	p<0.05	p<0.05	NOUN
dpc-5027	143	2	statistically	statistically	ADV
dpc-5027	143	3	significant	significant	ADJ
dpc-5027	143	4	.	.	PUNCT
dpc-5027	144	1	p≥0.05	p≥0.05	NOUN
dpc-5027	144	2	statistically	statistically	ADV
dpc-5027	144	3	not	not	PART
dpc-5027	144	4	significant	significant	ADJ
dpc-5027	144	5	.	.	PUNCT
dpc-5027	145	1	abbreviations	abbreviation	NOUN
dpc-5027	145	2	:	:	PUNCT
dpc-5027	146	1	f	f	X
dpc-5027	146	2	:	:	PUNCT
dpc-5027	146	3	anova	anova	PROPN
dpc-5027	146	4	test	test	NOUN
dpc-5027	146	5	;	;	PUNCT
dpc-5027	146	6	sd	sd	X
dpc-5027	146	7	:	:	PUNCT
dpc-5027	146	8	standard	standard	ADJ
dpc-5027	146	9	deviation	deviation	NOUN
dpc-5027	146	10	.	.	PUNCT
dpc-5027	147	1	table	table	NOUN
dpc-5027	147	2	6	6	NUM
dpc-5027	147	3	.	.	X
dpc-5027	148	1	relationship	relationship	NOUN
dpc-5027	148	2	between	between	ADP
dpc-5027	148	3	fusobacterium	fusobacterium	NOUN
dpc-5027	148	4	gut	gut	NOUN
dpc-5027	148	5	microbiome	microbiome	NOUN
dpc-5027	148	6	and	and	CCONJ
dpc-5027	148	7	subtypes	subtype	NOUN
dpc-5027	148	8	of	of	ADP
dpc-5027	148	9	rosacea	rosacea	NOUN
dpc-5027	148	10	in	in	ADP
dpc-5027	148	11	the	the	DET
dpc-5027	148	12	rosacea	rosacea	NOUN
dpc-5027	148	13	group	group	NOUN
dpc-5027	148	14	.	.	PUNCT
dpc-5027	149	1	fusobacterium	fusobacterium	NOUN
dpc-5027	149	2	subtype	subtype	NOUN
dpc-5027	149	3	of	of	ADP
dpc-5027	149	4	rosacea	rosacea	NOUN
dpc-5027	149	5	erythematotelangiectatic	erythematotelangiectatic	ADJ
dpc-5027	149	6	papulopustular	papulopustular	ADJ
dpc-5027	149	7	rhinophyma	rhinophyma	NOUN
dpc-5027	149	8	range	range	VERB
dpc-5027	149	9	5.1	5.1	NUM
dpc-5027	149	10	–	–	PUNCT
dpc-5027	149	11	7.9	7.9	NUM
dpc-5027	149	12	5.2	5.2	NUM
dpc-5027	149	13	–	–	PUNCT
dpc-5027	149	14	5.8	5.8	NUM
dpc-5027	149	15	7.3	7.3	NUM
dpc-5027	149	16	–	–	PUNCT
dpc-5027	149	17	8.02	8.02	NUM
dpc-5027	149	18	mean	mean	NOUN
dpc-5027	149	19	±	±	NUM
dpc-5027	149	20	sd	sd	ADP
dpc-5027	149	21	6.57	6.57	NUM
dpc-5027	149	22	±	±	NUM
dpc-5027	149	23	0.93	0.93	NUM
dpc-5027	149	24	5.44	5.44	NUM
dpc-5027	149	25	±	±	NUM
dpc-5027	149	26	0.23	0.23	NUM
dpc-5027	149	27	7.66	7.66	NUM
dpc-5027	149	28	±	±	NUM
dpc-5027	149	29	0.51	0.51	NUM
dpc-5027	149	30	f.	f.	PROPN
dpc-5027	149	31	test	test	NOUN
dpc-5027	149	32	6.254	6.254	NUM
dpc-5027	149	33	p	p	ADJ
dpc-5027	149	34	-	-	PUNCT
dpc-5027	149	35	value	value	NOUN
dpc-5027	149	36	0.009	0.009	NUM
dpc-5027	149	37	*	*	NOUN
dpc-5027	149	38	erythematotelangiectatic	erythematotelangiectatic	ADJ
dpc-5027	149	39	and	and	CCONJ
dpc-5027	149	40	papulopustular	papulopustular	ADJ
dpc-5027	149	41	erythematotelangiectatic	erythematotelangiectatic	NOUN
dpc-5027	149	42	and	and	CCONJ
dpc-5027	149	43	rhinophyma	rhinophyma	NOUN
dpc-5027	149	44	papulopustular	papulopustular	ADJ
dpc-5027	149	45	and	and	CCONJ
dpc-5027	149	46	rhinophyma	rhinophyma	NOUN
dpc-5027	149	47	0.015	0.015	NUM
dpc-5027	149	48	*	*	NOUN
dpc-5027	149	49	0.093	0.093	NUM
dpc-5027	149	50	0.004	0.004	NUM
dpc-5027	149	51	*	*	NOUN
dpc-5027	149	52	data	datum	NOUN
dpc-5027	149	53	are	be	AUX
dpc-5027	149	54	presented	present	VERB
dpc-5027	149	55	as	as	ADP
dpc-5027	149	56	mean	mean	NOUN
dpc-5027	149	57	±	±	NUM
dpc-5027	149	58	sd	sd	NOUN
dpc-5027	149	59	.	.	PUNCT
dpc-5027	150	1	p<0.05	p<0.05	NOUN
dpc-5027	150	2	statistically	statistically	ADV
dpc-5027	150	3	significant	significant	ADJ
dpc-5027	150	4	.	.	PUNCT
dpc-5027	151	1	p≥0.05	p≥0.05	NOUN
dpc-5027	151	2	statistically	statistically	ADV
dpc-5027	151	3	not	not	PART
dpc-5027	151	4	significant	significant	ADJ
dpc-5027	151	5	.	.	PUNCT
dpc-5027	152	1	abbreviations	abbreviation	NOUN
dpc-5027	152	2	:	:	PUNCT
dpc-5027	153	1	f	f	X
dpc-5027	153	2	:	:	PUNCT
dpc-5027	153	3	anova	anova	PROPN
dpc-5027	153	4	test	test	NOUN
dpc-5027	153	5	;	;	PUNCT
dpc-5027	153	6	sd	sd	X
dpc-5027	153	7	:	:	PUNCT
dpc-5027	153	8	standard	standard	ADJ
dpc-5027	153	9	deviation	deviation	NOUN
dpc-5027	153	10	.	.	PUNCT
dpc-5027	154	1	these	these	DET
dpc-5027	154	2	findings	finding	NOUN
dpc-5027	154	3	suggest	suggest	VERB
dpc-5027	154	4	that	that	SCONJ
dpc-5027	154	5	the	the	DET
dpc-5027	154	6	significant	significant	ADJ
dpc-5027	154	7	increase	increase	NOUN
dpc-5027	154	8	in	in	ADP
dpc-5027	154	9	serum	serum	NOUN
dpc-5027	154	10	zonulin	zonulin	PROPN
dpc-5027	154	11	observed	observe	VERB
dpc-5027	154	12	in	in	ADP
dpc-5027	154	13	rosacea	rosacea	NOUN
dpc-5027	154	14	patients	patient	NOUN
dpc-5027	154	15	indicates	indicate	VERB
dpc-5027	154	16	enhanced	enhanced	ADJ
dpc-5027	154	17	intestinal	intestinal	ADJ
dpc-5027	154	18	permeability	permeability	NOUN
dpc-5027	154	19	,	,	PUNCT
dpc-5027	154	20	which	which	PRON
dpc-5027	154	21	may	may	AUX
dpc-5027	154	22	contribute	contribute	VERB
dpc-5027	154	23	to	to	ADP
dpc-5027	154	24	a	a	DET
dpc-5027	154	25	“	"	PUNCT
dpc-5027	154	26	leaky	leaky	ADJ
dpc-5027	154	27	gut	gut	NOUN
dpc-5027	154	28	”	"	PUNCT
dpc-5027	154	29	and	and	CCONJ
dpc-5027	154	30	potentially	potentially	ADV
dpc-5027	154	31	play	play	VERB
dpc-5027	154	32	a	a	DET
dpc-5027	154	33	role	role	NOUN
dpc-5027	154	34	in	in	ADP
dpc-5027	154	35	the	the	DET
dpc-5027	154	36	pathophysiology	pathophysiology	NOUN
dpc-5027	154	37	of	of	ADP
dpc-5027	154	38	the	the	DET
dpc-5027	154	39	disease	disease	NOUN
dpc-5027	154	40	,	,	PUNCT
dpc-5027	154	41	indicating	indicate	VERB
dpc-5027	154	42	that	that	SCONJ
dpc-5027	154	43	enhanced	enhance	VERB
dpc-5027	154	44	intestinal	intestinal	ADJ
dpc-5027	154	45	permeability	permeability	NOUN
dpc-5027	154	46	could	could	AUX
dpc-5027	154	47	be	be	AUX
dpc-5027	154	48	responsible	responsible	ADJ
dpc-5027	154	49	for	for	ADP
dpc-5027	154	50	a	a	DET
dpc-5027	154	51	leaky	leaky	ADJ
dpc-5027	154	52	gut	gut	NOUN
dpc-5027	154	53	in	in	ADP
dpc-5027	154	54	rosacea	rosacea	NOUN
dpc-5027	154	55	patients	patient	NOUN
dpc-5027	154	56	,	,	PUNCT
dpc-5027	154	57	hence	hence	ADV
dpc-5027	154	58	might	might	AUX
dpc-5027	154	59	have	have	VERB
dpc-5027	154	60	a	a	DET
dpc-5027	154	61	role	role	NOUN
dpc-5027	154	62	in	in	ADP
dpc-5027	154	63	the	the	DET
dpc-5027	154	64	disease	disease	NOUN
dpc-5027	154	65	pathophysiology	pathophysiology	NOUN
dpc-5027	154	66	[	[	X
dpc-5027	154	67	7	7	NUM
dpc-5027	154	68	]	]	PUNCT
dpc-5027	154	69	.	.	PUNCT
dpc-5027	155	1	based	base	VERB
dpc-5027	155	2	on	on	ADP
dpc-5027	155	3	our	our	PRON
dpc-5027	155	4	roc	roc	PROPN
dpc-5027	155	5	curve	curve	NOUN
dpc-5027	155	6	results	result	NOUN
dpc-5027	155	7	,	,	PUNCT
dpc-5027	155	8	serum	serum	PROPN
dpc-5027	155	9	zonulin	zonulin	PROPN
dpc-5027	155	10	level	level	NOUN
dpc-5027	155	11	at	at	ADP
dpc-5027	155	12	a	a	DET
dpc-5027	155	13	cut	cut	NOUN
dpc-5027	155	14	-	-	PUNCT
dpc-5027	155	15	off	off	NOUN
dpc-5027	155	16	of	of	ADP
dpc-5027	155	17	>	>	PROPN
dpc-5027	155	18	16.25	16.25	NUM
dpc-5027	155	19	ng	ng	NOUN
dpc-5027	155	20	/	/	SYM
dpc-5027	155	21	ml	ml	PROPN
dpc-5027	155	22	could	could	AUX
dpc-5027	155	23	be	be	AUX
dpc-5027	155	24	a	a	DET
dpc-5027	155	25	reliable	reliable	ADJ
dpc-5027	155	26	predicting	predicting	NOUN
dpc-5027	155	27	marker	marker	NOUN
dpc-5027	155	28	for	for	ADP
dpc-5027	155	29	patients	patient	NOUN
dpc-5027	155	30	with	with	ADP
dpc-5027	155	31	rosacea	rosacea	NOUN
dpc-5027	155	32	.	.	PUNCT
dpc-5027	156	1	however	however	ADV
dpc-5027	156	2	,	,	PUNCT
dpc-5027	156	3	we	we	PRON
dpc-5027	156	4	did	do	AUX
dpc-5027	156	5	not	not	PART
dpc-5027	156	6	find	find	VERB
dpc-5027	156	7	an	an	DET
dpc-5027	156	8	association	association	NOUN
dpc-5027	156	9	between	between	ADP
dpc-5027	156	10	serum	serum	PROPN
dpc-5027	156	11	zonulin	zonulin	PROPN
dpc-5027	156	12	level	level	NOUN
dpc-5027	156	13	and	and	CCONJ
dpc-5027	156	14	the	the	DET
dpc-5027	156	15	degree	degree	NOUN
dpc-5027	156	16	of	of	ADP
dpc-5027	156	17	disease	disease	NOUN
dpc-5027	156	18	severity	severity	NOUN
dpc-5027	156	19	.	.	PUNCT
dpc-5027	157	1	this	this	PRON
dpc-5027	157	2	could	could	AUX
dpc-5027	157	3	be	be	AUX
dpc-5027	157	4	explained	explain	VERB
dpc-5027	157	5	by	by	ADP
dpc-5027	157	6	the	the	DET
dpc-5027	157	7	small	small	ADJ
dpc-5027	157	8	sample	sample	NOUN
dpc-5027	157	9	size	size	NOUN
dpc-5027	157	10	.	.	PUNCT
dpc-5027	158	1	the	the	DET
dpc-5027	158	2	present	present	ADJ
dpc-5027	158	3	study	study	NOUN
dpc-5027	158	4	indicated	indicate	VERB
dpc-5027	158	5	a	a	DET
dpc-5027	158	6	significant	significant	ADJ
dpc-5027	158	7	elevation	elevation	NOUN
dpc-5027	158	8	in	in	ADP
dpc-5027	158	9	bacteroides	bacteroide	NOUN
dpc-5027	158	10	and	and	CCONJ
dpc-5027	158	11	lactobacillus	lactobacillus	NOUN
dpc-5027	158	12	gut	gut	NOUN
dpc-5027	158	13	microbiomes	microbiome	NOUN
dpc-5027	158	14	in	in	ADP
dpc-5027	158	15	rosacea	rosacea	NOUN
dpc-5027	158	16	patients	patient	NOUN
dpc-5027	158	17	8	8	NUM
dpc-5027	158	18	original	original	ADJ
dpc-5027	158	19	article	article	NOUN
dpc-5027	158	20	|	|	ADV
dpc-5027	158	21	dermatol	dermatol	ADJ
dpc-5027	158	22	pract	pract	NOUN
dpc-5027	158	23	concept	concept	NOUN
dpc-5027	158	24	.	.	PUNCT
dpc-5027	159	1	2025;15(3):5027	2025;15(3):5027	NUM
dpc-5027	159	2	erythematotelangiectatic	erythematotelangiectatic	ADJ
dpc-5027	159	3	and	and	CCONJ
dpc-5027	159	4	papulopustular	papulopustular	ADJ
dpc-5027	159	5	subtypes	subtype	NOUN
dpc-5027	159	6	.	.	PUNCT
dpc-5027	160	1	regarding	regard	VERB
dpc-5027	160	2	bacteroides	bacteroide	NOUN
dpc-5027	160	3	and	and	CCONJ
dpc-5027	160	4	fusobacterium	fusobacterium	NOUN
dpc-5027	160	5	,	,	PUNCT
dpc-5027	160	6	these	these	DET
dpc-5027	160	7	findings	finding	NOUN
dpc-5027	160	8	may	may	AUX
dpc-5027	160	9	be	be	AUX
dpc-5027	160	10	attributed	attribute	VERB
dpc-5027	160	11	to	to	ADP
dpc-5027	160	12	papulopustular	papulopustular	ADJ
dpc-5027	160	13	rosacea	rosacea	NOUN
dpc-5027	160	14	,	,	PUNCT
dpc-5027	160	15	as	as	SCONJ
dpc-5027	160	16	antibiotic	antibiotic	ADJ
dpc-5027	160	17	(	(	PUNCT
dpc-5027	160	18	oral	oral	ADJ
dpc-5027	160	19	metronidazole	metronidazole	NOUN
dpc-5027	160	20	)	)	PUNCT
dpc-5027	160	21	treatment	treatment	NOUN
dpc-5027	160	22	could	could	AUX
dpc-5027	160	23	improve	improve	VERB
dpc-5027	160	24	both	both	DET
dpc-5027	160	25	rosacea	rosacea	NOUN
dpc-5027	160	26	symptoms	symptom	NOUN
dpc-5027	160	27	and	and	CCONJ
dpc-5027	160	28	inflammatory	inflammatory	ADJ
dpc-5027	160	29	enteritis	enteritis	NOUN
dpc-5027	160	30	,	,	PUNCT
dpc-5027	160	31	suggesting	suggest	VERB
dpc-5027	160	32	a	a	DET
dpc-5027	160	33	bacterial	bacterial	ADJ
dpc-5027	160	34	pathogen	pathogen	NOUN
dpc-5027	160	35	may	may	AUX
dpc-5027	160	36	be	be	AUX
dpc-5027	160	37	involved	involve	VERB
dpc-5027	160	38	[	[	PUNCT
dpc-5027	160	39	22	22	NUM
dpc-5027	160	40	]	]	PUNCT
dpc-5027	160	41	.	.	PUNCT
dpc-5027	161	1	additionally	additionally	ADV
dpc-5027	161	2	,	,	PUNCT
dpc-5027	161	3	rosacea	rosacea	PROPN
dpc-5027	161	4	is	be	AUX
dpc-5027	161	5	reported	report	VERB
dpc-5027	161	6	to	to	PART
dpc-5027	161	7	be	be	AUX
dpc-5027	161	8	associated	associate	VERB
dpc-5027	161	9	with	with	ADP
dpc-5027	161	10	gastrointestinal	gastrointestinal	ADJ
dpc-5027	161	11	comorbidities	comorbiditie	NOUN
dpc-5027	161	12	,	,	PUNCT
dpc-5027	161	13	and	and	CCONJ
dpc-5027	161	14	certain	certain	ADJ
dpc-5027	161	15	studies	study	NOUN
dpc-5027	161	16	have	have	AUX
dpc-5027	161	17	linked	link	VERB
dpc-5027	161	18	this	this	DET
dpc-5027	161	19	coexistence	coexistence	NOUN
dpc-5027	161	20	to	to	ADP
dpc-5027	161	21	alterations	alteration	NOUN
dpc-5027	161	22	in	in	ADP
dpc-5027	161	23	the	the	DET
dpc-5027	161	24	gut	gut	NOUN
dpc-5027	161	25	microbiome	microbiome	NOUN
dpc-5027	162	1	[	[	X
dpc-5027	162	2	23	23	NUM
dpc-5027	162	3	]	]	PUNCT
dpc-5027	162	4	.	.	PUNCT
dpc-5027	163	1	it	it	PRON
dpc-5027	163	2	has	have	AUX
dpc-5027	163	3	been	be	AUX
dpc-5027	163	4	mentioned	mention	VERB
dpc-5027	163	5	by	by	ADP
dpc-5027	163	6	ellis	ellis	PROPN
dpc-5027	163	7	et	et	PROPN
dpc-5027	163	8	al	al	PROPN
dpc-5027	163	9	.	.	PUNCT
dpc-5027	164	1	[	[	X
dpc-5027	164	2	24	24	NUM
dpc-5027	164	3	]	]	PUNCT
dpc-5027	164	4	that	that	SCONJ
dpc-5027	164	5	alterations	alteration	NOUN
dpc-5027	164	6	in	in	ADP
dpc-5027	164	7	the	the	DET
dpc-5027	164	8	gut	gut	NOUN
dpc-5027	164	9	microbiome	microbiome	NOUN
dpc-5027	164	10	could	could	AUX
dpc-5027	164	11	lead	lead	VERB
dpc-5027	164	12	to	to	ADP
dpc-5027	164	13	cutaneous	cutaneous	ADJ
dpc-5027	164	14	manifestations	manifestation	NOUN
dpc-5027	164	15	through	through	ADP
dpc-5027	164	16	the	the	DET
dpc-5027	164	17	brain	brain	NOUN
dpc-5027	164	18	-	-	PUNCT
dpc-5027	164	19	gut	gut	NOUN
dpc-5027	164	20	-	-	PUNCT
dpc-5027	164	21	skin	skin	NOUN
dpc-5027	164	22	axis	axis	NOUN
dpc-5027	164	23	,	,	PUNCT
dpc-5027	164	24	which	which	PRON
dpc-5027	164	25	explains	explain	VERB
dpc-5027	164	26	the	the	DET
dpc-5027	164	27	presence	presence	NOUN
dpc-5027	164	28	of	of	ADP
dpc-5027	164	29	rhinophyma	rhinophyma	NOUN
dpc-5027	164	30	.	.	PUNCT
dpc-5027	165	1	they	they	PRON
dpc-5027	165	2	postulated	postulate	VERB
dpc-5027	165	3	that	that	PRON
dpc-5027	165	4	negative	negative	ADJ
dpc-5027	165	5	emotional	emotional	ADJ
dpc-5027	165	6	states	state	NOUN
dpc-5027	165	7	,	,	PUNCT
dpc-5027	165	8	for	for	ADP
dpc-5027	165	9	example	example	NOUN
dpc-5027	165	10	,	,	PUNCT
dpc-5027	165	11	anxiety	anxiety	NOUN
dpc-5027	165	12	and	and	CCONJ
dpc-5027	165	13	depression	depression	NOUN
dpc-5027	165	14	,	,	PUNCT
dpc-5027	165	15	disrupt	disrupt	VERB
dpc-5027	165	16	the	the	DET
dpc-5027	165	17	gastrointestinal	gastrointestinal	ADJ
dpc-5027	165	18	system	system	NOUN
dpc-5027	165	19	,	,	PUNCT
dpc-5027	165	20	resulting	result	VERB
dpc-5027	165	21	in	in	ADP
dpc-5027	165	22	altered	altered	ADJ
dpc-5027	165	23	gut	gut	NOUN
dpc-5027	165	24	flora	flora	NOUN
dpc-5027	165	25	and	and	CCONJ
dpc-5027	165	26	increased	increase	VERB
dpc-5027	165	27	intestinal	intestinal	ADJ
dpc-5027	165	28	permeability	permeability	NOUN
dpc-5027	165	29	in	in	ADP
dpc-5027	165	30	the	the	DET
dpc-5027	165	31	intestine	intestine	NOUN
dpc-5027	165	32	.	.	PUNCT
dpc-5027	166	1	it	it	PRON
dpc-5027	166	2	leads	lead	VERB
dpc-5027	166	3	to	to	ADP
dpc-5027	166	4	systemic	systemic	ADJ
dpc-5027	166	5	inflammation	inflammation	NOUN
dpc-5027	166	6	that	that	PRON
dpc-5027	166	7	can	can	AUX
dpc-5027	166	8	disrupt	disrupt	VERB
dpc-5027	166	9	cutaneous	cutaneous	ADJ
dpc-5027	166	10	homeostasis	homeostasis	NOUN
dpc-5027	166	11	by	by	ADP
dpc-5027	166	12	activating	activate	VERB
dpc-5027	166	13	t	t	NOUN
dpc-5027	166	14	cells	cell	NOUN
dpc-5027	166	15	and	and	CCONJ
dpc-5027	166	16	disrupting	disrupt	VERB
dpc-5027	166	17	immunosuppressive	immunosuppressive	ADJ
dpc-5027	166	18	cytokines	cytokine	NOUN
dpc-5027	166	19	[	[	X
dpc-5027	166	20	24	24	NUM
dpc-5027	166	21	]	]	PUNCT
dpc-5027	166	22	.	.	PUNCT
dpc-5027	167	1	besides	besides	SCONJ
dpc-5027	167	2	,	,	PUNCT
dpc-5027	167	3	cutaneous	cutaneous	ADJ
dpc-5027	167	4	microbiomes	microbiomes	PROPN
dpc-5027	167	5	promote	promote	VERB
dpc-5027	167	6	efficient	efficient	ADJ
dpc-5027	167	7	immune	immune	ADJ
dpc-5027	167	8	functions	function	NOUN
dpc-5027	167	9	,	,	PUNCT
dpc-5027	167	10	acting	act	VERB
dpc-5027	167	11	as	as	ADP
dpc-5027	167	12	a	a	DET
dpc-5027	167	13	potential	potential	ADJ
dpc-5027	167	14	contributor	contributor	NOUN
dpc-5027	167	15	to	to	ADP
dpc-5027	167	16	the	the	DET
dpc-5027	167	17	development	development	NOUN
dpc-5027	167	18	of	of	ADP
dpc-5027	167	19	rosacea	rosacea	NOUN
dpc-5027	167	20	[	[	X
dpc-5027	167	21	25	25	NUM
dpc-5027	167	22	]	]	PUNCT
dpc-5027	167	23	.	.	PUNCT
dpc-5027	168	1	rhinophyma	rhinophyma	NOUN
dpc-5027	168	2	is	be	AUX
dpc-5027	168	3	considered	consider	VERB
dpc-5027	168	4	a	a	DET
dpc-5027	168	5	more	more	ADV
dpc-5027	168	6	pronounced	pronounced	ADJ
dpc-5027	168	7	inflammatory	inflammatory	ADJ
dpc-5027	168	8	rosacea	rosacea	NOUN
dpc-5027	168	9	with	with	ADP
dpc-5027	168	10	sebaceous	sebaceous	ADJ
dpc-5027	168	11	gland	gland	NOUN
dpc-5027	168	12	hypertrophy	hypertrophy	NOUN
dpc-5027	168	13	and	and	CCONJ
dpc-5027	168	14	excessive	excessive	ADJ
dpc-5027	168	15	fibrous	fibrous	ADJ
dpc-5027	168	16	tissue	tissue	NOUN
dpc-5027	168	17	overgrowth	overgrowth	NOUN
dpc-5027	168	18	of	of	ADP
dpc-5027	168	19	the	the	DET
dpc-5027	168	20	skin	skin	NOUN
dpc-5027	168	21	[	[	X
dpc-5027	168	22	26	26	NUM
dpc-5027	168	23	]	]	PUNCT
dpc-5027	168	24	.	.	PUNCT
dpc-5027	169	1	it	it	PRON
dpc-5027	169	2	is	be	AUX
dpc-5027	169	3	mediated	mediate	VERB
dpc-5027	169	4	by	by	ADP
dpc-5027	169	5	the	the	DET
dpc-5027	169	6	fibrogenic	fibrogenic	ADJ
dpc-5027	169	7	cytokine	cytokine	NOUN
dpc-5027	169	8	tgf	tgf	PROPN
dpc-5027	169	9	-	-	PUNCT
dpc-5027	169	10	β	β	PROPN
dpc-5027	169	11	and	and	CCONJ
dpc-5027	169	12	the	the	DET
dpc-5027	169	13	tgf	tgf	PROPN
dpc-5027	169	14	-	-	PUNCT
dpc-5027	169	15	β	β	NOUN
dpc-5027	169	16	receptor	receptor	NOUN
dpc-5027	169	17	,	,	PUNCT
dpc-5027	169	18	which	which	PRON
dpc-5027	169	19	is	be	AUX
dpc-5027	169	20	upregulated	upregulate	VERB
dpc-5027	169	21	in	in	ADP
dpc-5027	169	22	rhinophyma	rhinophyma	NOUN
dpc-5027	169	23	by	by	ADP
dpc-5027	169	24	fibroblast	fibroblast	ADJ
dpc-5027	169	25	activation	activation	NOUN
dpc-5027	169	26	.	.	PUNCT
dpc-5027	170	1	furthermore	furthermore	ADV
dpc-5027	170	2	,	,	PUNCT
dpc-5027	170	3	a	a	DET
dpc-5027	170	4	higher	high	ADJ
dpc-5027	170	5	number	number	NOUN
dpc-5027	170	6	of	of	ADP
dpc-5027	170	7	fibroblasts	fibroblast	NOUN
dpc-5027	170	8	correlates	correlate	VERB
dpc-5027	170	9	with	with	ADP
dpc-5027	170	10	increased	increase	VERB
dpc-5027	170	11	mast	mast	NOUN
dpc-5027	170	12	cell	cell	NOUN
dpc-5027	170	13	number	number	NOUN
dpc-5027	170	14	,	,	PUNCT
dpc-5027	170	15	which	which	PRON
dpc-5027	170	16	is	be	AUX
dpc-5027	170	17	fibrosis	fibrosis	NOUN
dpc-5027	170	18	-	-	PUNCT
dpc-5027	170	19	driven	drive	VERB
dpc-5027	170	20	[	[	X
dpc-5027	170	21	27	27	NUM
dpc-5027	170	22	]	]	PUNCT
dpc-5027	170	23	.	.	PUNCT
dpc-5027	171	1	moreover	moreover	ADV
dpc-5027	171	2	,	,	PUNCT
dpc-5027	171	3	demodex	demodex	NOUN
dpc-5027	171	4	folliculorum	folliculorum	NOUN
dpc-5027	171	5	has	have	AUX
dpc-5027	171	6	been	be	AUX
dpc-5027	171	7	implicated	implicate	VERB
dpc-5027	171	8	in	in	ADP
dpc-5027	171	9	triggering	trigger	VERB
dpc-5027	171	10	rosacea	rosacea	NOUN
dpc-5027	171	11	due	due	ADP
dpc-5027	171	12	to	to	ADP
dpc-5027	171	13	inflammation	inflammation	NOUN
dpc-5027	171	14	within	within	ADP
dpc-5027	171	15	pilosebaceous	pilosebaceous	ADJ
dpc-5027	171	16	follicles	follicle	NOUN
dpc-5027	171	17	[	[	X
dpc-5027	171	18	28	28	NUM
dpc-5027	171	19	]	]	PUNCT
dpc-5027	171	20	,	,	PUNCT
dpc-5027	171	21	which	which	PRON
dpc-5027	171	22	pcr	pcr	NOUN
dpc-5027	171	23	can	can	AUX
dpc-5027	171	24	detect	detect	VERB
dpc-5027	171	25	because	because	SCONJ
dpc-5027	171	26	it	it	PRON
dpc-5027	171	27	is	be	AUX
dpc-5027	171	28	a	a	DET
dpc-5027	171	29	very	very	ADV
dpc-5027	171	30	sensitive	sensitive	ADJ
dpc-5027	171	31	tool	tool	NOUN
dpc-5027	171	32	for	for	ADP
dpc-5027	171	33	the	the	DET
dpc-5027	171	34	diagnosis	diagnosis	NOUN
dpc-5027	171	35	of	of	ADP
dpc-5027	171	36	demodex	demodex	NOUN
dpc-5027	171	37	in	in	ADP
dpc-5027	171	38	patients	patient	NOUN
dpc-5027	171	39	with	with	ADP
dpc-5027	171	40	rosacea	rosacea	NOUN
dpc-5027	171	41	.	.	PUNCT
dpc-5027	172	1	in	in	ADP
dpc-5027	172	2	a	a	DET
dpc-5027	172	3	case	case	NOUN
dpc-5027	172	4	-	-	PUNCT
dpc-5027	172	5	control	control	NOUN
dpc-5027	172	6	study	study	NOUN
dpc-5027	172	7	,	,	PUNCT
dpc-5027	172	8	trave	trave	PROPN
dpc-5027	172	9	et	et	PROPN
dpc-5027	172	10	al	al	PROPN
dpc-5027	172	11	.	.	PUNCT
dpc-5027	173	1	[	[	X
dpc-5027	173	2	29	29	NUM
dpc-5027	173	3	]	]	PUNCT
dpc-5027	173	4	found	find	VERB
dpc-5027	173	5	that	that	SCONJ
dpc-5027	173	6	pcr	pcr	NOUN
dpc-5027	173	7	is	be	AUX
dpc-5027	173	8	a	a	DET
dpc-5027	173	9	sensitive	sensitive	ADJ
dpc-5027	173	10	method	method	NOUN
dpc-5027	173	11	for	for	ADP
dpc-5027	173	12	identifying	identify	VERB
dpc-5027	173	13	the	the	DET
dpc-5027	173	14	presence	presence	NOUN
dpc-5027	173	15	of	of	ADP
dpc-5027	173	16	demodex	demodex	NOUN
dpc-5027	173	17	on	on	ADP
dpc-5027	173	18	the	the	DET
dpc-5027	173	19	faces	face	NOUN
dpc-5027	173	20	and	and	CCONJ
dpc-5027	173	21	scalps	scalp	NOUN
dpc-5027	173	22	of	of	ADP
dpc-5027	173	23	patients	patient	NOUN
dpc-5027	173	24	with	with	ADP
dpc-5027	173	25	papulopustular	papulopustular	ADJ
dpc-5027	173	26	rosacea	rosacea	NOUN
dpc-5027	173	27	.	.	PUNCT
dpc-5027	174	1	taken	take	VERB
dpc-5027	174	2	all	all	ADV
dpc-5027	174	3	together	together	ADV
dpc-5027	174	4	,	,	PUNCT
dpc-5027	174	5	these	these	DET
dpc-5027	174	6	cutaneous	cutaneous	ADJ
dpc-5027	174	7	mechanisms	mechanism	NOUN
dpc-5027	174	8	enhance	enhance	VERB
dpc-5027	174	9	the	the	DET
dpc-5027	174	10	effect	effect	NOUN
dpc-5027	174	11	of	of	ADP
dpc-5027	174	12	gut	gut	PROPN
dpc-5027	174	13	microbiomes	microbiome	NOUN
dpc-5027	174	14	.	.	PUNCT
dpc-5027	175	1	this	this	DET
dpc-5027	175	2	study	study	NOUN
dpc-5027	175	3	found	find	VERB
dpc-5027	175	4	a	a	PRON
dpc-5027	175	5	compared	compare	VERB
dpc-5027	175	6	to	to	ADP
dpc-5027	175	7	the	the	DET
dpc-5027	175	8	control	control	NOUN
dpc-5027	175	9	group	group	NOUN
dpc-5027	175	10	,	,	PUNCT
dpc-5027	175	11	while	while	SCONJ
dpc-5027	175	12	there	there	PRON
dpc-5027	175	13	was	be	VERB
dpc-5027	175	14	no	no	DET
dpc-5027	175	15	significant	significant	ADJ
dpc-5027	175	16	increase	increase	NOUN
dpc-5027	175	17	in	in	ADP
dpc-5027	175	18	fusobacterium	fusobacterium	NOUN
dpc-5027	175	19	gut	gut	NOUN
dpc-5027	175	20	microbiomes	microbiome	NOUN
dpc-5027	175	21	in	in	ADP
dpc-5027	175	22	rosacea	rosacea	NOUN
dpc-5027	175	23	patients	patient	NOUN
dpc-5027	175	24	.	.	PUNCT
dpc-5027	176	1	in	in	ADP
dpc-5027	176	2	line	line	NOUN
dpc-5027	176	3	with	with	ADP
dpc-5027	176	4	our	our	PRON
dpc-5027	176	5	findings	finding	NOUN
dpc-5027	176	6	,	,	PUNCT
dpc-5027	176	7	chen	chen	PROPN
dpc-5027	176	8	et	et	PROPN
dpc-5027	176	9	al	al	PROPN
dpc-5027	176	10	.	.	PUNCT
dpc-5027	177	1	[	[	X
dpc-5027	177	2	18	18	NUM
dpc-5027	177	3	]	]	PUNCT
dpc-5027	177	4	found	find	VERB
dpc-5027	177	5	abundant	abundant	ADJ
dpc-5027	177	6	relative	relative	ADJ
dpc-5027	177	7	fusobacterium	fusobacterium	NOUN
dpc-5027	177	8	and	and	CCONJ
dpc-5027	177	9	bacteroides	bacteroide	NOUN
dpc-5027	177	10	.	.	PUNCT
dpc-5027	178	1	however	however	ADV
dpc-5027	178	2	,	,	PUNCT
dpc-5027	178	3	they	they	PRON
dpc-5027	178	4	found	find	VERB
dpc-5027	178	5	a	a	DET
dpc-5027	178	6	reduced	reduced	ADJ
dpc-5027	178	7	abundance	abundance	NOUN
dpc-5027	178	8	of	of	ADP
dpc-5027	178	9	lactobacillus	lactobacillus	NOUN
dpc-5027	178	10	gut	gut	NOUN
dpc-5027	178	11	microbiota	microbiota	NOUN
dpc-5027	178	12	in	in	ADP
dpc-5027	178	13	rosacea	rosacea	NOUN
dpc-5027	178	14	patients	patient	NOUN
dpc-5027	178	15	compared	compare	VERB
dpc-5027	178	16	to	to	ADP
dpc-5027	178	17	the	the	DET
dpc-5027	178	18	controls	control	NOUN
dpc-5027	178	19	.	.	PUNCT
dpc-5027	179	1	similar	similar	ADJ
dpc-5027	179	2	to	to	ADP
dpc-5027	179	3	our	our	PRON
dpc-5027	179	4	finding	finding	NOUN
dpc-5027	179	5	,	,	PUNCT
dpc-5027	179	6	nam	nam	NOUN
dpc-5027	179	7	et	et	PROPN
dpc-5027	179	8	al	al	PROPN
dpc-5027	179	9	.	.	PUNCT
dpc-5027	180	1	[	[	X
dpc-5027	180	2	19	19	NUM
dpc-5027	180	3	]	]	PUNCT
dpc-5027	180	4	have	have	AUX
dpc-5027	180	5	detected	detect	VERB
dpc-5027	180	6	an	an	DET
dpc-5027	180	7	increased	increase	VERB
dpc-5027	180	8	abundance	abundance	NOUN
dpc-5027	180	9	of	of	ADP
dpc-5027	180	10	lactobacillus	lactobacillus	NOUN
dpc-5027	180	11	gut	gut	NOUN
dpc-5027	180	12	microbiota	microbiota	NOUN
dpc-5027	180	13	in	in	ADP
dpc-5027	180	14	rosacea	rosacea	NOUN
dpc-5027	180	15	patients	patient	NOUN
dpc-5027	180	16	compared	compare	VERB
dpc-5027	180	17	to	to	ADP
dpc-5027	180	18	the	the	DET
dpc-5027	180	19	controls	control	NOUN
dpc-5027	180	20	.	.	PUNCT
dpc-5027	181	1	however	however	ADV
dpc-5027	181	2	,	,	PUNCT
dpc-5027	181	3	they	they	PRON
dpc-5027	181	4	detected	detect	VERB
dpc-5027	181	5	changes	change	NOUN
dpc-5027	181	6	in	in	ADP
dpc-5027	181	7	other	other	ADJ
dpc-5027	181	8	microbiomes	microbiome	NOUN
dpc-5027	181	9	not	not	PART
dpc-5027	181	10	investigated	investigate	VERB
dpc-5027	181	11	by	by	ADP
dpc-5027	181	12	our	our	PRON
dpc-5027	181	13	study	study	NOUN
dpc-5027	181	14	.	.	PUNCT
dpc-5027	182	1	the	the	DET
dpc-5027	182	2	disagreement	disagreement	NOUN
dpc-5027	182	3	with	with	ADP
dpc-5027	182	4	the	the	DET
dpc-5027	182	5	chen	chen	PROPN
dpc-5027	182	6	et	et	PROPN
dpc-5027	182	7	al	al	PROPN
dpc-5027	182	8	.	.	PUNCT
dpc-5027	183	1	[	[	X
dpc-5027	183	2	18	18	NUM
dpc-5027	183	3	]	]	PUNCT
dpc-5027	183	4	study	study	NOUN
dpc-5027	183	5	about	about	ADP
dpc-5027	183	6	fusobacterium	fusobacterium	NOUN
dpc-5027	183	7	and	and	CCONJ
dpc-5027	183	8	lactobacillus	lactobacillus	NOUN
dpc-5027	183	9	could	could	AUX
dpc-5027	183	10	be	be	AUX
dpc-5027	183	11	attributed	attribute	VERB
dpc-5027	183	12	to	to	ADP
dpc-5027	183	13	the	the	DET
dpc-5027	183	14	differences	difference	NOUN
dpc-5027	183	15	in	in	ADP
dpc-5027	183	16	demographic	demographic	ADJ
dpc-5027	183	17	and	and	CCONJ
dpc-5027	183	18	clinical	clinical	ADJ
dpc-5027	183	19	characteristics	characteristic	NOUN
dpc-5027	183	20	of	of	ADP
dpc-5027	183	21	the	the	DET
dpc-5027	183	22	included	include	VERB
dpc-5027	183	23	sample	sample	NOUN
dpc-5027	183	24	,	,	PUNCT
dpc-5027	183	25	as	as	ADV
dpc-5027	183	26	well	well	ADV
dpc-5027	183	27	as	as	ADP
dpc-5027	183	28	the	the	DET
dpc-5027	183	29	difference	difference	NOUN
dpc-5027	183	30	in	in	ADP
dpc-5027	183	31	sample	sample	NOUN
dpc-5027	183	32	size	size	NOUN
dpc-5027	183	33	and	and	CCONJ
dpc-5027	183	34	geographical	geographical	ADJ
dpc-5027	183	35	distribution	distribution	NOUN
dpc-5027	183	36	between	between	ADP
dpc-5027	183	37	our	our	PRON
dpc-5027	183	38	and	and	CCONJ
dpc-5027	183	39	their	their	PRON
dpc-5027	183	40	studies	study	NOUN
dpc-5027	183	41	.	.	PUNCT
dpc-5027	184	1	these	these	DET
dpc-5027	184	2	findings	finding	NOUN
dpc-5027	184	3	of	of	ADP
dpc-5027	184	4	changed	change	VERB
dpc-5027	184	5	gut	gut	NOUN
dpc-5027	184	6	microbiome	microbiome	ADJ
dpc-5027	184	7	levels	level	NOUN
dpc-5027	184	8	in	in	ADP
dpc-5027	184	9	rosacea	rosacea	NOUN
dpc-5027	184	10	patients	patient	NOUN
dpc-5027	184	11	explain	explain	VERB
dpc-5027	184	12	their	their	PRON
dpc-5027	184	13	importance	importance	NOUN
dpc-5027	184	14	in	in	ADP
dpc-5027	184	15	the	the	DET
dpc-5027	184	16	pathogenesis	pathogenesis	NOUN
dpc-5027	184	17	of	of	ADP
dpc-5027	184	18	the	the	DET
dpc-5027	184	19	disease	disease	NOUN
dpc-5027	184	20	.	.	PUNCT
dpc-5027	185	1	in	in	ADP
dpc-5027	185	2	a	a	DET
dpc-5027	185	3	healthy	healthy	ADJ
dpc-5027	185	4	state	state	NOUN
dpc-5027	185	5	,	,	PUNCT
dpc-5027	185	6	a	a	DET
dpc-5027	185	7	diverse	diverse	ADJ
dpc-5027	185	8	and	and	CCONJ
dpc-5027	185	9	extensive	extensive	ADJ
dpc-5027	185	10	enteric	enteric	ADJ
dpc-5027	185	11	microbiome	microbiome	NOUN
dpc-5027	185	12	is	be	AUX
dpc-5027	185	13	responsible	responsible	ADJ
dpc-5027	185	14	for	for	ADP
dpc-5027	185	15	preventing	prevent	VERB
dpc-5027	185	16	the	the	DET
dpc-5027	185	17	passage	passage	NOUN
dpc-5027	185	18	of	of	ADP
dpc-5027	185	19	noxious	noxious	ADJ
dpc-5027	185	20	substances	substance	NOUN
dpc-5027	185	21	across	across	ADP
dpc-5027	185	22	the	the	DET
dpc-5027	185	23	gut	gut	NOUN
dpc-5027	185	24	mucosal	mucosal	NOUN
dpc-5027	185	25	surface	surface	NOUN
dpc-5027	185	26	.	.	PUNCT
dpc-5027	186	1	however	however	ADV
dpc-5027	186	2	,	,	PUNCT
dpc-5027	186	3	a	a	DET
dpc-5027	186	4	disturbance	disturbance	NOUN
dpc-5027	186	5	in	in	ADP
dpc-5027	186	6	the	the	DET
dpc-5027	186	7	mucosal	mucosal	NOUN
dpc-5027	186	8	surface	surface	NOUN
dpc-5027	186	9	,	,	PUNCT
dpc-5027	186	10	which	which	PRON
dpc-5027	186	11	may	may	AUX
dpc-5027	186	12	be	be	AUX
dpc-5027	186	13	caused	cause	VERB
dpc-5027	186	14	by	by	ADP
dpc-5027	186	15	a	a	DET
dpc-5027	186	16	difference	difference	NOUN
dpc-5027	186	17	in	in	ADP
dpc-5027	186	18	the	the	DET
dpc-5027	186	19	enteric	enteric	ADJ
dpc-5027	186	20	microbiome	microbiome	NOUN
dpc-5027	186	21	or	or	CCONJ
dpc-5027	186	22	intrinsic	intrinsic	ADJ
dpc-5027	186	23	composition	composition	NOUN
dpc-5027	186	24	due	due	ADP
dpc-5027	186	25	to	to	ADP
dpc-5027	186	26	inflammatory	inflammatory	ADJ
dpc-5027	186	27	or	or	CCONJ
dpc-5027	186	28	autoimmune	autoimmune	ADJ
dpc-5027	186	29	diseases	disease	NOUN
dpc-5027	186	30	,	,	PUNCT
dpc-5027	186	31	may	may	AUX
dpc-5027	186	32	permit	permit	VERB
dpc-5027	186	33	harmful	harmful	ADJ
dpc-5027	186	34	substances	substance	NOUN
dpc-5027	186	35	to	to	PART
dpc-5027	186	36	enter	enter	VERB
dpc-5027	186	37	the	the	DET
dpc-5027	186	38	bloodstream	bloodstream	NOUN
dpc-5027	186	39	,	,	PUNCT
dpc-5027	186	40	leading	lead	VERB
dpc-5027	186	41	to	to	ADP
dpc-5027	186	42	adverse	adverse	ADJ
dpc-5027	186	43	effects	effect	NOUN
dpc-5027	186	44	at	at	ADP
dpc-5027	186	45	peripheral	peripheral	ADJ
dpc-5027	186	46	sites	site	NOUN
dpc-5027	186	47	[	[	X
dpc-5027	186	48	20	20	NUM
dpc-5027	186	49	]	]	PUNCT
dpc-5027	186	50	.	.	PUNCT
dpc-5027	187	1	also	also	ADV
dpc-5027	187	2	,	,	PUNCT
dpc-5027	187	3	the	the	DET
dpc-5027	187	4	intestinal	intestinal	ADJ
dpc-5027	187	5	microbial	microbial	ADJ
dpc-5027	187	6	population	population	NOUN
dpc-5027	187	7	appears	appear	VERB
dpc-5027	187	8	to	to	PART
dpc-5027	187	9	have	have	VERB
dpc-5027	187	10	an	an	DET
dpc-5027	187	11	immunomodulatory	immunomodulatory	ADJ
dpc-5027	187	12	effect	effect	NOUN
dpc-5027	187	13	on	on	ADP
dpc-5027	187	14	non	non	ADJ
dpc-5027	187	15	-	-	ADJ
dpc-5027	187	16	enteric	enteric	ADJ
dpc-5027	187	17	systems	system	NOUN
dpc-5027	187	18	,	,	PUNCT
dpc-5027	187	19	including	include	VERB
dpc-5027	187	20	the	the	DET
dpc-5027	187	21	skin	skin	NOUN
dpc-5027	187	22	;	;	PUNCT
dpc-5027	187	23	however	however	ADV
dpc-5027	187	24	,	,	PUNCT
dpc-5027	187	25	the	the	DET
dpc-5027	187	26	precise	precise	ADJ
dpc-5027	187	27	mechanism	mechanism	NOUN
dpc-5027	187	28	for	for	ADP
dpc-5027	187	29	this	this	DET
dpc-5027	187	30	effect	effect	NOUN
dpc-5027	187	31	is	be	AUX
dpc-5027	187	32	still	still	ADV
dpc-5027	187	33	not	not	PART
dpc-5027	187	34	fully	fully	ADV
dpc-5027	187	35	understood	understand	VERB
dpc-5027	187	36	[	[	X
dpc-5027	187	37	19	19	NUM
dpc-5027	187	38	,	,	PUNCT
dpc-5027	187	39	21	21	NUM
dpc-5027	187	40	]	]	PUNCT
dpc-5027	187	41	.	.	PUNCT
dpc-5027	188	1	in	in	ADP
dpc-5027	188	2	this	this	DET
dpc-5027	188	3	study	study	NOUN
dpc-5027	188	4	,	,	PUNCT
dpc-5027	188	5	we	we	PRON
dpc-5027	188	6	detected	detect	VERB
dpc-5027	188	7	a	a	DET
dpc-5027	188	8	significant	significant	ADJ
dpc-5027	188	9	relation	relation	NOUN
dpc-5027	188	10	between	between	ADP
dpc-5027	188	11	bacteroides	bacteroide	NOUN
dpc-5027	188	12	and	and	CCONJ
dpc-5027	188	13	fusobacterium	fusobacterium	NOUN
dpc-5027	188	14	gut	gut	NOUN
dpc-5027	188	15	microbiomes	microbiome	NOUN
dpc-5027	188	16	with	with	ADP
dpc-5027	188	17	subtypes	subtype	NOUN
dpc-5027	188	18	of	of	ADP
dpc-5027	188	19	rosacea	rosacea	NOUN
dpc-5027	188	20	.	.	PUNCT
dpc-5027	189	1	bacteroid	bacteroid	PROPN
dpc-5027	189	2	microbiome	microbiome	PROPN
dpc-5027	189	3	showed	show	VERB
dpc-5027	189	4	the	the	DET
dpc-5027	189	5	highest	high	ADJ
dpc-5027	189	6	significant	significant	ADJ
dpc-5027	189	7	relation	relation	NOUN
dpc-5027	189	8	between	between	ADP
dpc-5027	189	9	papulopustular	papulopustular	ADJ
dpc-5027	189	10	and	and	CCONJ
dpc-5027	189	11	rhinophyma	rhinophyma	NOUN
dpc-5027	189	12	subtypes	subtype	NOUN
dpc-5027	189	13	and	and	CCONJ
dpc-5027	189	14	a	a	DET
dpc-5027	189	15	less	less	ADV
dpc-5027	189	16	significant	significant	ADJ
dpc-5027	189	17	relation	relation	NOUN
dpc-5027	189	18	between	between	ADP
dpc-5027	189	19	erythematotelangiectatic	erythematotelangiectatic	ADJ
dpc-5027	189	20	and	and	CCONJ
dpc-5027	189	21	rhinophyma	rhinophyma	NOUN
dpc-5027	189	22	subtypes	subtype	NOUN
dpc-5027	189	23	.	.	PUNCT
dpc-5027	190	1	fusobacterium	fusobacterium	NOUN
dpc-5027	190	2	microbiome	microbiome	NOUN
dpc-5027	190	3	showed	show	VERB
dpc-5027	190	4	the	the	DET
dpc-5027	190	5	highest	high	ADJ
dpc-5027	190	6	significant	significant	ADJ
dpc-5027	190	7	relation	relation	NOUN
dpc-5027	190	8	between	between	ADP
dpc-5027	190	9	papulopustular	papulopustular	ADJ
dpc-5027	190	10	and	and	CCONJ
dpc-5027	190	11	rhinophyma	rhinophyma	NOUN
dpc-5027	190	12	subtypes	subtype	NOUN
dpc-5027	190	13	and	and	CCONJ
dpc-5027	190	14	a	a	DET
dpc-5027	190	15	less	less	ADV
dpc-5027	190	16	significant	significant	ADJ
dpc-5027	190	17	relation	relation	NOUN
dpc-5027	190	18	between	between	ADP
dpc-5027	190	19	table	table	NOUN
dpc-5027	190	20	7	7	NUM
dpc-5027	190	21	.	.	X
dpc-5027	190	22	relationship	relationship	NOUN
dpc-5027	190	23	between	between	ADP
dpc-5027	190	24	lactobacillus	lactobacillus	NOUN
dpc-5027	190	25	gut	gut	NOUN
dpc-5027	190	26	microbiome	microbiome	NOUN
dpc-5027	190	27	and	and	CCONJ
dpc-5027	190	28	degree	degree	NOUN
dpc-5027	190	29	of	of	ADP
dpc-5027	190	30	severity	severity	NOUN
dpc-5027	190	31	in	in	ADP
dpc-5027	190	32	the	the	DET
dpc-5027	190	33	rosacea	rosacea	NOUN
dpc-5027	190	34	group	group	NOUN
dpc-5027	190	35	.	.	PUNCT
dpc-5027	191	1	lactobacillus	lactobacillus	NOUN
dpc-5027	191	2	degree	degree	NOUN
dpc-5027	191	3	of	of	ADP
dpc-5027	191	4	severity	severity	NOUN
dpc-5027	191	5	mild	mild	ADJ
dpc-5027	191	6	moderate	moderate	ADJ
dpc-5027	191	7	severe	severe	ADJ
dpc-5027	191	8	range	range	NOUN
dpc-5027	191	9	12.4	12.4	NUM
dpc-5027	191	10	–	–	PUNCT
dpc-5027	191	11	12.8	12.8	NUM
dpc-5027	191	12	9.1	9.1	NUM
dpc-5027	191	13	–	–	PUNCT
dpc-5027	191	14	12.9	12.9	NUM
dpc-5027	191	15	10.1	10.1	NUM
dpc-5027	191	16	–	–	PUNCT
dpc-5027	191	17	12.3	12.3	NUM
dpc-5027	191	18	mean	mean	NOUN
dpc-5027	191	19	±	±	NUM
dpc-5027	191	20	sd	sd	ADP
dpc-5027	191	21	12.58	12.58	NUM
dpc-5027	191	22	±	±	NUM
dpc-5027	191	23	0.17	0.17	NUM
dpc-5027	191	24	10.95	10.95	NUM
dpc-5027	191	25	±	±	NUM
dpc-5027	191	26	1.21	1.21	NUM
dpc-5027	191	27	10.76	10.76	NUM
dpc-5027	191	28	±	±	NUM
dpc-5027	191	29	0.91	0.91	NUM
dpc-5027	191	30	f.	f.	PROPN
dpc-5027	191	31	test	test	PROPN
dpc-5027	191	32	4.277	4.277	NUM
dpc-5027	191	33	p	p	NOUN
dpc-5027	191	34	-	-	PUNCT
dpc-5027	191	35	value	value	NOUN
dpc-5027	191	36	0.030	0.030	NUM
dpc-5027	191	37	*	*	NOUN
dpc-5027	191	38	mild	mild	ADJ
dpc-5027	191	39	and	and	CCONJ
dpc-5027	191	40	moderate	moderate	ADJ
dpc-5027	191	41	mild	mild	ADJ
dpc-5027	191	42	and	and	CCONJ
dpc-5027	191	43	severe	severe	ADJ
dpc-5027	191	44	moderate	moderate	ADJ
dpc-5027	191	45	and	and	CCONJ
dpc-5027	191	46	severe	severe	ADJ
dpc-5027	191	47	0.014	0.014	NUM
dpc-5027	191	48	*	*	SYM
dpc-5027	191	49	0.018	0.018	NUM
dpc-5027	191	50	*	*	SYM
dpc-5027	191	51	0.742	0.742	NUM
dpc-5027	191	52	data	datum	NOUN
dpc-5027	191	53	are	be	AUX
dpc-5027	191	54	presented	present	VERB
dpc-5027	191	55	as	as	ADP
dpc-5027	191	56	mean	mean	NOUN
dpc-5027	191	57	±	±	NUM
dpc-5027	191	58	sd	sd	NOUN
dpc-5027	191	59	.	.	PUNCT
dpc-5027	192	1	p<0.05	p<0.05	NOUN
dpc-5027	192	2	statistically	statistically	ADV
dpc-5027	192	3	significant	significant	ADJ
dpc-5027	192	4	.	.	PUNCT
dpc-5027	193	1	p≥0.05	p≥0.05	NOUN
dpc-5027	193	2	statistically	statistically	ADV
dpc-5027	193	3	not	not	PART
dpc-5027	193	4	significant	significant	ADJ
dpc-5027	193	5	.	.	PUNCT
dpc-5027	194	1	abbreviations	abbreviation	NOUN
dpc-5027	194	2	:	:	PUNCT
dpc-5027	195	1	f	f	X
dpc-5027	195	2	:	:	PUNCT
dpc-5027	195	3	anova	anova	PROPN
dpc-5027	195	4	test	test	NOUN
dpc-5027	195	5	;	;	PUNCT
dpc-5027	195	6	sd	sd	X
dpc-5027	195	7	:	:	PUNCT
dpc-5027	195	8	standard	standard	ADJ
dpc-5027	195	9	deviation	deviation	NOUN
dpc-5027	195	10	.	.	PUNCT
dpc-5027	196	1	original	original	ADJ
dpc-5027	196	2	article	article	NOUN
dpc-5027	196	3	|	|	ADV
dpc-5027	196	4	dermatol	dermatol	ADJ
dpc-5027	196	5	pract	pract	NOUN
dpc-5027	196	6	concept	concept	NOUN
dpc-5027	196	7	.	.	PUNCT
dpc-5027	197	1	2025;15(3):5027	2025;15(3):5027	NUM
dpc-5027	197	2	9	9	NUM
dpc-5027	197	3	3	3	NUM
dpc-5027	197	4	.	.	PUNCT
dpc-5027	198	1	buddenkotte	buddenkotte	PROPN
dpc-5027	198	2	j	j	PROPN
dpc-5027	198	3	,	,	PUNCT
dpc-5027	198	4	steinhoff	steinhoff	PROPN
dpc-5027	198	5	m.	m.	NOUN
dpc-5027	198	6	recent	recent	ADJ
dpc-5027	198	7	advances	advance	NOUN
dpc-5027	198	8	in	in	ADP
dpc-5027	198	9	understanding	understanding	NOUN
dpc-5027	198	10	and	and	CCONJ
dpc-5027	198	11	managing	manage	VERB
dpc-5027	198	12	rosacea	rosacea	NOUN
dpc-5027	198	13	.	.	PUNCT
dpc-5027	199	1	f1000res	f1000res	PROPN
dpc-5027	199	2	.	.	PUNCT
dpc-5027	200	1	2018;7	2018;7	NUM
dpc-5027	200	2	:	:	PUNCT
dpc-5027	200	3	f1000	f1000	ADJ
dpc-5027	200	4	faculty	faculty	NOUN
dpc-5027	200	5	rev-1885	rev-1885	NOUN
dpc-5027	200	6	.	.	PUNCT
dpc-5027	201	1	doi	doi	NOUN
dpc-5027	201	2	:	:	PUNCT
dpc-5027	201	3	10.12688	10.12688	NUM
dpc-5027	201	4	/	/	SYM
dpc-5027	201	5	f1000research.16537.1	f1000research.16537.1	NOUN
dpc-5027	201	6	.	.	PUNCT
dpc-5027	202	1	pmid	pmid	NOUN
dpc-5027	202	2	:	:	PUNCT
dpc-5027	202	3	30631431	30631431	NUM
dpc-5027	202	4	4	4	NUM
dpc-5027	202	5	.	.	PUNCT
dpc-5027	202	6	park	park	PROPN
dpc-5027	202	7	k	k	PROPN
dpc-5027	202	8	,	,	PUNCT
dpc-5027	202	9	ikushiro	ikushiro	PROPN
dpc-5027	202	10	h	h	NOUN
dpc-5027	202	11	,	,	PUNCT
dpc-5027	202	12	seo	seo	PROPN
dpc-5027	202	13	hs	hs	PROPN
dpc-5027	202	14	,	,	PUNCT
dpc-5027	202	15	et	et	PROPN
dpc-5027	202	16	al	al	PROPN
dpc-5027	202	17	.	.	PUNCT
dpc-5027	203	1	er	er	INTJ
dpc-5027	203	2	stress	stress	NOUN
dpc-5027	203	3	stimulates	stimulate	VERB
dpc-5027	203	4	production	production	NOUN
dpc-5027	203	5	of	of	ADP
dpc-5027	203	6	the	the	DET
dpc-5027	203	7	key	key	ADJ
dpc-5027	203	8	antimicrobial	antimicrobial	ADJ
dpc-5027	203	9	peptide	peptide	NOUN
dpc-5027	203	10	,	,	PUNCT
dpc-5027	203	11	cathelicidin	cathelicidin	NOUN
dpc-5027	203	12	,	,	PUNCT
dpc-5027	203	13	by	by	ADP
dpc-5027	203	14	forming	form	VERB
dpc-5027	203	15	a	a	DET
dpc-5027	203	16	previously	previously	ADV
dpc-5027	203	17	unidentified	unidentified	ADJ
dpc-5027	203	18	intracellular	intracellular	ADJ
dpc-5027	203	19	s1p	s1p	NUM
dpc-5027	203	20	signaling	signal	VERB
dpc-5027	203	21	complex	complex	NOUN
dpc-5027	203	22	.	.	PUNCT
dpc-5027	204	1	proceedings	proceeding	NOUN
dpc-5027	204	2	of	of	ADP
dpc-5027	204	3	the	the	DET
dpc-5027	204	4	national	national	PROPN
dpc-5027	204	5	academy	academy	PROPN
dpc-5027	204	6	of	of	ADP
dpc-5027	204	7	sciences	sciences	PROPN
dpc-5027	204	8	of	of	ADP
dpc-5027	204	9	the	the	DET
dpc-5027	204	10	united	united	PROPN
dpc-5027	204	11	states	states	PROPN
dpc-5027	204	12	of	of	ADP
dpc-5027	204	13	america	america	PROPN
dpc-5027	204	14	.	.	PUNCT
dpc-5027	205	1	2016;113(10):e1334	2016;113(10):e1334	NUM
dpc-5027	205	2	-	-	PUNCT
dpc-5027	205	3	42.doi	42.doi	NOUN
dpc-5027	205	4	:	:	PUNCT
dpc-5027	205	5	10.1073	10.1073	NUM
dpc-5027	205	6	/	/	SYM
dpc-5027	205	7	pnas	pna	NOUN
dpc-5027	205	8	.	.	PUNCT
dpc-5027	205	9	1504555113	1504555113	NUM
dpc-5027	205	10	.	.	PUNCT
dpc-5027	206	1	pmid	pmid	NOUN
dpc-5027	206	2	:	:	PUNCT
dpc-5027	206	3	26903652	26903652	NUM
dpc-5027	206	4	.	.	PUNCT
dpc-5027	207	1	5	5	X
dpc-5027	207	2	.	.	X
dpc-5027	207	3	chen	chen	PROPN
dpc-5027	207	4	c	c	PROPN
dpc-5027	207	5	,	,	PUNCT
dpc-5027	207	6	wang	wang	PROPN
dpc-5027	207	7	p	p	PROPN
dpc-5027	207	8	,	,	PUNCT
dpc-5027	207	9	zhang	zhang	PROPN
dpc-5027	207	10	l	l	PROPN
dpc-5027	207	11	,	,	PUNCT
dpc-5027	207	12	et	et	PROPN
dpc-5027	207	13	al	al	PROPN
dpc-5027	207	14	.	.	PUNCT
dpc-5027	207	15	exploring	explore	VERB
dpc-5027	207	16	the	the	DET
dpc-5027	207	17	pathogenesis	pathogenesis	NOUN
dpc-5027	207	18	and	and	CCONJ
dpc-5027	207	19	mechanism	mechanism	NOUN
dpc-5027	207	20	-	-	PUNCT
dpc-5027	207	21	targeted	target	VERB
dpc-5027	207	22	treatments	treatment	NOUN
dpc-5027	207	23	of	of	ADP
dpc-5027	207	24	rosacea	rosacea	NOUN
dpc-5027	207	25	:	:	PUNCT
dpc-5027	207	26	previous	previous	ADJ
dpc-5027	207	27	understanding	understanding	NOUN
dpc-5027	207	28	and	and	CCONJ
dpc-5027	207	29	updates	update	NOUN
dpc-5027	207	30	.	.	PUNCT
dpc-5027	208	1	biomedicines	biomedicine	NOUN
dpc-5027	208	2	.	.	PUNCT
dpc-5027	209	1	2023;11(8):2153	2023;11(8):2153	X
dpc-5027	209	2	.	.	PUNCT
dpc-5027	210	1	doi	doi	NOUN
dpc-5027	210	2	:	:	PUNCT
dpc-5027	210	3	10.3390	10.3390	NUM
dpc-5027	210	4	/	/	SYM
dpc-5027	210	5	biomedicines11082153	biomedicines11082153	NOUN
dpc-5027	210	6	.	.	PUNCT
dpc-5027	211	1	pmid	pmid	NOUN
dpc-5027	211	2	:	:	PUNCT
dpc-5027	211	3	37626650	37626650	NUM
dpc-5027	211	4	.	.	PUNCT
dpc-5027	212	1	6	6	NUM
dpc-5027	212	2	.	.	X
dpc-5027	212	3	wang	wang	PROPN
dpc-5027	212	4	w	w	PROPN
dpc-5027	212	5	,	,	PUNCT
dpc-5027	212	6	uzzau	uzzau	NOUN
dpc-5027	212	7	s	s	PROPN
dpc-5027	212	8	,	,	PUNCT
dpc-5027	212	9	goldblum	goldblum	PROPN
dpc-5027	212	10	se	se	PROPN
dpc-5027	212	11	,	,	PUNCT
dpc-5027	212	12	fasano	fasano	PROPN
dpc-5027	212	13	a.	a.	PROPN
dpc-5027	212	14	human	human	PROPN
dpc-5027	212	15	zonulin	zonulin	PROPN
dpc-5027	212	16	,	,	PUNCT
dpc-5027	212	17	a	a	DET
dpc-5027	212	18	potential	potential	ADJ
dpc-5027	212	19	modulator	modulator	NOUN
dpc-5027	212	20	of	of	ADP
dpc-5027	212	21	intestinal	intestinal	ADJ
dpc-5027	212	22	tight	tight	ADJ
dpc-5027	212	23	junctions	junction	NOUN
dpc-5027	212	24	.	.	PUNCT
dpc-5027	213	1	j	j	PROPN
dpc-5027	213	2	cell	cell	PROPN
dpc-5027	213	3	sci	sci	PROPN
dpc-5027	213	4	.	.	PUNCT
dpc-5027	214	1	2000;113	2000;113	PROPN
dpc-5027	214	2	pt	pt	PROPN
dpc-5027	214	3	24:4435	24:4435	NUM
dpc-5027	214	4	-	-	SYM
dpc-5027	214	5	40	40	NUM
dpc-5027	214	6	.	.	PUNCT
dpc-5027	215	1	doi	doi	NOUN
dpc-5027	215	2	:	:	PUNCT
dpc-5027	215	3	10.1242	10.1242	NUM
dpc-5027	215	4	/	/	SYM
dpc-5027	215	5	jcs.113.24.4435	jcs.113.24.4435	VERB
dpc-5027	215	6	.	.	PUNCT
dpc-5027	216	1	pmid	pmid	NOUN
dpc-5027	216	2	:	:	PUNCT
dpc-5027	216	3	11082037	11082037	NUM
dpc-5027	216	4	.	.	PUNCT
dpc-5027	217	1	7	7	X
dpc-5027	217	2	.	.	X
dpc-5027	217	3	serek	serek	PROPN
dpc-5027	217	4	p	p	NOUN
dpc-5027	217	5	,	,	PUNCT
dpc-5027	217	6	oleksy	oleksy	ADJ
dpc-5027	217	7	-	-	PUNCT
dpc-5027	217	8	wawrzyniak	wawrzyniak	NOUN
dpc-5027	217	9	m.	m.	NOUN
dpc-5027	217	10	the	the	DET
dpc-5027	217	11	effect	effect	NOUN
dpc-5027	217	12	of	of	ADP
dpc-5027	217	13	bacterial	bacterial	ADJ
dpc-5027	217	14	infections	infection	NOUN
dpc-5027	217	15	,	,	PUNCT
dpc-5027	217	16	probiotics	probiotic	NOUN
dpc-5027	217	17	and	and	CCONJ
dpc-5027	217	18	zonulin	zonulin	NOUN
dpc-5027	217	19	on	on	ADP
dpc-5027	217	20	intestinal	intestinal	ADJ
dpc-5027	217	21	barrier	barrier	NOUN
dpc-5027	217	22	integrity	integrity	NOUN
dpc-5027	217	23	.	.	PUNCT
dpc-5027	218	1	int	int	PROPN
dpc-5027	218	2	j	j	PROPN
dpc-5027	218	3	mol	mol	ADP
dpc-5027	218	4	sci	sci	PROPN
dpc-5027	218	5	.	.	PROPN
dpc-5027	218	6	2021	2021	NUM
dpc-5027	218	7	;	;	PUNCT
dpc-5027	218	8	22(21):11359	22(21):11359	NUM
dpc-5027	218	9	.	.	PUNCT
dpc-5027	219	1	doi	doi	NOUN
dpc-5027	219	2	:	:	PUNCT
dpc-5027	219	3	10.3390	10.3390	NUM
dpc-5027	219	4	/	/	SYM
dpc-5027	219	5	ijms222111359	ijms222111359	PROPN
dpc-5027	219	6	.	.	PUNCT
dpc-5027	220	1	pmid	pmid	NOUN
dpc-5027	220	2	:	:	PUNCT
dpc-5027	220	3	34768787	34768787	NUM
dpc-5027	220	4	.	.	PUNCT
dpc-5027	221	1	8	8	X
dpc-5027	221	2	.	.	X
dpc-5027	221	3	sturgeon	sturgeon	NOUN
dpc-5027	221	4	c	c	PROPN
dpc-5027	221	5	,	,	PUNCT
dpc-5027	221	6	fasano	fasano	PROPN
dpc-5027	221	7	a.	a.	PROPN
dpc-5027	221	8	zonulin	zonulin	PROPN
dpc-5027	221	9	,	,	PUNCT
dpc-5027	221	10	a	a	DET
dpc-5027	221	11	regulator	regulator	NOUN
dpc-5027	221	12	of	of	ADP
dpc-5027	221	13	epithelial	epithelial	ADJ
dpc-5027	221	14	and	and	CCONJ
dpc-5027	221	15	endothelial	endothelial	ADJ
dpc-5027	221	16	barrier	barrier	NOUN
dpc-5027	221	17	functions	function	NOUN
dpc-5027	221	18	,	,	PUNCT
dpc-5027	221	19	and	and	CCONJ
dpc-5027	221	20	its	its	PRON
dpc-5027	221	21	involvement	involvement	NOUN
dpc-5027	221	22	in	in	ADP
dpc-5027	221	23	chronic	chronic	ADJ
dpc-5027	221	24	inflammatory	inflammatory	ADJ
dpc-5027	221	25	diseases	disease	NOUN
dpc-5027	221	26	.	.	PUNCT
dpc-5027	222	1	tissue	tissue	NOUN
dpc-5027	222	2	barriers	barrier	NOUN
dpc-5027	222	3	.	.	PUNCT
dpc-5027	223	1	2016	2016	NUM
dpc-5027	223	2	;	;	PUNCT
dpc-5027	223	3	4(4):e1251384	4(4):e1251384	NUM
dpc-5027	223	4	.	.	PUNCT
dpc-5027	224	1	doi	doi	NOUN
dpc-5027	224	2	:	:	PUNCT
dpc-5027	224	3	10.1080/21688370.2016.1251384	10.1080/21688370.2016.1251384	NUM
dpc-5027	224	4	.	.	PUNCT
dpc-5027	225	1	pmid	pmid	NOUN
dpc-5027	225	2	:	:	PUNCT
dpc-5027	225	3	28123927	28123927	NUM
dpc-5027	225	4	.	.	PUNCT
dpc-5027	226	1	9	9	X
dpc-5027	226	2	.	.	X
dpc-5027	226	3	wood	wood	NOUN
dpc-5027	226	4	heickman	heickman	ADJ
dpc-5027	226	5	lk	lk	PROPN
dpc-5027	226	6	,	,	PUNCT
dpc-5027	226	7	deboer	deboer	PROPN
dpc-5027	226	8	md	md	PROPN
dpc-5027	226	9	,	,	PUNCT
dpc-5027	226	10	fasano	fasano	PROPN
dpc-5027	226	11	a.	a.	PROPN
dpc-5027	226	12	zonulin	zonulin	PROPN
dpc-5027	226	13	as	as	ADP
dpc-5027	226	14	a	a	DET
dpc-5027	226	15	potential	potential	ADJ
dpc-5027	226	16	putative	putative	ADJ
dpc-5027	226	17	biomarker	biomarker	NOUN
dpc-5027	226	18	of	of	ADP
dpc-5027	226	19	risk	risk	NOUN
dpc-5027	226	20	for	for	ADP
dpc-5027	226	21	shared	shared	ADJ
dpc-5027	226	22	type	type	NOUN
dpc-5027	226	23	1	1	NUM
dpc-5027	226	24	diabetes	diabetes	NOUN
dpc-5027	226	25	and	and	CCONJ
dpc-5027	226	26	celiac	celiac	ADJ
dpc-5027	226	27	disease	disease	NOUN
dpc-5027	226	28	autoimmunity	autoimmunity	NOUN
dpc-5027	226	29	.	.	PUNCT
dpc-5027	227	1	diabetes	diabetes	NOUN
dpc-5027	227	2	metab	metab	NOUN
dpc-5027	227	3	res	re	NOUN
dpc-5027	227	4	rev	rev	X
dpc-5027	227	5	.	.	PROPN
dpc-5027	227	6	2020	2020	NUM
dpc-5027	228	1	;	;	PUNCT
dpc-5027	228	2	36(5):e3309	36(5):e3309	X
dpc-5027	228	3	.	.	PUNCT
dpc-5027	228	4	doi	doi	PROPN
dpc-5027	228	5	:	:	PUNCT
dpc-5027	228	6	10.1002	10.1002	NUM
dpc-5027	228	7	/	/	SYM
dpc-5027	228	8	dmrr.3309	dmrr.3309	NOUN
dpc-5027	228	9	.	.	PUNCT
dpc-5027	229	1	pmid	pmid	NOUN
dpc-5027	229	2	:	:	PUNCT
dpc-5027	229	3	32162764	32162764	NUM
dpc-5027	229	4	.	.	PUNCT
dpc-5027	230	1	10	10	NUM
dpc-5027	230	2	.	.	PUNCT
dpc-5027	231	1	veres	vere	NOUN
dpc-5027	231	2	-	-	PUNCT
dpc-5027	231	3	székely	székely	ADV
dpc-5027	231	4	a	a	DET
dpc-5027	231	5	,	,	PUNCT
dpc-5027	231	6	szász	szász	NOUN
dpc-5027	231	7	c	c	NOUN
dpc-5027	231	8	,	,	PUNCT
dpc-5027	231	9	pap	pap	NOUN
dpc-5027	231	10	d	d	NOUN
dpc-5027	231	11	,	,	PUNCT
dpc-5027	231	12	szebeni	szebeni	ADJ
dpc-5027	231	13	b	b	NOUN
dpc-5027	231	14	,	,	PUNCT
dpc-5027	231	15	bokrossy	bokrossy	ADJ
dpc-5027	231	16	p	p	NOUN
dpc-5027	231	17	,	,	PUNCT
dpc-5027	231	18	vannay	vannay	PROPN
dpc-5027	231	19	á	á	PROPN
dpc-5027	231	20	.	.	PUNCT
dpc-5027	231	21	zonulin	zonulin	PROPN
dpc-5027	231	22	as	as	ADP
dpc-5027	231	23	a	a	DET
dpc-5027	231	24	potential	potential	ADJ
dpc-5027	231	25	therapeutic	therapeutic	ADJ
dpc-5027	231	26	target	target	NOUN
dpc-5027	231	27	in	in	ADP
dpc-5027	231	28	microbiota	microbiota	NOUN
dpc-5027	231	29	-	-	PUNCT
dpc-5027	231	30	gut	gut	NOUN
dpc-5027	231	31	-	-	PUNCT
dpc-5027	231	32	brain	brain	NOUN
dpc-5027	231	33	axis	axis	NOUN
dpc-5027	231	34	disorders	disorder	NOUN
dpc-5027	231	35	:	:	PUNCT
dpc-5027	231	36	encouraging	encourage	VERB
dpc-5027	231	37	results	result	NOUN
dpc-5027	231	38	and	and	CCONJ
dpc-5027	231	39	emerging	emerge	VERB
dpc-5027	231	40	questions	question	NOUN
dpc-5027	231	41	.	.	PUNCT
dpc-5027	232	1	int	int	PROPN
dpc-5027	232	2	j	j	PROPN
dpc-5027	232	3	mol	mol	ADP
dpc-5027	232	4	sci	sci	PROPN
dpc-5027	232	5	.	.	PUNCT
dpc-5027	233	1	2023;24	2023;24	NUM
dpc-5027	233	2	(	(	PUNCT
dpc-5027	233	3	8):7548	8):7548	NOUN
dpc-5027	233	4	.	.	PUNCT
dpc-5027	234	1	doi	doi	NOUN
dpc-5027	234	2	:	:	PUNCT
dpc-5027	234	3	10.3390	10.3390	NUM
dpc-5027	234	4	/ijms24087548	/ijms24087548	PUNCT
dpc-5027	234	5	.	.	PUNCT
dpc-5027	235	1	pmid	pmid	NOUN
dpc-5027	235	2	:	:	PUNCT
dpc-5027	235	3	37108711	37108711	NUM
dpc-5027	235	4	.	.	PUNCT
dpc-5027	236	1	11	11	NUM
dpc-5027	236	2	.	.	PUNCT
dpc-5027	237	1	yüksel	yüksel	PROPN
dpc-5027	237	2	m	m	PROPN
dpc-5027	237	3	,	,	PUNCT
dpc-5027	237	4	ülfer	ülfer	PROPN
dpc-5027	237	5	g.	g.	PROPN
dpc-5027	237	6	measurement	measurement	NOUN
dpc-5027	237	7	of	of	ADP
dpc-5027	237	8	the	the	DET
dpc-5027	237	9	serum	serum	PROPN
dpc-5027	237	10	zonulin	zonulin	PROPN
dpc-5027	237	11	levels	level	NOUN
dpc-5027	237	12	in	in	ADP
dpc-5027	237	13	patients	patient	NOUN
dpc-5027	237	14	with	with	ADP
dpc-5027	237	15	acne	acne	NOUN
dpc-5027	237	16	rosacea	rosacea	PROPN
dpc-5027	237	17	.	.	PUNCT
dpc-5027	238	1	j	j	PROPN
dpc-5027	238	2	dermatolog	dermatolog	PROPN
dpc-5027	238	3	treat	treat	NOUN
dpc-5027	238	4	.	.	PUNCT
dpc-5027	239	1	2022	2022	NUM
dpc-5027	239	2	;	;	PUNCT
dpc-5027	239	3	33(1	33(1	NUM
dpc-5027	239	4	)	)	PUNCT
dpc-5027	240	1	389–392	389–392	NUM
dpc-5027	240	2	.	.	PUNCT
dpc-5027	240	3	doi	doi	NOUN
dpc-5027	240	4	:	:	PUNCT
dpc-5027	240	5	10.1080/09546634.2020.1757015	10.1080/09546634.2020.1757015	NUM
dpc-5027	240	6	12	12	NUM
dpc-5027	240	7	.	.	PUNCT
dpc-5027	241	1	wang	wang	PROPN
dpc-5027	241	2	fy	fy	PROPN
dpc-5027	241	3	,	,	PUNCT
dpc-5027	241	4	chi	chi	PROPN
dpc-5027	241	5	cc	cc	PROPN
dpc-5027	241	6	.	.	PROPN
dpc-5027	241	7	association	association	PROPN
dpc-5027	241	8	of	of	ADP
dpc-5027	241	9	rosacea	rosacea	PROPN
dpc-5027	241	10	with	with	ADP
dpc-5027	241	11	inflammatory	inflammatory	ADJ
dpc-5027	241	12	bowel	bowel	NOUN
dpc-5027	241	13	disease	disease	NOUN
dpc-5027	241	14	:	:	PUNCT
dpc-5027	241	15	a	a	DET
dpc-5027	241	16	moose	moose	NOUN
dpc-5027	241	17	-	-	PUNCT
dpc-5027	241	18	compliant	compliant	NOUN
dpc-5027	241	19	meta	meta	ADJ
dpc-5027	241	20	-	-	PUNCT
dpc-5027	241	21	analysis	analysis	NOUN
dpc-5027	241	22	.	.	PUNCT
dpc-5027	242	1	medicine	medicine	NOUN
dpc-5027	242	2	(	(	PUNCT
dpc-5027	242	3	baltimore	baltimore	PROPN
dpc-5027	242	4	)	)	PUNCT
dpc-5027	242	5	.	.	PUNCT
dpc-5027	243	1	2019	2019	NUM
dpc-5027	243	2	;	;	PUNCT
dpc-5027	243	3	98(41):e16448	98(41):e16448	X
dpc-5027	243	4	.	.	PUNCT
dpc-5027	244	1	doi	doi	NOUN
dpc-5027	244	2	:	:	PUNCT
dpc-5027	244	3	10.1097	10.1097	NUM
dpc-5027	244	4	/	/	SYM
dpc-5027	244	5	md.00000	md.00000	NUM
dpc-5027	244	6	00000016448	00000016448	NUM
dpc-5027	244	7	.	.	PUNCT
dpc-5027	245	1	pmid	pmid	NOUN
dpc-5027	245	2	:	:	PUNCT
dpc-5027	245	3	31593075	31593075	NUM
dpc-5027	245	4	13	13	NUM
dpc-5027	245	5	.	.	PUNCT
dpc-5027	245	6	muszer	muszer	PROPN
dpc-5027	245	7	m	m	PROPN
dpc-5027	245	8	,	,	PUNCT
dpc-5027	245	9	noszczyńska	noszczyńska	ADJ
dpc-5027	245	10	m	m	PROPN
dpc-5027	245	11	,	,	PUNCT
dpc-5027	245	12	kasperkiewicz	kasperkiewicz	PROPN
dpc-5027	245	13	k	k	NOUN
dpc-5027	245	14	,	,	PUNCT
dpc-5027	245	15	skurnik	skurnik	X
dpc-5027	245	16	m.	m.	NOUN
dpc-5027	245	17	human	human	ADJ
dpc-5027	245	18	microbiome	microbiome	NOUN
dpc-5027	245	19	:	:	PUNCT
dpc-5027	245	20	when	when	SCONJ
dpc-5027	245	21	a	a	DET
dpc-5027	245	22	friend	friend	NOUN
dpc-5027	245	23	becomes	become	VERB
dpc-5027	245	24	an	an	DET
dpc-5027	245	25	enemy	enemy	NOUN
dpc-5027	245	26	.	.	PUNCT
dpc-5027	246	1	arch	arch	ADJ
dpc-5027	246	2	immunol	immunol	NOUN
dpc-5027	246	3	ther	ther	PROPN
dpc-5027	246	4	exp	exp	PROPN
dpc-5027	246	5	(	(	PUNCT
dpc-5027	246	6	warsz	warsz	PROPN
dpc-5027	246	7	)	)	PUNCT
dpc-5027	246	8	.	.	PUNCT
dpc-5027	247	1	2015	2015	NUM
dpc-5027	247	2	;	;	PUNCT
dpc-5027	247	3	63(4):287	63(4):287	NUM
dpc-5027	247	4	-	-	SYM
dpc-5027	247	5	98	98	NUM
dpc-5027	247	6	.	.	PUNCT
dpc-5027	248	1	doi	doi	NOUN
dpc-5027	248	2	:	:	PUNCT
dpc-5027	248	3	10.1007	10.1007	NUM
dpc-5027	248	4	/s00005	/s00005	NOUN
dpc-5027	248	5	-	-	PUNCT
dpc-5027	248	6	015	015	NUM
dpc-5027	248	7	-	-	PUNCT
dpc-5027	248	8	0332	0332	NUM
dpc-5027	248	9	-	-	PUNCT
dpc-5027	248	10	3	3	NUM
dpc-5027	248	11	.	.	PUNCT
dpc-5027	249	1	pmid	pmid	NOUN
dpc-5027	249	2	:	:	PUNCT
dpc-5027	249	3	25682593	25682593	NUM
dpc-5027	249	4	14	14	NUM
dpc-5027	249	5	.	.	PUNCT
dpc-5027	250	1	brown	brown	PROPN
dpc-5027	250	2	k	k	PROPN
dpc-5027	250	3	,	,	PUNCT
dpc-5027	250	4	decoffe	decoffe	PROPN
dpc-5027	250	5	d	d	NOUN
dpc-5027	250	6	,	,	PUNCT
dpc-5027	250	7	molcan	molcan	PROPN
dpc-5027	250	8	e	e	PROPN
dpc-5027	250	9	,	,	PUNCT
dpc-5027	250	10	gibson	gibson	PROPN
dpc-5027	250	11	dl	dl	PROPN
dpc-5027	250	12	.	.	PROPN
dpc-5027	250	13	diet	diet	NOUN
dpc-5027	250	14	-	-	PUNCT
dpc-5027	250	15	induced	induce	VERB
dpc-5027	250	16	dysbiosis	dysbiosis	NOUN
dpc-5027	250	17	of	of	ADP
dpc-5027	250	18	the	the	DET
dpc-5027	250	19	intestinal	intestinal	ADJ
dpc-5027	250	20	microbiota	microbiota	NOUN
dpc-5027	250	21	and	and	CCONJ
dpc-5027	250	22	the	the	DET
dpc-5027	250	23	effects	effect	NOUN
dpc-5027	250	24	on	on	ADP
dpc-5027	250	25	immunity	immunity	NOUN
dpc-5027	250	26	and	and	CCONJ
dpc-5027	250	27	disease	disease	NOUN
dpc-5027	250	28	.	.	PUNCT
dpc-5027	251	1	nutrients	nutrient	NOUN
dpc-5027	251	2	.	.	PUNCT
dpc-5027	252	1	2012	2012	NUM
dpc-5027	252	2	;	;	PUNCT
dpc-5027	252	3	4(8):1095	4(8):1095	NUM
dpc-5027	252	4	-	-	SYM
dpc-5027	252	5	119	119	NUM
dpc-5027	252	6	.	.	PUNCT
dpc-5027	253	1	doi	doi	NOUN
dpc-5027	253	2	:	:	PUNCT
dpc-5027	253	3	10.3390	10.3390	NUM
dpc-5027	253	4	/nu4081095	/nu4081095	NOUN
dpc-5027	253	5	.	.	PUNCT
dpc-5027	254	1	pmid	pmid	NOUN
dpc-5027	254	2	:	:	PUNCT
dpc-5027	254	3	23016134	23016134	NUM
dpc-5027	254	4	.	.	PUNCT
dpc-5027	255	1	15	15	NUM
dpc-5027	255	2	.	.	PUNCT
dpc-5027	256	1	mahmud	mahmud	PROPN
dpc-5027	256	2	mr	mr	PROPN
dpc-5027	256	3	,	,	PUNCT
dpc-5027	256	4	akter	akter	NOUN
dpc-5027	256	5	s	s	PART
dpc-5027	256	6	,	,	PUNCT
dpc-5027	256	7	tamanna	tamanna	PROPN
dpc-5027	256	8	sk	sk	PROPN
dpc-5027	256	9	,	,	PUNCT
dpc-5027	256	10	et	et	PROPN
dpc-5027	256	11	al	al	PROPN
dpc-5027	256	12	.	.	PROPN
dpc-5027	256	13	impact	impact	NOUN
dpc-5027	256	14	of	of	ADP
dpc-5027	256	15	gut	gut	NOUN
dpc-5027	256	16	microbiome	microbiome	NOUN
dpc-5027	256	17	on	on	ADP
dpc-5027	256	18	skin	skin	NOUN
dpc-5027	256	19	health	health	NOUN
dpc-5027	256	20	:	:	PUNCT
dpc-5027	256	21	gut	gut	NOUN
dpc-5027	256	22	-	-	PUNCT
dpc-5027	256	23	skin	skin	NOUN
dpc-5027	256	24	axis	axis	NOUN
dpc-5027	256	25	observed	observe	VERB
dpc-5027	256	26	through	through	ADP
dpc-5027	256	27	the	the	DET
dpc-5027	256	28	lenses	lense	NOUN
dpc-5027	256	29	of	of	ADP
dpc-5027	256	30	therapeutics	therapeutic	NOUN
dpc-5027	256	31	and	and	CCONJ
dpc-5027	256	32	skin	skin	NOUN
dpc-5027	256	33	diseases	disease	NOUN
dpc-5027	256	34	.	.	PUNCT
dpc-5027	257	1	gut	gut	NOUN
dpc-5027	257	2	microbes	microbe	NOUN
dpc-5027	257	3	.	.	PUNCT
dpc-5027	258	1	2022;14	2022;14	NUM
dpc-5027	258	2	(	(	PUNCT
dpc-5027	258	3	1):2096995	1):2096995	NUM
dpc-5027	258	4	.	.	PUNCT
dpc-5027	259	1	doi	doi	NOUN
dpc-5027	259	2	:	:	PUNCT
dpc-5027	259	3	10.1080/19490976.2022.2096995	10.1080/19490976.2022.2096995	NUM
dpc-5027	259	4	.	.	PUNCT
dpc-5027	260	1	pmid	pmid	NOUN
dpc-5027	260	2	:	:	PUNCT
dpc-5027	260	3	35866234	35866234	NUM
dpc-5027	260	4	.	.	PUNCT
dpc-5027	261	1	16	16	NUM
dpc-5027	261	2	.	.	PUNCT
dpc-5027	262	1	schaller	schaller	PROPN
dpc-5027	262	2	m	m	PROPN
dpc-5027	262	3	,	,	PUNCT
dpc-5027	262	4	almeida	almeida	PROPN
dpc-5027	262	5	lmc	lmc	PROPN
dpc-5027	262	6	,	,	PUNCT
dpc-5027	262	7	bewley	bewley	PROPN
dpc-5027	262	8	a	a	PROPN
dpc-5027	262	9	,	,	PUNCT
dpc-5027	262	10	et	et	PROPN
dpc-5027	262	11	al	al	PROPN
dpc-5027	262	12	.	.	PUNCT
dpc-5027	263	1	recommendations	recommendation	NOUN
dpc-5027	263	2	for	for	ADP
dpc-5027	263	3	rosacea	rosacea	NOUN
dpc-5027	263	4	diagnosis	diagnosis	NOUN
dpc-5027	263	5	,	,	PUNCT
dpc-5027	263	6	classification	classification	NOUN
dpc-5027	263	7	and	and	CCONJ
dpc-5027	263	8	management	management	NOUN
dpc-5027	263	9	:	:	PUNCT
dpc-5027	263	10	update	update	NOUN
dpc-5027	263	11	from	from	ADP
dpc-5027	263	12	the	the	DET
dpc-5027	263	13	global	global	ADJ
dpc-5027	263	14	rosacea	rosacea	PROPN
dpc-5027	263	15	consensus	consensus	PROPN
dpc-5027	263	16	2019	2019	NUM
dpc-5027	263	17	panel	panel	NOUN
dpc-5027	263	18	.	.	PUNCT
dpc-5027	264	1	br	br	PROPN
dpc-5027	264	2	j	j	PROPN
dpc-5027	264	3	dermatol	dermatol	NOUN
dpc-5027	264	4	.	.	PUNCT
dpc-5027	265	1	2020;182	2020;182	NUM
dpc-5027	266	1	(	(	PUNCT
dpc-5027	266	2	5):1269	5):1269	NOUN
dpc-5027	266	3	-	-	NOUN
dpc-5027	266	4	1276	1276	NUM
dpc-5027	266	5	.	.	PUNCT
dpc-5027	267	1	doi	doi	NOUN
dpc-5027	267	2	:	:	PUNCT
dpc-5027	267	3	10.1111	10.1111	NUM
dpc-5027	267	4	/	/	SYM
dpc-5027	267	5	bjd.18420	bjd.18420	PROPN
dpc-5027	267	6	.	.	PUNCT
dpc-5027	268	1	pmid	pmid	NOUN
dpc-5027	268	2	:	:	PUNCT
dpc-5027	268	3	31392722	31392722	NUM
dpc-5027	268	4	.	.	PUNCT
dpc-5027	269	1	significant	significant	ADJ
dpc-5027	269	2	relation	relation	NOUN
dpc-5027	269	3	between	between	ADP
dpc-5027	269	4	the	the	DET
dpc-5027	269	5	lactobacillus	lactobacillus	NOUN
dpc-5027	269	6	gut	gut	NOUN
dpc-5027	269	7	microbiome	microbiome	NOUN
dpc-5027	269	8	and	and	CCONJ
dpc-5027	269	9	the	the	DET
dpc-5027	269	10	degree	degree	NOUN
dpc-5027	269	11	of	of	ADP
dpc-5027	269	12	severity	severity	NOUN
dpc-5027	269	13	.	.	PUNCT
dpc-5027	270	1	lactobacillus	lactobacillus	PROPN
dpc-5027	270	2	had	have	VERB
dpc-5027	270	3	the	the	DET
dpc-5027	270	4	highest	high	ADJ
dpc-5027	270	5	significant	significant	ADJ
dpc-5027	270	6	relation	relation	NOUN
dpc-5027	270	7	in	in	ADP
dpc-5027	270	8	patients	patient	NOUN
dpc-5027	270	9	with	with	ADP
dpc-5027	270	10	mild	mild	ADJ
dpc-5027	270	11	and	and	CCONJ
dpc-5027	270	12	moderate	moderate	ADJ
dpc-5027	270	13	disease	disease	NOUN
dpc-5027	270	14	.	.	PUNCT
dpc-5027	271	1	some	some	DET
dpc-5027	271	2	intestinal	intestinal	ADJ
dpc-5027	271	3	bacterial	bacterial	ADJ
dpc-5027	271	4	species	specie	NOUN
dpc-5027	271	5	,	,	PUNCT
dpc-5027	271	6	such	such	ADJ
dpc-5027	271	7	as	as	ADP
dpc-5027	271	8	lactobacillus	lactobacillus	NOUN
dpc-5027	271	9	,	,	PUNCT
dpc-5027	271	10	are	be	AUX
dpc-5027	271	11	reported	report	VERB
dpc-5027	271	12	to	to	PART
dpc-5027	271	13	confer	confer	VERB
dpc-5027	271	14	a	a	DET
dpc-5027	271	15	health	health	NOUN
dpc-5027	271	16	advantage	advantage	NOUN
dpc-5027	271	17	to	to	ADP
dpc-5027	271	18	the	the	DET
dpc-5027	271	19	host	host	NOUN
dpc-5027	271	20	[	[	X
dpc-5027	271	21	30	30	NUM
dpc-5027	271	22	]	]	PUNCT
dpc-5027	271	23	.	.	PUNCT
dpc-5027	272	1	limitations	limitation	NOUN
dpc-5027	272	2	study	study	NOUN
dpc-5027	272	3	limitations	limitation	NOUN
dpc-5027	272	4	include	include	VERB
dpc-5027	272	5	the	the	DET
dpc-5027	272	6	small	small	ADJ
dpc-5027	272	7	sample	sample	NOUN
dpc-5027	272	8	size	size	NOUN
dpc-5027	272	9	and	and	CCONJ
dpc-5027	272	10	the	the	DET
dpc-5027	272	11	lack	lack	NOUN
dpc-5027	272	12	of	of	ADP
dpc-5027	272	13	confirmation	confirmation	NOUN
dpc-5027	272	14	of	of	ADP
dpc-5027	272	15	diagnosis	diagnosis	NOUN
dpc-5027	272	16	of	of	ADP
dpc-5027	272	17	rosacea	rosacea	NOUN
dpc-5027	272	18	with	with	ADP
dpc-5027	272	19	the	the	DET
dpc-5027	272	20	gold	gold	ADJ
dpc-5027	272	21	standard	standard	NOUN
dpc-5027	272	22	histopathology	histopathology	NOUN
dpc-5027	272	23	,	,	PUNCT
dpc-5027	272	24	as	as	SCONJ
dpc-5027	272	25	it	it	PRON
dpc-5027	272	26	could	could	AUX
dpc-5027	272	27	have	have	AUX
dpc-5027	272	28	given	give	VERB
dpc-5027	272	29	a	a	DET
dpc-5027	272	30	better	well	ADJ
dpc-5027	272	31	assessment	assessment	NOUN
dpc-5027	272	32	of	of	ADP
dpc-5027	272	33	rosacea	rosacea	NOUN
dpc-5027	272	34	than	than	ADP
dpc-5027	272	35	dermoscopy	dermoscopy	NOUN
dpc-5027	272	36	.	.	PUNCT
dpc-5027	273	1	also	also	ADV
dpc-5027	273	2	,	,	PUNCT
dpc-5027	273	3	body	body	NOUN
dpc-5027	273	4	mass	mass	NOUN
dpc-5027	273	5	index	index	NOUN
dpc-5027	273	6	(	(	PUNCT
dpc-5027	273	7	bmi)-matched	bmi)-matche	VERB
dpc-5027	273	8	healthy	healthy	ADJ
dpc-5027	273	9	individuals	individual	NOUN
dpc-5027	273	10	limited	limit	VERB
dpc-5027	273	11	the	the	DET
dpc-5027	273	12	evaluation	evaluation	NOUN
dpc-5027	273	13	of	of	ADP
dpc-5027	273	14	obesity	obesity	NOUN
dpc-5027	273	15	in	in	ADP
dpc-5027	273	16	relation	relation	NOUN
dpc-5027	273	17	to	to	ADP
dpc-5027	273	18	rosacea	rosacea	NOUN
dpc-5027	273	19	.	.	PUNCT
dpc-5027	274	1	conclusion	conclusion	NOUN
dpc-5027	274	2	concerning	concern	VERB
dpc-5027	274	3	the	the	DET
dpc-5027	274	4	descriptive	descriptive	ADJ
dpc-5027	274	5	results	result	NOUN
dpc-5027	274	6	of	of	ADP
dpc-5027	274	7	our	our	PRON
dpc-5027	274	8	study	study	NOUN
dpc-5027	274	9	,	,	PUNCT
dpc-5027	274	10	the	the	DET
dpc-5027	274	11	serum	serum	NOUN
dpc-5027	274	12	zonulin	zonulin	PROPN
dpc-5027	274	13	shows	show	VERB
dpc-5027	274	14	a	a	DET
dpc-5027	274	15	significant	significant	ADJ
dpc-5027	274	16	elevation	elevation	NOUN
dpc-5027	274	17	in	in	ADP
dpc-5027	274	18	rosacea	rosacea	NOUN
dpc-5027	274	19	patients	patient	NOUN
dpc-5027	274	20	compared	compare	VERB
dpc-5027	274	21	to	to	ADP
dpc-5027	274	22	healthy	healthy	ADJ
dpc-5027	274	23	controls	control	NOUN
dpc-5027	274	24	.	.	PUNCT
dpc-5027	275	1	accordingly	accordingly	ADV
dpc-5027	275	2	,	,	PUNCT
dpc-5027	275	3	high	high	ADJ
dpc-5027	275	4	sensitivity	sensitivity	NOUN
dpc-5027	275	5	and	and	CCONJ
dpc-5027	275	6	specificity	specificity	NOUN
dpc-5027	275	7	of	of	ADP
dpc-5027	275	8	serum	serum	PROPN
dpc-5027	275	9	zonulin	zonulin	PROPN
dpc-5027	275	10	measurement	measurement	PROPN
dpc-5027	275	11	can	can	AUX
dpc-5027	275	12	be	be	AUX
dpc-5027	275	13	used	use	VERB
dpc-5027	275	14	as	as	ADP
dpc-5027	275	15	a	a	DET
dpc-5027	275	16	discriminating	discriminate	VERB
dpc-5027	275	17	marker	marker	NOUN
dpc-5027	275	18	between	between	ADP
dpc-5027	275	19	rosacea	rosacea	NOUN
dpc-5027	275	20	and	and	CCONJ
dpc-5027	275	21	control	control	NOUN
dpc-5027	275	22	due	due	ADP
dpc-5027	275	23	to	to	ADP
dpc-5027	275	24	getting	get	VERB
dpc-5027	275	25	a	a	DET
dpc-5027	275	26	specific	specific	ADJ
dpc-5027	275	27	cut	cut	NOUN
dpc-5027	275	28	-	-	PUNCT
dpc-5027	275	29	off	off	ADP
dpc-5027	275	30	point	point	NOUN
dpc-5027	275	31	in	in	ADP
dpc-5027	275	32	roc	roc	PROPN
dpc-5027	275	33	analysis	analysis	NOUN
dpc-5027	275	34	,	,	PUNCT
dpc-5027	275	35	especially	especially	ADV
dpc-5027	275	36	in	in	ADP
dpc-5027	275	37	dark	dark	ADJ
dpc-5027	275	38	-	-	PUNCT
dpc-5027	275	39	skinned	skinned	ADJ
dpc-5027	275	40	people	people	NOUN
dpc-5027	275	41	,	,	PUNCT
dpc-5027	275	42	who	who	PRON
dpc-5027	275	43	might	might	AUX
dpc-5027	275	44	be	be	AUX
dpc-5027	275	45	underdiagnosed	underdiagnose	VERB
dpc-5027	275	46	.	.	PUNCT
dpc-5027	276	1	the	the	DET
dpc-5027	276	2	findings	finding	NOUN
dpc-5027	276	3	of	of	ADP
dpc-5027	276	4	changed	change	VERB
dpc-5027	276	5	gut	gut	NOUN
dpc-5027	276	6	microbiome	microbiome	ADJ
dpc-5027	276	7	levels	level	NOUN
dpc-5027	276	8	in	in	ADP
dpc-5027	276	9	rosacea	rosacea	NOUN
dpc-5027	276	10	patients	patient	NOUN
dpc-5027	276	11	explain	explain	VERB
dpc-5027	276	12	their	their	PRON
dpc-5027	276	13	importance	importance	NOUN
dpc-5027	276	14	in	in	ADP
dpc-5027	276	15	the	the	DET
dpc-5027	276	16	pathogenesis	pathogenesis	NOUN
dpc-5027	276	17	of	of	ADP
dpc-5027	276	18	the	the	DET
dpc-5027	276	19	disease	disease	NOUN
dpc-5027	276	20	.	.	PUNCT
dpc-5027	277	1	further	further	ADJ
dpc-5027	277	2	studies	study	NOUN
dpc-5027	277	3	with	with	ADP
dpc-5027	277	4	a	a	DET
dpc-5027	277	5	larger	large	ADJ
dpc-5027	277	6	sample	sample	NOUN
dpc-5027	277	7	size	size	NOUN
dpc-5027	277	8	of	of	ADP
dpc-5027	277	9	rosacea	rosacea	NOUN
dpc-5027	277	10	patients	patient	NOUN
dpc-5027	277	11	should	should	AUX
dpc-5027	277	12	assess	assess	VERB
dpc-5027	277	13	the	the	DET
dpc-5027	277	14	serum	serum	NOUN
dpc-5027	277	15	zonulin	zonulin	PROPN
dpc-5027	277	16	level	level	NOUN
dpc-5027	277	17	and	and	CCONJ
dpc-5027	277	18	correlate	correlate	VERB
dpc-5027	277	19	it	it	PRON
dpc-5027	277	20	with	with	ADP
dpc-5027	277	21	subtypes	subtype	NOUN
dpc-5027	277	22	of	of	ADP
dpc-5027	277	23	rosacea	rosacea	NOUN
dpc-5027	277	24	and	and	CCONJ
dpc-5027	277	25	the	the	DET
dpc-5027	277	26	degree	degree	NOUN
dpc-5027	277	27	of	of	ADP
dpc-5027	277	28	severity	severity	NOUN
dpc-5027	277	29	.	.	PUNCT
dpc-5027	278	1	more	more	ADJ
dpc-5027	278	2	research	research	NOUN
dpc-5027	278	3	should	should	AUX
dpc-5027	278	4	also	also	ADV
dpc-5027	278	5	explore	explore	VERB
dpc-5027	278	6	the	the	DET
dpc-5027	278	7	gut	gut	NOUN
dpc-5027	278	8	microbiome	microbiome	NOUN
dpc-5027	278	9	’s	’s	PART
dpc-5027	278	10	role	role	NOUN
dpc-5027	278	11	in	in	ADP
dpc-5027	278	12	rosacea	rosacea	NOUN
dpc-5027	278	13	pathogenesis	pathogenesis	NOUN
dpc-5027	278	14	by	by	ADP
dpc-5027	278	15	studying	study	VERB
dpc-5027	278	16	more	more	ADJ
dpc-5027	278	17	subtypes	subtype	NOUN
dpc-5027	278	18	of	of	ADP
dpc-5027	278	19	the	the	DET
dpc-5027	278	20	microbiome	microbiome	NOUN
dpc-5027	278	21	.	.	PUNCT
dpc-5027	279	1	wider	wide	ADJ
dpc-5027	279	2	studies	study	NOUN
dpc-5027	279	3	are	be	AUX
dpc-5027	279	4	recommended	recommend	VERB
dpc-5027	279	5	to	to	PART
dpc-5027	279	6	correlate	correlate	VERB
dpc-5027	279	7	serum	serum	PROPN
dpc-5027	279	8	zonulin	zonulin	PROPN
dpc-5027	279	9	levels	level	NOUN
dpc-5027	279	10	with	with	ADP
dpc-5027	279	11	various	various	ADJ
dpc-5027	279	12	types	type	NOUN
dpc-5027	279	13	of	of	ADP
dpc-5027	279	14	gut	gut	PROPN
dpc-5027	279	15	microbiomes	microbiome	NOUN
dpc-5027	279	16	,	,	PUNCT
dpc-5027	279	17	because	because	SCONJ
dpc-5027	279	18	bacterial	bacterial	ADJ
dpc-5027	279	19	zonulin	zonulin	NOUN
dpc-5027	279	20	system	system	NOUN
dpc-5027	279	21	induction	induction	NOUN
dpc-5027	279	22	is	be	AUX
dpc-5027	279	23	not	not	PART
dpc-5027	279	24	completely	completely	ADV
dpc-5027	279	25	explained	explain	VERB
dpc-5027	279	26	.	.	PUNCT
dpc-5027	280	1	based	base	VERB
dpc-5027	280	2	on	on	ADP
dpc-5027	280	3	the	the	DET
dpc-5027	280	4	relation	relation	NOUN
dpc-5027	280	5	between	between	ADP
dpc-5027	280	6	zonulin	zonulin	NOUN
dpc-5027	280	7	and	and	CCONJ
dpc-5027	280	8	intestinal	intestinal	ADJ
dpc-5027	280	9	dysbiosis	dysbiosis	NOUN
dpc-5027	280	10	,	,	PUNCT
dpc-5027	280	11	zonulin	zonulin	NOUN
dpc-5027	280	12	receptor	receptor	NOUN
dpc-5027	280	13	antagonists	antagonist	NOUN
dpc-5027	280	14	need	need	VERB
dpc-5027	280	15	to	to	PART
dpc-5027	280	16	be	be	AUX
dpc-5027	280	17	investigated	investigate	VERB
dpc-5027	280	18	as	as	ADP
dpc-5027	280	19	a	a	DET
dpc-5027	280	20	future	future	ADJ
dpc-5027	280	21	new	new	ADJ
dpc-5027	280	22	target	target	NOUN
dpc-5027	280	23	in	in	ADP
dpc-5027	280	24	rosacea	rosacea	PROPN
dpc-5027	280	25	treatment	treatment	NOUN
dpc-5027	280	26	.	.	PUNCT
dpc-5027	281	1	the	the	DET
dpc-5027	281	2	role	role	NOUN
dpc-5027	281	3	of	of	ADP
dpc-5027	281	4	gluten	gluten	ADJ
dpc-5027	281	5	restriction	restriction	NOUN
dpc-5027	281	6	on	on	ADP
dpc-5027	281	7	rosacea	rosacea	NOUN
dpc-5027	281	8	severity	severity	NOUN
dpc-5027	281	9	and	and	CCONJ
dpc-5027	281	10	zonulin	zonulin	NOUN
dpc-5027	281	11	level	level	NOUN
dpc-5027	281	12	needs	need	VERB
dpc-5027	281	13	to	to	PART
dpc-5027	281	14	be	be	AUX
dpc-5027	281	15	investigated	investigate	VERB
dpc-5027	281	16	.	.	PUNCT
dpc-5027	282	1	in	in	ADP
dpc-5027	282	2	addition	addition	NOUN
dpc-5027	282	3	,	,	PUNCT
dpc-5027	282	4	the	the	DET
dpc-5027	282	5	role	role	NOUN
dpc-5027	282	6	of	of	ADP
dpc-5027	282	7	probiotics	probiotic	NOUN
dpc-5027	282	8	and	and	CCONJ
dpc-5027	282	9	prebiotics	prebiotic	NOUN
dpc-5027	282	10	on	on	ADP
dpc-5027	282	11	zonulin	zonulin	PROPN
dpc-5027	282	12	levels	level	NOUN
dpc-5027	282	13	needs	need	VERB
dpc-5027	282	14	to	to	PART
dpc-5027	282	15	be	be	AUX
dpc-5027	282	16	inspected	inspect	VERB
dpc-5027	282	17	.	.	PUNCT
dpc-5027	283	1	references	reference	NOUN
dpc-5027	283	2	1	1	NUM
dpc-5027	283	3	.	.	PUNCT
dpc-5027	284	1	daou	daou	PROPN
dpc-5027	284	2	h	h	PROPN
dpc-5027	284	3	,	,	PUNCT
dpc-5027	284	4	paradiso	paradiso	PROPN
dpc-5027	284	5	m	m	PROPN
dpc-5027	284	6	,	,	PUNCT
dpc-5027	284	7	hennessy	hennessy	PROPN
dpc-5027	284	8	k	k	PROPN
dpc-5027	284	9	,	,	PUNCT
dpc-5027	284	10	seminario	seminario	NOUN
dpc-5027	284	11	-	-	PUNCT
dpc-5027	284	12	vidal	vidal	NOUN
dpc-5027	284	13	,	,	PUNCT
dpc-5027	284	14	l.	l.	PROPN
dpc-5027	284	15	rosacea	rosacea	PROPN
dpc-5027	284	16	and	and	CCONJ
dpc-5027	284	17	the	the	DET
dpc-5027	284	18	microbiome	microbiome	NOUN
dpc-5027	284	19	:	:	PUNCT
dpc-5027	284	20	a	a	DET
dpc-5027	284	21	systematic	systematic	ADJ
dpc-5027	284	22	review	review	NOUN
dpc-5027	284	23	.	.	PUNCT
dpc-5027	285	1	dermatol	dermatol	NOUN
dpc-5027	285	2	ther	ther	ADV
dpc-5027	285	3	(	(	PUNCT
dpc-5027	285	4	heidelb	heidelb	NOUN
dpc-5027	285	5	)	)	PUNCT
dpc-5027	285	6	.	.	PUNCT
dpc-5027	286	1	2021;11:1	2021;11:1	NUM
dpc-5027	286	2	-	-	PUNCT
dpc-5027	286	3	12	12	NUM
dpc-5027	286	4	.	.	PUNCT
dpc-5027	287	1	doi	doi	NOUN
dpc-5027	287	2	:	:	PUNCT
dpc-5027	287	3	10.1007	10.1007	NUM
dpc-5027	287	4	/	/	SYM
dpc-5027	287	5	s13555	s13555	PROPN
dpc-5027	287	6	-	-	PUNCT
dpc-5027	287	7	020	020	NUM
dpc-5027	287	8	-	-	PUNCT
dpc-5027	287	9	00460	00460	NUM
dpc-5027	287	10	-	-	SYM
dpc-5027	287	11	1	1	NUM
dpc-5027	287	12	.	.	PUNCT
dpc-5027	288	1	pmid	pmid	NOUN
dpc-5027	288	2	:	:	PUNCT
dpc-5027	288	3	33170492	33170492	NUM
dpc-5027	288	4	.	.	PUNCT
dpc-5027	289	1	2	2	NUM
dpc-5027	289	2	.	.	X
dpc-5027	289	3	rodrigues	rodrigue	NOUN
dpc-5027	289	4	-	-	PUNCT
dpc-5027	289	5	braz	braz	PROPN
dpc-5027	289	6	d	d	PROPN
dpc-5027	289	7	,	,	PUNCT
dpc-5027	289	8	zhao	zhao	PROPN
dpc-5027	289	9	m	m	PROPN
dpc-5027	289	10	,	,	PUNCT
dpc-5027	289	11	yesilirmak	yesilirmak	PROPN
dpc-5027	289	12	n	n	CCONJ
dpc-5027	289	13	,	,	PUNCT
dpc-5027	289	14	aractingi	aractingi	PROPN
dpc-5027	289	15	s	s	PROPN
dpc-5027	289	16	,	,	PUNCT
dpc-5027	289	17	beharcohen	beharcohen	PROPN
dpc-5027	289	18	f	f	NUM
dpc-5027	289	19	,	,	PUNCT
dpc-5027	289	20	bourges	bourge	VERB
dpc-5027	289	21	jl	jl	PROPN
dpc-5027	289	22	.	.	PUNCT
dpc-5027	290	1	cutaneous	cutaneous	ADJ
dpc-5027	290	2	and	and	CCONJ
dpc-5027	290	3	ocular	ocular	ADJ
dpc-5027	290	4	rosacea	rosacea	NOUN
dpc-5027	290	5	:	:	PUNCT
dpc-5027	290	6	common	common	ADJ
dpc-5027	290	7	and	and	CCONJ
dpc-5027	290	8	specific	specific	ADJ
dpc-5027	290	9	physiopathogenic	physiopathogenic	ADJ
dpc-5027	290	10	mechanisms	mechanism	NOUN
dpc-5027	290	11	and	and	CCONJ
dpc-5027	290	12	study	study	NOUN
dpc-5027	290	13	models	model	NOUN
dpc-5027	290	14	.	.	PUNCT
dpc-5027	291	1	mol	mol	ADP
dpc-5027	291	2	vis	vis	X
dpc-5027	291	3	.	.	PUNCT
dpc-5027	292	1	2021;27:323	2021;27:323	X
dpc-5027	292	2	-	-	SYM
dpc-5027	292	3	53	53	NUM
dpc-5027	292	4	.	.	PUNCT
dpc-5027	293	1	pmid	pmid	NOUN
dpc-5027	293	2	:	:	PUNCT
dpc-5027	293	3	34035646	34035646	NUM
dpc-5027	293	4	;	;	PUNCT
dpc-5027	293	5	pmcid	pmcid	NOUN
dpc-5027	293	6	:	:	PUNCT
dpc-5027	293	7	pmc8131178	pmc8131178	X
dpc-5027	293	8	.	.	PUNCT
dpc-5027	294	1	10	10	NUM
dpc-5027	294	2	original	original	ADJ
dpc-5027	294	3	article	article	NOUN
dpc-5027	294	4	|	|	ADV
dpc-5027	294	5	dermatol	dermatol	ADJ
dpc-5027	294	6	pract	pract	NOUN
dpc-5027	294	7	concept	concept	NOUN
dpc-5027	294	8	.	.	PUNCT
dpc-5027	295	1	2025;15(3):5027	2025;15(3):5027	NUM
dpc-5027	295	2	24	24	NUM
dpc-5027	295	3	.	.	PUNCT
dpc-5027	296	1	ellis	ellis	PROPN
dpc-5027	296	2	sr	sr	PROPN
dpc-5027	296	3	,	,	PUNCT
dpc-5027	296	4	nguyen	nguyen	PROPN
dpc-5027	296	5	m	m	PROPN
dpc-5027	296	6	,	,	PUNCT
dpc-5027	296	7	vaughn	vaughn	PROPN
dpc-5027	296	8	ar	ar	PROPN
dpc-5027	296	9	,	,	PUNCT
dpc-5027	296	10	et	et	PROPN
dpc-5027	296	11	al	al	PROPN
dpc-5027	296	12	.	.	PUNCT
dpc-5027	297	1	the	the	DET
dpc-5027	297	2	skin	skin	NOUN
dpc-5027	297	3	and	and	CCONJ
dpc-5027	297	4	gut	gut	NOUN
dpc-5027	297	5	microbiome	microbiome	NOUN
dpc-5027	297	6	and	and	CCONJ
dpc-5027	297	7	its	its	PRON
dpc-5027	297	8	role	role	NOUN
dpc-5027	297	9	in	in	ADP
dpc-5027	297	10	common	common	ADJ
dpc-5027	297	11	dermatologic	dermatologic	ADJ
dpc-5027	297	12	conditions	condition	NOUN
dpc-5027	297	13	.	.	PUNCT
dpc-5027	298	1	microorganisms	microorganism	NOUN
dpc-5027	298	2	.	.	PUNCT
dpc-5027	299	1	2019	2019	NUM
dpc-5027	299	2	;	;	PUNCT
dpc-5027	300	1	7(11):550	7(11):550	NUM
dpc-5027	300	2	.	.	PUNCT
dpc-5027	301	1	doi	doi	NOUN
dpc-5027	301	2	:	:	PUNCT
dpc-5027	301	3	10.3390	10.3390	NUM
dpc-5027	301	4	/	/	SYM
dpc-5027	301	5	microorganisms	microorganism	NOUN
dpc-5027	301	6	7110550	7110550	NUM
dpc-5027	301	7	.	.	PUNCT
dpc-5027	302	1	pmid	pmid	NOUN
dpc-5027	302	2	:	:	PUNCT
dpc-5027	302	3	31717915	31717915	NUM
dpc-5027	302	4	.	.	PUNCT
dpc-5027	303	1	25	25	NUM
dpc-5027	303	2	.	.	PUNCT
dpc-5027	303	3	holmes	holmes	PROPN
dpc-5027	303	4	ad	ad	PROPN
dpc-5027	303	5	.	.	PUNCT
dpc-5027	304	1	potential	potential	ADJ
dpc-5027	304	2	role	role	NOUN
dpc-5027	304	3	of	of	ADP
dpc-5027	304	4	microorganisms	microorganism	NOUN
dpc-5027	304	5	in	in	ADP
dpc-5027	304	6	the	the	DET
dpc-5027	304	7	pathogenesis	pathogenesis	NOUN
dpc-5027	304	8	of	of	ADP
dpc-5027	304	9	rosacea	rosacea	NOUN
dpc-5027	304	10	.	.	PUNCT
dpc-5027	305	1	j	j	PROPN
dpc-5027	305	2	am	be	AUX
dpc-5027	305	3	acad	acad	ADJ
dpc-5027	305	4	dermatol	dermatol	NOUN
dpc-5027	305	5	.	.	PUNCT
dpc-5027	306	1	2013	2013	NUM
dpc-5027	306	2	;	;	PUNCT
dpc-5027	306	3	69(6):1025	69(6):1025	X
dpc-5027	306	4	-	-	SYM
dpc-5027	306	5	32	32	NUM
dpc-5027	306	6	.	.	PUNCT
dpc-5027	307	1	doi	doi	NOUN
dpc-5027	307	2	:	:	PUNCT
dpc-5027	307	3	10.1016	10.1016	NUM
dpc-5027	307	4	/	/	SYM
dpc-5027	307	5	j.jaad.2013.08.006	j.jaad.2013.08.006	PROPN
dpc-5027	307	6	.	.	PUNCT
dpc-5027	308	1	pmid	pmid	NOUN
dpc-5027	308	2	:	:	PUNCT
dpc-5027	308	3	24011460	24011460	NUM
dpc-5027	308	4	.	.	PUNCT
dpc-5027	309	1	26	26	NUM
dpc-5027	309	2	.	.	PUNCT
dpc-5027	309	3	rainer	rainer	PROPN
dpc-5027	309	4	bm	bm	PROPN
dpc-5027	309	5	,	,	PUNCT
dpc-5027	309	6	kang	kang	PROPN
dpc-5027	309	7	s	s	PROPN
dpc-5027	309	8	,	,	PUNCT
dpc-5027	309	9	chien	chien	PROPN
dpc-5027	309	10	al	al	PROPN
dpc-5027	309	11	.	.	PROPN
dpc-5027	309	12	rosacea	rosacea	PROPN
dpc-5027	309	13	:	:	PUNCT
dpc-5027	309	14	epidemiology	epidemiology	NOUN
dpc-5027	309	15	,	,	PUNCT
dpc-5027	309	16	pathogenesis	pathogenesis	NOUN
dpc-5027	309	17	,	,	PUNCT
dpc-5027	309	18	and	and	CCONJ
dpc-5027	309	19	treatment	treatment	NOUN
dpc-5027	309	20	.	.	PUNCT
dpc-5027	310	1	dermatoendocrinol	dermatoendocrinol	NOUN
dpc-5027	310	2	.	.	PROPN
dpc-5027	311	1	2017	2017	NUM
dpc-5027	311	2	;	;	PUNCT
dpc-5027	311	3	9(1):e1361574	9(1):e1361574	NUM
dpc-5027	311	4	.	.	PUNCT
dpc-5027	311	5	doi	doi	NOUN
dpc-5027	311	6	:	:	PUNCT
dpc-5027	311	7	10.1080/19381980.2017.1361574	10.1080/19381980.2017.1361574	NUM
dpc-5027	311	8	.	.	PUNCT
dpc-5027	312	1	pmid	pmid	NOUN
dpc-5027	312	2	:	:	PUNCT
dpc-5027	312	3	29484096	29484096	NUM
dpc-5027	312	4	.	.	PUNCT
dpc-5027	313	1	27	27	NUM
dpc-5027	313	2	.	.	NOUN
dpc-5027	313	3	steinhoff	steinhoff	PROPN
dpc-5027	313	4	m	m	PROPN
dpc-5027	313	5	,	,	PUNCT
dpc-5027	313	6	schauber	schauber	PROPN
dpc-5027	313	7	j	j	PROPN
dpc-5027	313	8	,	,	PUNCT
dpc-5027	313	9	leyden	leyden	PROPN
dpc-5027	313	10	jj	jj	PROPN
dpc-5027	313	11	.	.	PROPN
dpc-5027	313	12	new	new	ADJ
dpc-5027	313	13	insights	insight	NOUN
dpc-5027	313	14	into	into	ADP
dpc-5027	313	15	rosacea	rosacea	NOUN
dpc-5027	313	16	pathophysiology	pathophysiology	NOUN
dpc-5027	313	17	:	:	PUNCT
dpc-5027	313	18	a	a	DET
dpc-5027	313	19	review	review	NOUN
dpc-5027	313	20	of	of	ADP
dpc-5027	313	21	recent	recent	ADJ
dpc-5027	313	22	findings	finding	NOUN
dpc-5027	313	23	.	.	PUNCT
dpc-5027	314	1	j	j	PROPN
dpc-5027	314	2	am	be	AUX
dpc-5027	314	3	acad	acad	ADJ
dpc-5027	314	4	dermatol	dermatol	NOUN
dpc-5027	314	5	.	.	PUNCT
dpc-5027	315	1	2013	2013	NUM
dpc-5027	315	2	;	;	PUNCT
dpc-5027	315	3	69(6	69(6	NUM
dpc-5027	315	4	suppl	suppl	NOUN
dpc-5027	315	5	1):s15	1):s15	NUM
dpc-5027	315	6	-	-	SYM
dpc-5027	315	7	26	26	NUM
dpc-5027	315	8	.	.	PUNCT
dpc-5027	316	1	doi	doi	NOUN
dpc-5027	316	2	:	:	PUNCT
dpc-5027	316	3	10.1016	10.1016	NUM
dpc-5027	316	4	/	/	SYM
dpc-5027	316	5	j.jaad	j.jaad	NOUN
dpc-5027	316	6	.2013.04.045	.2013.04.045	PROPN
dpc-5027	316	7	.	.	PUNCT
dpc-5027	317	1	pmid	pmid	NOUN
dpc-5027	317	2	:	:	PUNCT
dpc-5027	317	3	24229632	24229632	NUM
dpc-5027	317	4	.	.	PUNCT
dpc-5027	318	1	28	28	NUM
dpc-5027	318	2	.	.	PUNCT
dpc-5027	319	1	chen	chen	PROPN
dpc-5027	319	2	w	w	PROPN
dpc-5027	319	3	,	,	PUNCT
dpc-5027	319	4	plewig	plewig	PROPN
dpc-5027	319	5	g.	g.	PROPN
dpc-5027	319	6	are	be	AUX
dpc-5027	319	7	demodex	demodex	NOUN
dpc-5027	319	8	mites	mite	NOUN
dpc-5027	319	9	principal	principal	NOUN
dpc-5027	319	10	,	,	PUNCT
dpc-5027	319	11	conspirator	conspirator	NOUN
dpc-5027	319	12	,	,	PUNCT
dpc-5027	319	13	accomplice	accomplice	NOUN
dpc-5027	319	14	,	,	PUNCT
dpc-5027	319	15	witness	witness	NOUN
dpc-5027	319	16	or	or	CCONJ
dpc-5027	319	17	bystander	bystander	NOUN
dpc-5027	319	18	in	in	ADP
dpc-5027	319	19	the	the	DET
dpc-5027	319	20	cause	cause	NOUN
dpc-5027	319	21	of	of	ADP
dpc-5027	319	22	rosacea	rosacea	NOUN
dpc-5027	319	23	?	?	PUNCT
dpc-5027	320	1	am	be	AUX
dpc-5027	320	2	j	j	PROPN
dpc-5027	320	3	clin	clin	PROPN
dpc-5027	320	4	dermatol	dermatol	NOUN
dpc-5027	320	5	.	.	PUNCT
dpc-5027	321	1	2015	2015	NUM
dpc-5027	321	2	;	;	PUNCT
dpc-5027	321	3	16(2):67	16(2):67	NUM
dpc-5027	321	4	-	-	SYM
dpc-5027	321	5	72	72	NUM
dpc-5027	321	6	.	.	PUNCT
dpc-5027	322	1	doi	doi	NOUN
dpc-5027	322	2	:	:	PUNCT
dpc-5027	322	3	10.1007	10.1007	NUM
dpc-5027	322	4	/	/	SYM
dpc-5027	322	5	s40257	s40257	NOUN
dpc-5027	322	6	-	-	PUNCT
dpc-5027	322	7	0150115	0150115	NUM
dpc-5027	322	8	-	-	PUNCT
dpc-5027	322	9	y.	y.	NOUN
dpc-5027	322	10	pmid	pmid	PROPN
dpc-5027	322	11	:	:	PUNCT
dpc-5027	322	12	25666117	25666117	NUM
dpc-5027	322	13	.	.	PUNCT
dpc-5027	323	1	29	29	NUM
dpc-5027	323	2	.	.	X
dpc-5027	323	3	trave	trave	PROPN
dpc-5027	324	1	i	i	PRON
dpc-5027	324	2	,	,	PUNCT
dpc-5027	324	3	salvi	salvi	PROPN
dpc-5027	324	4	i	i	PRON
dpc-5027	324	5	,	,	PUNCT
dpc-5027	324	6	canepa	canepa	NOUN
dpc-5027	324	7	p	p	NOUN
dpc-5027	324	8	,	,	PUNCT
dpc-5027	324	9	parodi	parodi	X
dpc-5027	324	10	a	a	PRON
dpc-5027	324	11	,	,	PUNCT
dpc-5027	324	12	cozzani	cozzani	PROPN
dpc-5027	324	13	e.	e.	PROPN
dpc-5027	324	14	detection	detection	PROPN
dpc-5027	324	15	of	of	ADP
dpc-5027	324	16	demodex	demodex	NOUN
dpc-5027	324	17	mites	mite	NOUN
dpc-5027	324	18	in	in	ADP
dpc-5027	324	19	papulopustular	papulopustular	ADJ
dpc-5027	324	20	rosacea	rosacea	NOUN
dpc-5027	324	21	using	use	VERB
dpc-5027	324	22	microscopic	microscopic	ADJ
dpc-5027	324	23	examination	examination	NOUN
dpc-5027	324	24	and	and	CCONJ
dpc-5027	324	25	polymerase	polymerase	NOUN
dpc-5027	324	26	chain	chain	NOUN
dpc-5027	324	27	reaction	reaction	NOUN
dpc-5027	324	28	:	:	PUNCT
dpc-5027	324	29	a	a	DET
dpc-5027	324	30	comparative	comparative	ADJ
dpc-5027	324	31	case	case	NOUN
dpc-5027	324	32	-	-	PUNCT
dpc-5027	324	33	control	control	NOUN
dpc-5027	324	34	study	study	NOUN
dpc-5027	324	35	.	.	PUNCT
dpc-5027	325	1	arch	arch	ADJ
dpc-5027	325	2	dermatol	dermatol	NOUN
dpc-5027	325	3	res	re	NOUN
dpc-5027	325	4	.	.	PUNCT
dpc-5027	326	1	2024;316(7):485	2024;316(7):485	X
dpc-5027	326	2	.	.	PUNCT
dpc-5027	326	3	doi	doi	NOUN
dpc-5027	326	4	:	:	PUNCT
dpc-5027	326	5	10.1007	10.1007	NUM
dpc-5027	326	6	/s00403	/s00403	NOUN
dpc-5027	326	7	-	-	PUNCT
dpc-5027	326	8	024	024	NUM
dpc-5027	326	9	-	-	PUNCT
dpc-5027	326	10	03228	03228	NUM
dpc-5027	326	11	-	-	SYM
dpc-5027	326	12	1	1	NUM
dpc-5027	326	13	.	.	PUNCT
dpc-5027	327	1	pmid	pmid	NOUN
dpc-5027	327	2	:	:	PUNCT
dpc-5027	327	3	39042262	39042262	NUM
dpc-5027	327	4	.	.	PUNCT
dpc-5027	328	1	30	30	NUM
dpc-5027	328	2	.	.	PUNCT
dpc-5027	329	1	zhu	zhu	PROPN
dpc-5027	329	2	w	w	PROPN
dpc-5027	329	3	,	,	PUNCT
dpc-5027	329	4	hamblin	hamblin	PROPN
dpc-5027	329	5	mr	mr	PROPN
dpc-5027	329	6	,	,	PUNCT
dpc-5027	329	7	wen	wen	PROPN
dpc-5027	329	8	x.	x.	PROPN
dpc-5027	329	9	role	role	NOUN
dpc-5027	329	10	of	of	ADP
dpc-5027	329	11	the	the	DET
dpc-5027	329	12	skin	skin	NOUN
dpc-5027	329	13	microbiota	microbiota	NOUN
dpc-5027	329	14	and	and	CCONJ
dpc-5027	329	15	intestinal	intestinal	ADJ
dpc-5027	329	16	microbiome	microbiome	NOUN
dpc-5027	329	17	in	in	ADP
dpc-5027	329	18	rosacea	rosacea	NOUN
dpc-5027	329	19	.	.	PUNCT
dpc-5027	330	1	front	front	PROPN
dpc-5027	330	2	microbiol	microbiol	PROPN
dpc-5027	330	3	.	.	PUNCT
dpc-5027	331	1	2023;14:1108661	2023;14:1108661	NUM
dpc-5027	331	2	.	.	PUNCT
dpc-5027	331	3	doi	doi	NOUN
dpc-5027	331	4	:	:	PUNCT
dpc-5027	331	5	10.3389	10.3389	NUM
dpc-5027	331	6	/	/	SYM
dpc-5027	331	7	fmicb.2023.1108661	fmicb.2023.1108661	PROPN
dpc-5027	331	8	.	.	PUNCT
dpc-5027	332	1	pmid	pmid	NOUN
dpc-5027	332	2	:	:	PUNCT
dpc-5027	332	3	36846769	36846769	NUM
dpc-5027	332	4	.	.	PUNCT
dpc-5027	333	1	17	17	NUM
dpc-5027	333	2	.	.	PUNCT
dpc-5027	334	1	kang	kang	PROPN
dpc-5027	334	2	cn	cn	PROPN
dpc-5027	334	3	,	,	PUNCT
dpc-5027	334	4	shah	shah	PROPN
dpc-5027	334	5	m	m	PROPN
dpc-5027	334	6	,	,	PUNCT
dpc-5027	334	7	tan	tan	PROPN
dpc-5027	334	8	j.	j.	PROPN
dpc-5027	334	9	rosacea	rosacea	PROPN
dpc-5027	334	10	:	:	PUNCT
dpc-5027	334	11	an	an	DET
dpc-5027	334	12	update	update	NOUN
dpc-5027	334	13	in	in	ADP
dpc-5027	334	14	diagnosis	diagnosis	NOUN
dpc-5027	334	15	,	,	PUNCT
dpc-5027	334	16	classification	classification	NOUN
dpc-5027	334	17	and	and	CCONJ
dpc-5027	334	18	management	management	NOUN
dpc-5027	334	19	.	.	PUNCT
dpc-5027	335	1	skin	skin	NOUN
dpc-5027	335	2	therapy	therapy	NOUN
dpc-5027	335	3	lett	lett	PROPN
dpc-5027	335	4	.	.	PUNCT
dpc-5027	336	1	2021;26	2021;26	NUM
dpc-5027	336	2	(	(	PUNCT
dpc-5027	336	3	4):1	4):1	NOUN
dpc-5027	336	4	-	-	SYM
dpc-5027	336	5	8	8	NUM
dpc-5027	336	6	.	.	PUNCT
dpc-5027	337	1	pmid	pmid	NOUN
dpc-5027	337	2	:	:	PUNCT
dpc-5027	337	3	34347259	34347259	NUM
dpc-5027	337	4	.	.	PUNCT
dpc-5027	338	1	18	18	NUM
dpc-5027	338	2	.	.	PUNCT
dpc-5027	339	1	chen	chen	PROPN
dpc-5027	339	2	yj	yj	PROPN
dpc-5027	339	3	,	,	PUNCT
dpc-5027	339	4	lee	lee	PROPN
dpc-5027	339	5	wh	wh	PROPN
dpc-5027	339	6	,	,	PUNCT
dpc-5027	339	7	ho	ho	PROPN
dpc-5027	339	8	hj	hj	PROPN
dpc-5027	339	9	,	,	PUNCT
dpc-5027	339	10	tseng	tseng	PROPN
dpc-5027	339	11	ch	ch	PROPN
dpc-5027	339	12	,	,	PUNCT
dpc-5027	339	13	wu	wu	PROPN
dpc-5027	339	14	cy	cy	PROPN
dpc-5027	339	15	.	.	PROPN
dpc-5027	340	1	an	an	DET
dpc-5027	340	2	altered	alter	VERB
dpc-5027	340	3	fecal	fecal	ADJ
dpc-5027	340	4	microbial	microbial	ADJ
dpc-5027	340	5	profiling	profiling	NOUN
dpc-5027	340	6	in	in	ADP
dpc-5027	340	7	rosacea	rosacea	NOUN
dpc-5027	340	8	patients	patient	NOUN
dpc-5027	340	9	compared	compare	VERB
dpc-5027	340	10	to	to	ADP
dpc-5027	340	11	matched	match	VERB
dpc-5027	340	12	controls	control	NOUN
dpc-5027	340	13	.	.	PUNCT
dpc-5027	341	1	j	j	PROPN
dpc-5027	341	2	formos	formos	PROPN
dpc-5027	341	3	med	med	PROPN
dpc-5027	341	4	assoc	assoc	PROPN
dpc-5027	341	5	.	.	PUNCT
dpc-5027	341	6	2021	2021	NUM
dpc-5027	341	7	;	;	PUNCT
dpc-5027	341	8	120(1	120(1	NUM
dpc-5027	341	9	pt	pt	NOUN
dpc-5027	341	10	1):256	1):256	NUM
dpc-5027	341	11	-	-	PUNCT
dpc-5027	341	12	264	264	NUM
dpc-5027	341	13	.	.	PUNCT
dpc-5027	342	1	doi	doi	NOUN
dpc-5027	342	2	:	:	PUNCT
dpc-5027	342	3	10.1016	10.1016	NUM
dpc-5027	342	4	/	/	SYM
dpc-5027	342	5	j.jfma.2020.04.034	j.jfma.2020.04.034	PROPN
dpc-5027	342	6	.	.	PUNCT
dpc-5027	343	1	pmid	pmid	NOUN
dpc-5027	343	2	:	:	PUNCT
dpc-5027	343	3	32446756	32446756	NUM
dpc-5027	343	4	.	.	PUNCT
dpc-5027	344	1	19	19	NUM
dpc-5027	344	2	.	.	PUNCT
dpc-5027	344	3	nam	nam	PROPN
dpc-5027	344	4	jh	jh	PROPN
dpc-5027	344	5	,	,	PUNCT
dpc-5027	344	6	yun	yun	PROPN
dpc-5027	344	7	y	y	PROPN
dpc-5027	344	8	,	,	PUNCT
dpc-5027	344	9	kim	kim	PROPN
dpc-5027	344	10	hs	hs	PROPN
dpc-5027	344	11	,	,	PUNCT
dpc-5027	344	12	et	et	PROPN
dpc-5027	344	13	al	al	PROPN
dpc-5027	344	14	.	.	PROPN
dpc-5027	344	15	rosacea	rosacea	PROPN
dpc-5027	344	16	and	and	CCONJ
dpc-5027	344	17	its	its	PRON
dpc-5027	344	18	association	association	NOUN
dpc-5027	344	19	with	with	ADP
dpc-5027	344	20	enteral	enteral	ADJ
dpc-5027	344	21	microbiota	microbiota	NOUN
dpc-5027	344	22	in	in	ADP
dpc-5027	344	23	korean	korean	ADJ
dpc-5027	344	24	females	female	NOUN
dpc-5027	344	25	.	.	PUNCT
dpc-5027	345	1	exp	exp	NOUN
dpc-5027	345	2	dermatol	dermatol	NOUN
dpc-5027	345	3	.	.	PUNCT
dpc-5027	346	1	2018;27(1):37	2018;27(1):37	NUM
dpc-5027	346	2	-	-	SYM
dpc-5027	346	3	42	42	NUM
dpc-5027	346	4	.	.	PUNCT
dpc-5027	346	5	doi	doi	NOUN
dpc-5027	346	6	:	:	PUNCT
dpc-5027	346	7	10.1111	10.1111	NUM
dpc-5027	346	8	/	/	SYM
dpc-5027	346	9	exd.13398	exd.13398	NOUN
dpc-5027	346	10	.	.	PUNCT
dpc-5027	347	1	pmid	pmid	NOUN
dpc-5027	347	2	:	:	PUNCT
dpc-5027	347	3	28636759	28636759	NUM
dpc-5027	347	4	.	.	PUNCT
dpc-5027	348	1	20	20	NUM
dpc-5027	348	2	.	.	PUNCT
dpc-5027	349	1	o’neill	o’neill	INTJ
dpc-5027	349	2	ca	ca	PROPN
dpc-5027	349	3	,	,	PUNCT
dpc-5027	349	4	monteleone	monteleone	PROPN
dpc-5027	349	5	g	g	PROPN
dpc-5027	349	6	,	,	PUNCT
dpc-5027	349	7	mclaughlin	mclaughlin	PROPN
dpc-5027	349	8	jt	jt	PROPN
dpc-5027	349	9	,	,	PUNCT
dpc-5027	349	10	paus	paus	PROPN
dpc-5027	349	11	r.	r.	PROPN
dpc-5027	349	12	the	the	DET
dpc-5027	349	13	gutskin	gutskin	NOUN
dpc-5027	349	14	axis	axis	VERB
dpc-5027	349	15	in	in	ADP
dpc-5027	349	16	health	health	NOUN
dpc-5027	349	17	and	and	CCONJ
dpc-5027	349	18	disease	disease	PROPN
dpc-5027	349	19	:	:	PUNCT
dpc-5027	349	20	a	a	DET
dpc-5027	349	21	paradigm	paradigm	NOUN
dpc-5027	349	22	with	with	ADP
dpc-5027	349	23	therapeutic	therapeutic	ADJ
dpc-5027	349	24	implications	implication	NOUN
dpc-5027	349	25	.	.	PUNCT
dpc-5027	350	1	bioessays	bioessay	NOUN
dpc-5027	350	2	.	.	PUNCT
dpc-5027	351	1	2016	2016	NUM
dpc-5027	351	2	;	;	PUNCT
dpc-5027	351	3	38(11):1167	38(11):1167	NUM
dpc-5027	351	4	-	-	SYM
dpc-5027	351	5	1176	1176	NUM
dpc-5027	351	6	.	.	PUNCT
dpc-5027	352	1	doi	doi	NOUN
dpc-5027	352	2	:	:	PUNCT
dpc-5027	352	3	10.1002	10.1002	NUM
dpc-5027	352	4	/bies.201600008	/bies.201600008	NOUN
dpc-5027	352	5	.	.	PUNCT
dpc-5027	353	1	pmid	pmid	NOUN
dpc-5027	353	2	:	:	PUNCT
dpc-5027	353	3	27554239	27554239	NUM
dpc-5027	353	4	.	.	PUNCT
dpc-5027	354	1	21	21	NUM
dpc-5027	354	2	.	.	X
dpc-5027	354	3	21	21	NUM
dpc-5027	354	4	searle	searle	PROPN
dpc-5027	354	5	t	t	PROPN
dpc-5027	354	6	,	,	PUNCT
dpc-5027	354	7	ali	ali	PROPN
dpc-5027	354	8	fr	fr	PROPN
dpc-5027	354	9	,	,	PUNCT
dpc-5027	354	10	carolides	carolide	VERB
dpc-5027	354	11	s	s	PART
dpc-5027	354	12	,	,	PUNCT
dpc-5027	354	13	al	al	PROPN
dpc-5027	354	14	-	-	PUNCT
dpc-5027	354	15	niaimi	niaimi	PROPN
dpc-5027	354	16	f.	f.	PROPN
dpc-5027	354	17	rosacea	rosacea	PROPN
dpc-5027	354	18	and	and	CCONJ
dpc-5027	354	19	the	the	DET
dpc-5027	354	20	gastrointestinal	gastrointestinal	ADJ
dpc-5027	354	21	system	system	NOUN
dpc-5027	354	22	.	.	PUNCT
dpc-5027	355	1	australas	australas	PROPN
dpc-5027	355	2	j	j	PROPN
dpc-5027	355	3	dermatol	dermatol	NOUN
dpc-5027	355	4	.	.	PUNCT
dpc-5027	356	1	2020	2020	NUM
dpc-5027	356	2	;	;	PUNCT
dpc-5027	356	3	61(4	61(4	NUM
dpc-5027	356	4	):	):	PUNCT
dpc-5027	356	5	307	307	NUM
dpc-5027	356	6	-	-	SYM
dpc-5027	356	7	311	311	NUM
dpc-5027	356	8	.	.	PUNCT
dpc-5027	357	1	doi	doi	NOUN
dpc-5027	357	2	:	:	PUNCT
dpc-5027	357	3	10.1111	10.1111	NUM
dpc-5027	357	4	/	/	SYM
dpc-5027	357	5	ajd.13401.pmid	ajd.13401.pmid	NOUN
dpc-5027	357	6	:	:	PUNCT
dpc-5027	357	7	32761824	32761824	NUM
dpc-5027	357	8	.	.	PUNCT
dpc-5027	358	1	22	22	NUM
dpc-5027	358	2	.	.	PUNCT
dpc-5027	358	3	koçak	koçak	PROPN
dpc-5027	358	4	m	m	PROPN
dpc-5027	358	5	,	,	PUNCT
dpc-5027	358	6	yağli	yağli	PROPN
dpc-5027	358	7	s	s	PROPN
dpc-5027	358	8	,	,	PUNCT
dpc-5027	358	9	vahapoğlu	vahapoğlu	VERB
dpc-5027	358	10	g	g	NOUN
dpc-5027	358	11	,	,	PUNCT
dpc-5027	358	12	ekşioğlu	ekşioğlu	PROPN
dpc-5027	358	13	m.	m.	NOUN
dpc-5027	358	14	permethrin	permethrin	NOUN
dpc-5027	358	15	5	5	NUM
dpc-5027	358	16	%	%	NOUN
dpc-5027	358	17	cream	cream	NOUN
dpc-5027	358	18	versus	versus	ADP
dpc-5027	358	19	metronidazole	metronidazole	NOUN
dpc-5027	358	20	0.75	0.75	NUM
dpc-5027	358	21	%	%	NOUN
dpc-5027	358	22	gel	gel	NOUN
dpc-5027	358	23	for	for	ADP
dpc-5027	358	24	the	the	DET
dpc-5027	358	25	treatment	treatment	NOUN
dpc-5027	358	26	of	of	ADP
dpc-5027	358	27	papulopustular	papulopustular	ADJ
dpc-5027	358	28	rosacea	rosacea	NOUN
dpc-5027	358	29	.	.	PUNCT
dpc-5027	359	1	a	a	DET
dpc-5027	359	2	randomized	randomized	ADJ
dpc-5027	359	3	double	double	ADJ
dpc-5027	359	4	-	-	PUNCT
dpc-5027	359	5	blind	blind	ADJ
dpc-5027	359	6	placebo	placebo	NOUN
dpc-5027	359	7	-	-	PUNCT
dpc-5027	359	8	controlled	control	VERB
dpc-5027	359	9	study	study	NOUN
dpc-5027	359	10	.	.	PUNCT
dpc-5027	360	1	dermatology	dermatology	NOUN
dpc-5027	360	2	.	.	PUNCT
dpc-5027	361	1	2002	2002	NUM
dpc-5027	361	2	;	;	PUNCT
dpc-5027	361	3	205(3):265	205(3):265	NUM
dpc-5027	361	4	-	-	SYM
dpc-5027	361	5	70	70	NUM
dpc-5027	361	6	.	.	PUNCT
dpc-5027	362	1	doi	doi	NOUN
dpc-5027	362	2	:	:	PUNCT
dpc-5027	362	3	10.1159/0000	10.1159/0000	NUM
dpc-5027	362	4	65849	65849	NUM
dpc-5027	362	5	.	.	PUNCT
dpc-5027	363	1	pmid	pmid	NOUN
dpc-5027	363	2	:	:	PUNCT
dpc-5027	363	3	12399675	12399675	NUM
dpc-5027	363	4	.	.	PUNCT
dpc-5027	364	1	23	23	NUM
dpc-5027	364	2	.	.	PUNCT
dpc-5027	365	1	han	han	PROPN
dpc-5027	365	2	j	j	PROPN
dpc-5027	365	3	,	,	PUNCT
dpc-5027	365	4	liu	liu	PROPN
dpc-5027	365	5	t	t	PROPN
dpc-5027	365	6	,	,	PUNCT
dpc-5027	365	7	zhang	zhang	PROPN
dpc-5027	365	8	m	m	PROPN
dpc-5027	365	9	,	,	PUNCT
dpc-5027	365	10	wang	wang	PROPN
dpc-5027	365	11	a.	a.	PROPN
dpc-5027	365	12	the	the	DET
dpc-5027	365	13	relationship	relationship	NOUN
dpc-5027	365	14	between	between	ADP
dpc-5027	365	15	inflammatory	inflammatory	ADJ
dpc-5027	365	16	bowel	bowel	NOUN
dpc-5027	365	17	disease	disease	NOUN
dpc-5027	365	18	and	and	CCONJ
dpc-5027	365	19	rosacea	rosacea	NOUN
dpc-5027	365	20	over	over	ADP
dpc-5027	365	21	the	the	DET
dpc-5027	365	22	lifespan	lifespan	NOUN
dpc-5027	365	23	:	:	PUNCT
dpc-5027	365	24	a	a	DET
dpc-5027	365	25	meta	meta	ADJ
dpc-5027	365	26	-	-	PUNCT
dpc-5027	365	27	analysis	analysis	NOUN
dpc-5027	365	28	.	.	PUNCT
dpc-5027	366	1	clin	clin	PROPN
dpc-5027	366	2	res	re	VERB
dpc-5027	366	3	hepatol	hepatol	ADJ
dpc-5027	366	4	gastroenterol	gastroenterol	NOUN
dpc-5027	366	5	.	.	PUNCT
dpc-5027	367	1	2019	2019	NUM
dpc-5027	367	2	;	;	PUNCT
dpc-5027	368	1	43(4	43(4	NOUN
dpc-5027	368	2	):	):	PUNCT
dpc-5027	368	3	497	497	NUM
dpc-5027	368	4	-	-	SYM
dpc-5027	368	5	502	502	NUM
dpc-5027	368	6	.	.	PUNCT
dpc-5027	369	1	doi	doi	NOUN
dpc-5027	369	2	:	:	PUNCT
dpc-5027	369	3	10.1016	10.1016	NUM
dpc-5027	369	4	/	/	SYM
dpc-5027	369	5	j.clinre.2018.09.009	j.clinre.2018.09.009	PROPN
dpc-5027	369	6	.	.	PUNCT
dpc-5027	370	1	pmid	pmid	NOUN
dpc-5027	370	2	:	:	PUNCT
dpc-5027	370	3	30389397	30389397	NUM
dpc-5027	370	4	.	.	PUNCT